Every constituent, scored 0–10 on Downside Risk (lower = safer), Growth Quality, and Exponential Potential, with price, YTD, a base-case fair value (and its bear–bull range), and a one-line take. Click a ticker for the full interactive report. ← research hub
◆ Accumulation band for SPY itself: roughly $737–$745 — the index is richly priced, so dollar-cost-averaging on dips toward the 50/200-day average (near $692) beats chasing new highs.
SPY (market-cap-weighted) vs RSP (equal-weight), both rebased to 100 a year ago. When the cap-weighted line pulls ahead, the biggest names are carrying the index. Past year: SPY +20% vs RSP +17% — a +3 pt spread, so a few mega-caps are carrying the index — concentration is ELEVATED.
How many of the 87 names are actually participating — a check on whether the index is broad-based or driven by a handful of mega-caps. Right now breadth looks mixed.
| Name | Verdict | Risk | Growth | Exp | Price | YTD | Fair value (range) | Entry zone | One-line take |
|---|---|---|---|---|---|---|---|---|---|
| MA Mastercard Incorporated | Buy — Core | 4 | 9 | 4 | — | -5.5% | $610 ($430–$760) | — | Mastercard is a rational-duopoly toll bridge on global digital payments — FY25 revenue $32.8B (+16%), 83% gross margin, 59% operating margin, net income $15.0B, and a value-added-services leg growing 22% — owned as a core quality-compounder at a full-but-not-absurd 27× forward, with the whole call… |
| ADSK Autodesk, Inc. | Buy — Core | 4 | 8 | 4 | $207 | -29.9% | $300 ($215–$390) | $187–$207 | Autodesk is a genuinely elite software franchise — 91% gross margin, ~$2.4B free cash flow, near-monopoly grip on the world's CAD/design files — trading at ~16.5× forward non-GAAP earnings after a 33% drawdown, so the question is not quality but whether a messy sales restructuring and the… |
| MSFT Microsoft Corporation | Buy — Core | 4 | 8 | 4 | $390 | -19.3% | $545 ($340–$730) | $351–$390 | Microsoft is the rare megacap where the fundamentals (FY25 revenue +14.9% to $282B, 68% gross margin, $102B net income, 33% ROE) and a high-skill expert panel (Azure as one of the few at-scale AI clouds; a $1.3T contracted backlog) point the same way — and after a 28% drawdown the stock now trades… |
| V Visa Inc. | Buy — Core | 4 | 8 | 4 | — | +3.3% | $400 ($300–$470) | — | Visa is the closest thing public markets have to a toll booth on global commerce — 81% gross margin, 52% net margin, 59% ROE, net-debt/EBITDA 0.4× — and the expert panel and the quant screen agree it is a top-tier quality compounder; the only real debate is price (31× trailing, RSI 86) and the… |
| VEEV Veeva Systems Inc. | Buy — Core | 4 | 8 | 4 | — | -13.7% | $235 ($150–$300) | — | Veeva is the near-monopoly cloud platform for the life-sciences industry — 75% gross margin, net-cash balance sheet, ~$3.2B revenue growing 16% — that the market has taken from a ~$310 peak down to $193 (a −43% drawdown) as growth cooled from hypergrowth to the mid-teens; at ~21× forward non-GAAP… |
| CBOE Cboe Global Markets, Inc. | Buy — Core | 3 | 7 | 4 | — | -0.8% | $287 ($192–$384) | — | CBOE is a genuinely wide-moat, net-cash, ~25%-ROE derivatives-exchange monopolist (proprietary SPX and VIX options) that just posted a record quarter (net revenue +29%, EPS +54%) and *raised* guidance — yet the stock is down 32% from its high on fears that perpetual futures and tokenization will… |
| CME CME Group Inc. | Buy — Core | 3 | 7 | 2 | — | -13.4% | $309 ($215–$384) | — | CME is the toll-booth on global derivatives — an 88%-EBITDA-margin, net-cash monopoly with vertically integrated clearing — that the market has marked down 28% on rate-cut and crypto-displacement fears; at 20× trailing and a 4.8% dividend the risk/reward has flipped attractive for a Tactical buy… |
| CPRT Copart, Inc. | Buy — Core | 3 | 7 | 3 | $30 | -23.3% | $41 ($27–$52) | $27–$30 | Copart is a genuinely elite, net-cash, 33%-net-margin duopolist in online salvage auctions whose stock has been cut nearly in half (−40% over 12 months) as top-line growth collapsed from double digits to roughly flat — the de-rating has finally made a wonderful business reasonably priced, so this… |
| BLK BlackRock, Inc. | Buy — Core | 4 | 7 | 4 | — | -7.0% | $1175 ($850–$1450) | — | The world's largest asset manager ($13.9T AUM) is quietly re-shaping itself into a private-markets and technology firm via the GIP and HPS acquisitions — trading at a below-market ~18× forward earnings after a 17% pullback, which makes it a reasonable *tactical* buy for patient capital, tempered by… |
| DECK Deckers Outdoor Corporation | Buy — Core | 4 | 7 | 3 | — | +1.0% | $125 ($82–$171) | — | Deckers is a genuinely excellent, net-cash, high-return footwear house (UGG + HOKA) trading at a reasonable ~15× earnings — but growth has decelerated hard (revenue +9.8%, EPS +11% in FY26 vs +16%/+30% the year before), the stock has gone nowhere for a year, and with zero expert coverage and a… |
| SCHW The Charles Schwab Corporation | Buy — Core | 4 | 7 | 4 | — | -2.9% | $112 ($78–$140) | — | Schwab is the dominant US retail brokerage/custody platform whose earnings are visibly re-inflating (Q1'26 adjusted EPS $1.43, +38% YoY; net revenue record $6.5B, +16%) as the 2023 rate shock rolls off and the net interest margin re-expands — a good-quality, net-cash compounder trading at a… |
| SPGI S&P Global Inc. | Buy — Core | 4 | 7 | 3 | — | -15.8% | $545 ($360–$630) | — | SPGI is one of the best businesses in the S&P 500 — a toll-booth oligopoly (Ratings + Indices) throwing off 70% gross and 44% EBIT margins with ~$5.5B of free cash flow — that has quietly de-rated ~22% off its high as debt-issuance and FX tailwinds cooled; at ~23× forward adjusted EPS with a… |
| VRSK Verisk Analytics, Inc. | Buy — Core | 4 | 7 | 3 | — | -15.8% | $208 ($144–$248) | — | Verisk is a genuinely elite, wide-moat data monopoly on U.S. property-and-casualty insurance (67% gross margin, 54% EBITDA margin, ~29% return on invested capital) — but it grows revenue only ~6.5% a year, the stock still trades at ~28× trailing earnings after a brutal 40% drawdown, and there is no… |
| NVDA NVIDIA Corporation | Buy — Tactical | 6 | 10 | 8 | $195 | +4.5% | $245 ($110–$360) | $191–$195 | The most important company of the AI buildout is also, unusually, *not* priced like a bubble — FY26 revenue grew 65% to $216B, net margin is 63%, the balance sheet is net-cash, and the stock trades at ~30× trailing / ~22× forward earnings; we own it as a core position, with the whole call resting… |
| GOOGL Alphabet Inc. | Buy — Tactical | 4 | 9 | 6 | $360 | +15.0% | $445 ($250–$600) | $316–$360 | Alphabet is the unusual megacap where the fundamentals (FY25 revenue +15% to $403B, 60% gross margin, $132B net income, 39% ROE) *and* a broad AI-literate expert panel point the same way, *and* the stock trades at only ~27× trailing / ~25× forward — cheaper than the S&P on a growth-adjusted (PEG… |
| LLY Eli Lilly and Company | Buy — Tactical | 5 | 9 | 5 | — | +12.6% | $1430 ($800–$1880) | — | The rare megacap where the fundamentals (FY25 revenue +45% to $65B, 84% gross margin, net income $20.6B) and an unusually broad, high-quality expert panel point the same way — owned as a core compounder, not a bargain, with the whole call resting on the next-gen pipeline replacing tirzepatide… |
| ANET Arista Networks, Inc. | Buy — Tactical | 6 | 9 | 6 | — | +22.1% | $178 ($100–$240) | — | Arista is the highest-quality pure-play on AI/cloud back-end Ethernet networking — FY25 revenue +28.6% to $9.0B, 63% gross margin, 38% net margin, 31% ROE, and *zero debt with ~$10.7B net cash* — but you pay 54× trailing for it, the AI-capex cycle it rides is inherently cyclical, and a few… |
| AMZN Amazon.com, Inc. | Buy — Tactical | 4 | 8 | 6 | $243 | +5.1% | $300 ($175–$375) | $233–$243 | Amazon is three high-quality compounders — AWS ($129B, the profit engine), Advertising ($69B and highest-margin), and a third-party-marketplace-plus-Prime retail flywheel — stapled inside a "Specialty Retail" label; FY25 revenue grew 12% to $717B and net income grew 31% to $78B, yet free cash flow… |
| GOOG Alphabet Inc. | Buy — Tactical | 4 | 8 | 4 | $356 | +13.5% | $400 ($265–$490) | $316–$356 | Alphabet is a cash machine (FY25 revenue $403B +15%, net income $132B, 60% gross margin, $164.7B operating cash flow) whose Search franchise funds two credible next legs — Google Cloud (+36%) and the Gemini AI stack — and whose stock trades at a defensible ~25× forward earnings; we own it as a core… |
| MSCI MSCI Inc. | Buy — Tactical | 6 | 8 | 4 | — | +5.1% | $680 ($460–$835) | — | MSCI is a toll-road on global investing — an 82%-gross-margin index-and-analytics franchise with 95% retention and pricing power — but at 34× trailing earnings with growth easing into the high-single digits and the Street's own targets sitting essentially *at* today's price, there is no margin of… |
| VRTX Vertex Pharmaceuticals Incorpora | Buy — Tactical | 4 | 7 | 5 | $528 | +16.5% | $585 ($395–$725) | $447–$528 | Vertex is the most profitable pure biotech at scale — an 86%-gross-margin, net-cash monopoly in cystic fibrosis throwing off ~$3.2B of free cash flow — now trying to prove it can diversify beyond CF (Journavx non-opioid pain, Casgevy gene therapy, kidney and type-1-diabetes programs). It is a… |
| CPAY Corpay, Inc. | Buy — Tactical | 5 | 7 | 4 | — | +17.1% | $415 ($270–$500) | — | Corpay is a boring-in-a-good-way B2B payments compounder — 25% headline / 11% organic revenue growth, 73% gross margins, 31% ROE — trading at only ~13× forward adjusted earnings, so the math works if management simply keeps executing; the catch is there is zero expert coverage to corroborate the… |
| TPR Tapestry, Inc. | Buy — Tactical | 5 | 7 | 4 | — | +12.9% | $165 ($110–$205) | — | Tapestry has quietly become one of retail's best turnarounds — Coach is re-accelerating (+31% brand revenue in Q3 FY26), margins are expanding, free cash flow is ~$1.1B, and management just raised guidance again — yet the stock trades at only ~20× forward EPS. The catch: it's a cyclical, beta-1.45… |
| DELL Dell Technologies Inc. | Buy — Tactical | 6 | 7 | 6 | — | +213.2% | $440 ($235–$585) | — | Dell has turned into a genuine AI-infrastructure earnings story — Q1 FY27 revenue +88% to $43.8B, $24.4B of AI orders booked, management raising the full-year revenue outlook to $167B (+47%) and AI-server revenue to ~$60B — but it is still a low-margin (19% gross), cyclical, high-beta hardware… |
| HPE Hewlett Packard Enterprise Compa | Buy — Tactical | 6 | 7 | 6 | — | +71.6% | $52 ($32–$65) | — | HPE just closed the ~$14B Juniper Networks deal and posted a record Q2 FY26 (revenue +40% to $10.7B, Networking +148%, non-GAAP EPS $0.79 vs a $0.51–0.55 guide), pulling it "two years ahead" of its own FY28 plan — yet the stock trades at only ~12× forward non-GAAP EPS because the market doubts the… |
| XYZ Block, Inc. | Buy — Tactical | 6 | 7 | 6 | — | +21.1% | $91 ($50–$124) | — | Block is a two-sided fintech (Cash App + Square) whose *reported* revenue is flat and Bitcoin-inflated, but whose gross profit grew ~17% to $10.4B with margins and free cash flow inflecting — and it trades at just 15× FY27E earnings with a net-cash balance sheet, so the risk/reward is favorable… |
| ADP Automatic Data Processing, Inc. | Buy — Tactical | 3 | 6 | 2 | $242 | -5.8% | $268 ($209–$315) | $240–$242 | ADP is one of the highest-quality businesses in the S&P 500 — 25% ROIC, 69% ROE, a fortress balance sheet, ~30% adjusted EBIT margins and ~1.1M sticky clients — but it grows revenue only ~6% and EPS ~10%, so at 22× earnings you are paying a premium multiple for a slow, mature compounder that has… |
| A Agilent Technologies, Inc. | Buy — Tactical | 4 | 6 | 3 | — | -4.0% | $145 ($112–$172) | — | Agilent is a genuinely high-quality, recurring-revenue lab-instruments compounder — 53% gross margin, 21% ROE, strong free cash flow, low leverage — but it is growing revenue only mid-single-digits, the multiple already reflects the quality, and there is no expert conviction behind it, so it… |
| AMP Ameriprise Financial, Inc. | Buy — Tactical | 4 | 6 | 3 | — | -0.2% | $600 ($430–$780) | — | Ameriprise is a high-quality, US-centric wealth-and-asset manager throwing off a 54% return on equity and buying back ~5% of its stock a year, trading at a genuinely cheap ~12× trailing / ~10× FY27E earnings — but with no expert panel behind it and earnings structurally tied to equity markets and… |
| MSI Motorola Solutions, Inc. | Buy — Tactical | 5 | 6 | 3 | — | +10.3% | $475 ($345–$580) | — | Motorola Solutions owns a genuinely elite, near-monopoly franchise (roughly 80% of US land-mobile-radio, a sticky razor/razor-blade model selling networks then high-margin radios and software to governments) — but it grows only mid-single-digits, the stock has been dead money for a year (−0.7% vs… |
| RCL Royal Caribbean Cruises Ltd. | Buy — Tactical | 6 | 6 | 3 | — | +6.2% | $335 ($205–$430) | — | RCL is the best-run operator in a recovered cruise duopoly — record WAVE-season demand, 109% load factors, rising net yields, EBITDA margin near 39%, ROE 46%, and a de-levering balance sheet — trading at a genuinely modest ~18× trailing / ~15× FY27E with a PEG near 0.5. The catch is what it *is*: a… |
| ZBRA Zebra Technologies Corporation | Buy — Tactical | 6 | 6 | 4 | — | +10.0% | $309 ($226–$370) | — | ZBRA is a high-quality, market-leading enterprise-hardware franchise (barcode scanners, rugged mobile computers, RFID, industrial printers) trading at a genuinely undemanding ~13–14× forward non-GAAP earnings after a deep cyclical drawdown — but it is a *cyclical* with only ~4% organic growth… |
| AIG American International Group, In | Buy — Tactical | 3 | 5 | 2 | — | -7.2% | $88 ($63–$108) | — | AIG has finished its decade-long shrink-and-simplify into a leaner, US-anchored property-casualty underwriter that is finally posting a sub-90% combined ratio (87.3% in Q1'26) and a low-double-digit core ROE — and it trades at ~1.06× book and ~9× forward earnings, which is genuinely cheap; but this… |
| GILD Gilead Sciences, Inc. | Buy — Tactical | 3 | 5 | 3 | $131 | +6.9% | $146 ($102–$179) | $130–$131 | Gilead is a cheap, cash-gushing HIV franchise (79% gross margin, 6.3% FCF yield, 2.45% dividend, 1.0× net-debt/EBITDA) trading at ~18× earnings — a defensive income-and-value holding whose entire re-rating case rests on lenacapavir/Yeztugo extending the HIV moat past the Biktarvy cliff, with no… |
| MTB M&T Bank Corporation | Buy — Tactical | 3 | 5 | 2 | — | +18.6% | $272 ($190–$319) | — | M&T is a conservatively run, cheaply valued ($14× trailing, 1.4× book, ~2.5% yield) Northeast regional bank earning a solid ~15% ROE and buying back stock — a quality income-and-value holding, but with the shares near 52-week highs and the Street modeling roughly zero upside to consensus, the… |
| CI The Cigna Group | Buy — Tactical | 4 | 5 | 2 | — | +4.6% | $330 ($235–$400) | — | Cigna is a $275B-revenue health-services giant trading at a *single-digit* forward earnings multiple with a 0.30 beta and ~$8B of annual free cash flow — genuinely cheap and defensive — but the cheapness is the whole point: it is a low-margin, slow-growth, buyback-driven PBM/insurer facing real… |
| PFG Principal Financial Group, Inc. | Buy — Tactical | 4 | 5 | 2 | — | +25.7% | $123 ($88–$145) | — | Principal is a cheap, well-capitalized retirement/asset-management + benefits franchise ($770B AUM, $1.8T AUA) throwing off a ~2.9% dividend and buying back stock — but it grows revenue at mid-single digits, that growth is *slowing not speeding up*, it has no expert coverage to lean on, and it… |
| USB U.S. Bancorp | Buy — Tactical | 4 | 5 | 2 | — | +15.7% | $68 ($46–$82) | — | USB is a cheap (~13× earnings, ~2× tangible book), A-rated super-regional bank throwing off a 3.4% dividend and a 17% return on tangible common equity, with a genuine self-help efficiency story (efficiency ratio 58.2%, 440bps of positive operating leverage in Q1'26) — a reasonable value/income buy… |
| WFC Wells Fargo & Company | Buy — Tactical | 4 | 5 | 3 | — | -8.3% | $96 ($66–$116) | — | Wells Fargo is a cheap, de-risked megabank three years into a genuine expense-and-controls turnaround under Charles Scharf: with the Fed's asset cap now behind it, the story is buyback-driven ~12% EPS growth and a re-rating toward peers — a tactical value/self-help buy, not a durable compounder… |
| ALGN Align Technology, Inc. | Buy — Tactical | 5 | 5 | 3 | — | +18.2% | $210 ($155–$252) | — | Align is the category-defining clear-aligner and iTero-scanner franchise (68% gross margin, net-cash balance sheet, ~$490M FCF), but revenue has essentially stopped growing (FY25 +0.9%), the stock has lagged the market for a year, and at ~16× forward non-GAAP earnings it is *fairly* — not cheaply… |
| C Citigroup Inc. | Buy — Tactical | 5 | 5 | 3 | — | +19.9% | $158 ($96–$205) | — | Citi is the cheapest of the US money-center banks — trading at ~1.15× book and ~12.8× forward earnings — because it is still *mid-turnaround*: Jane Fraser's simplification is lifting return on tangible common equity from a dismal ~9% toward a 10–11% 2026 target and low-to-mid-teens beyond, and if… |
| COO The Cooper Companies, Inc. | Buy — Tactical | 5 | 5 | 3 | — | -9.5% | $95 ($70–$118) | — | Cooper is a defensive, low-beta medical-device duopolist (contact lenses + women's health) trading at a reasonable ~15–16× forward non-GAAP earnings after a rough year, but the top line only grows mid-single-digits, returns on capital are mediocre, a fresh $272M litigation charge just landed, and… |
| ELV Elevance Health Inc. | Buy — Tactical | 5 | 5 | 3 | — | +19.2% | $465 ($300–$590) | — | ELV is a cheap, low-beta health-benefits giant (~118M members, ~$199B revenue) trading at ~14× forward *adjusted* EPS because the market is (correctly) worried about a Medicaid medical-cost cycle and a live CMS billing matter — a Buy — Tactical for value/mean-reversion investors who can stomach a… |
| EXPE Expedia Group, Inc. | Buy — Tactical | 5 | 5 | 3 | — | -5.2% | $300 ($180–$385) | — | Expedia is a cheap, net-cash, cash-gushing travel platform (FY25 revenue $14.7B, FCF $3.1B, ~10% FCF yield) shrinking its share count aggressively — but it is a cyclical middleman whose entire business model faces a live, credible secular threat from AI booking agents, so we own it tactically for… |
| HBAN Huntington Bancshares Incorporat | Buy — Tactical | 5 | 5 | 3 | — | +2.9% | $20 ($13–$25) | — | Huntington is a cheap (13× earnings, ~book value), low-beta super-regional bank that just doubled its Texas/South footprint through the Veritex and Cadence acquisitions — the numbers are solid (NIM rising to 3.24%, NCOs low at 0.26%, CET1 10.2%) but the growth is bought, not organic, ROA is still… |
| QCOM QUALCOMM Incorporated | Buy — Tactical | 5 | 5 | 4 | $176 | +3.0% | $200 ($120–$265) | $168–$176 | QCOM is a high-return, cash-gushing wireless franchise trading at a genuine discount (~16× forward, 6.7% FCF yield) because the market is pricing the twin structural threats — Apple insourcing its modem and a mature smartphone TAM — against which management is racing to diversify into autos, IoT… |
| SYF Synchrony Financial | Buy — Tactical | 5 | 5 | 3 | — | -8.5% | $94 ($63–$114) | — | Synchrony is a well-run but deeply cyclical private-label credit-card lender trading at ~8× earnings and buying back a fifth of its market cap — a genuinely cheap return-of-capital story where the "growth" is share-count shrinkage, not a bigger business, and the whole call lives or dies on the US… |
| UNH UnitedHealth Group Incorporated | Buy — Tactical | 5 | 5 | 3 | — | +28.9% | $470 ($300–$610) | — | UNH is the largest US health insurer whose earnings *cratered* in 2025 (EPS $24 → $13) on runaway senior medical costs and a Medicare Advantage reset; the stock fell to $234, and the entire bull case is that management's repricing and cost actions restore earnings power — trading at ~23× a… |
| GEN Gen Digital Inc. | Buy — Tactical | 6 | 5 | 3 | — | -1.9% | $30 ($23–$40) | — | Gen Digital is the Norton/Avast/LifeLock consumer-cyber-safety cash machine — genuinely cheap (~9× forward non-GAAP earnings), a ~9.5% free-cash-flow yield, and a fat 76% gross margin — but the +27% FY26 headline was inflated by the MoneyLion acquisition, the underlying business grows… |
| GPN Global Payments Inc. | Buy — Tactical | 6 | 5 | 3 | — | +1.6% | $92 ($55–$130) | — | GPN is a cheap, cash-generative but heavily-indebted payments processor mid-way through a company-defining reshuffle — it bought Worldpay and sold Issuer Solutions in 2025 — trading at roughly 5.7× forward adjusted earnings while management guides to only ~5% organic growth; the whole call is… |
| IVZ Invesco Ltd. | Buy — Tactical | 6 | 5 | 3 | — | +2.8% | $31 ($21–$39) | — | Invesco is a genuine, quiet turnaround — 11 straight quarters of positive organic inflows, the QQQ open-end conversion lifting captured fees, a de-levering balance sheet and a raised dividend — but it is still a mature, cyclical, high-beta asset manager in a fee-compressing industry, so it earns a… |
| PCG PG&E Corporation | Buy — Tactical | 6 | 5 | 3 | — | +6.1% | $19 ($13–$24) | — | PG&E is a large California regulated electric-and-gas utility, freshly out of bankruptcy and rebuilding trust, trading at a deep utility discount (~10× forward core EPS vs a ~9% EPS growth plan) — the cheapness is *the compensation for* an unusually fat tail (wildfire liability), so it is a Watch… |
| STLD Steel Dynamics, Inc. | Buy — Tactical | 6 | 5 | 4 | — | +30.1% | $255 ($150–$330) | — | A best-in-class, low-cost US steelmaker trading at ~13–14× recovering forward earnings after a 2025 cyclical trough, with a fully-funded aluminum flat-rolled expansion as free-ish optionality — attractive as a tactical cyclical into an improving domestic steel market, but it is a commodity business… |
| UAL United Airlines Holdings, Inc. | Buy — Tactical | 6 | 5 | 4 | — | +19.2% | $148 ($82–$205) | — | United is a genuinely improving, well-run legacy airline trading at a single-digit-to-low-teens earnings multiple, with a credible self-help story (premium/loyalty mix, deleveraging toward investment grade, capacity discipline) — but it is still a capital-intensive, fuel-exposed, cyclical… |
| META Meta Platforms, Inc. | Watch | 4 | 9 | 6 | $583 | -11.7% | $700 ($430–$960) | — | A rare setup — a megacap whose fundamentals *accelerated* (FY25 revenue +22% to $201B, 82% gross margin, $60B net income) while the *stock fell 19%*, leaving it at ~18× forward earnings; the whole call is a bet that Meta's enormous AI capex converts into ad and agent revenue faster than it converts… |
| EME EMCOR Group, Inc. | Watch | 4 | 8 | 5 | — | +26.6% | $850 ($590–$1085) | — | EMCOR is a quietly elite operator — FY25 revenue $16.99B (+16.6%), 38% return on equity, a net-cash balance sheet, and a *record* $15.6B backlog (+33% YoY) riding the data-center, electrification and reshoring build-out — but after a 46% 12-month run the shares already discount much of that, growth… |
| IBKR Interactive Brokers Group, Inc. | Watch | 5 | 8 | 6 | — | +42.0% | $96 ($64–$128) | — | The lowest-cost, most-automated broker on earth is compounding accounts at +31% a year with almost no marketing spend and ~90% pretax margins — a genuine flywheel — but you are paying 39× earnings for a business where more than half of net revenue is net interest income that shrinks when the Fed… |
| INTU Intuit Inc. | Watch | 5 | 8 | 4 | $275 | -58.4% | $440 ($255–$585) | — | Intuit is a genuinely elite software franchise — 81% gross margin, 23% ROE, $6B free cash flow, growing double digits — that the market has repriced from ~$800 to $275 on the fear that AI makes tax and bookkeeping software a commodity; at ~10× forward earnings and a 10% FCF yield you are paid to… |
| PODD Insulet Corporation | Watch | 5 | 8 | 6 | — | -42.1% | $195 ($112–$252) | — | Insulet is the tubeless-insulin-pump leader still compounding revenue ~30%+ (FY25 $2.71B, +30.7%) with expanding margins and modest leverage, yet the stock has been cut in half from its 2025 peak — a rare case where a genuine ~20% grower now trades at ~20× next-year earnings; the catch is that… |
| TKO TKO Group Holdings, Inc. | Watch | 5 | 8 | 5 | — | -7.0% | $215 ($150–$265) | — | TKO owns two irreplaceable live-sports monopolies (UFC and WWE) plus IMG/On Location, throws off a ~12% free-cash-flow yield, and sits on structurally AI-proof "scarce live experience" IP — but the stock already prices ~40× forward earnings for a business that, post-WWE-merger, is a mid-teens… |
| UBER Uber Technologies, Inc. | Watch | 5 | 8 | 6 | — | -8.9% | $88 ($55–$118) | — | A genuine platform compounder now trading at its cheapest in years — FY25 revenue +18% to $52B, GAAP net income $10B, FCF $9.8B, ROE 33%, net-debt/EBITDA 1.1× — where the *entire* bull-vs-bear argument collapses into one unresolved question: does the autonomous-vehicle transition make Uber the… |
| ADBE Adobe Inc. | Watch | 4 | 7 | 3 | $220 | -37.2% | $265 ($150–$355) | — | Adobe is a genuinely elite software franchise — 89% gross margins, 96% subscription, $27B ARR, 62% ROE — trading at a beaten-down 9× forward non-GAAP earnings near a seven-year low because the market is pricing an AI-driven erosion of its moat; the debate is not about quality, it is entirely about… |
| BKNG Booking Holdings Inc. | Watch | 4 | 7 | 3 | $185 | -13.8% | $218 ($120–$285) | — | The world's dominant asset-light online-travel aggregator — 68% ROIC, ~$9B annual free cash flow, relentless buybacks — has sold off ~20% off its high on a genuine (not fabricated) fear that AI agents disintermediate it; at 17.7× forward earnings that pessimism is partly priced, so this is a Buy… |
| AJG Arthur J. Gallagher & Co. | Watch | 5 | 7 | 4 | — | -2.5% | $268 ($210–$320) | — | Gallagher is one of the best-run serial compounders in the market — 24 straight quarters of double-digit adjusted EBITDAC growth, a low-beta recurring-commission model, and a proven M&A machine — but after a massive debt-and-equity-funded AssuredPartners acquisition the balance sheet is more… |
| BSX Boston Scientific Corporation | Watch | 5 | 7 | 4 | — | -52.7% | $67 ($40–$87) | — | Boston Scientific is a genuinely good medical-device business — FY25 revenue +20% to $20.1B, 70% gross margin, adjusted EPS guided to $3.34–$3.41 for FY26 — that has been cut roughly in half over twelve months; if the fundamentals hold (Q1'26 beat and management *raised* the full-year outlook), 13×… |
| CEG Constellation Energy Corporation | Watch | 5 | 7 | 6 | $239 | -32.3% | $265 ($175–$345) | — | A best-in-class US nuclear-and-gas generation fleet (32,400 MW, now enlarged by the January-2026 Calpine acquisition) whose stock has fallen ~41% from its high even as FY26 adjusted-EPS guidance of $11.00–$12.00 was affirmed and analysts model ~16% forward EPS growth — the setup is a beaten-down… |
| CSGP CoStar Group, Inc. | Watch | 5 | 7 | 6 | — | -55.4% | $47 ($26–$62) | — | CoStar owns one of the best subscription data franchises in America (CoStar Suite: ~$1B revenue, near-monopoly commercial-real-estate data), and the market has thrown the stock out with the bathwater — down 63% in twelve months — because management deliberately torched GAAP profit to fund a… |
| EQIX Equinix, Inc. | Watch | 5 | 7 | 4 | — | +30.8% | $1100 ($835–$1295) | — | Equinix owns the world's premier neutral interconnection real estate and is riding a genuine AI-inferencing tailwind (management: ~60% of largest Q1'26 deals were AI-related), but the model runs on constant external capital — FY25 free cash flow was negative $0.4B after $4.3B capex — and at ~23.5×… |
| NDAQ Nasdaq, Inc. | Watch | 5 | 7 | 4 | — | -12.8% | $98 ($70–$120) | — | Post-Adenza, Nasdaq has quietly become a recurring-revenue financial-technology and index business bolted onto a still-cyclical exchange — Q1'26 net revenue +14%, ARR $3.2B +13%, FinTech +20% — trading at a mid-teens forward P/E after a 16% drawdown; the setup is a reasonably priced quality… |
| NFLX Netflix, Inc. | Watch | 5 | 7 | 4 | $78 | -17.2% | $100 ($59–$134) | — | Netflix has won the streaming wars — record engagement, a two-sided ad business scaling toward ~$3B in 2026, 49% gross margins and a 49% ROE — but the stock has fallen 40% in a year as revenue growth decelerates from mid-teens toward high-single-digits; the drawdown has handed patient buyers a… |
| PM Philip Morris International Inc. | Watch | 5 | 7 | 4 | — | +13.6% | $192 ($145–$221) | — | PM is executing one of the cleaner big-cap transitions in consumer staples — smoke-free (IQOS, ZYN, VEEV) is now 41% of revenue and growing double-digits, mix-accretive to margins, funded by a still-cash-gushing combustible base — but at ~22× forward EPS for ~11% EPS growth the easy money is priced… |
| ROP Roper Technologies, Inc. | Watch | 5 | 7 | 3 | $364 | -18.2% | $470 ($345–$560) | — | Roper is a high-quality vertical-market-software serial acquirer — 69% gross margins, ~$2.5B FY25 free cash flow, recurring revenue — whose stock has fallen ~36% in a year and now trades at a *reasonable* mid-teens forward multiple; the base case is a re-rating back toward fair value, but coverage… |
| SYK Stryker Corporation | Watch | 5 | 7 | 3 | — | -7.1% | $385 ($295–$455) | — | Stryker is a genuinely elite medical-device compounder — two decades of double-digit growth, a widening Mako robotics moat, 64% gross margins — but after a cyber incident dented Q1'26 (adjusted EPS −8.5%, adjusted operating margin −180bp), the stock trades at ~22× forward adjusted earnings on… |
| TYL Tyler Technologies, Inc. | Watch | 5 | 7 | 4 | — | -29.9% | $375 ($235–$480) | — | Tyler is the dominant vendor of mission-critical software to US state and local governments — recurring revenue is 88% of the total, SaaS has grown 20%+ for 21 straight quarters, the balance sheet is net-cash, and FCF is inflecting — but the stock has fallen ~49% from its high as the market… |
| ABT Abbott Laboratories | Watch | 3 | 6 | 3 | — | -23.9% | $112 ($77–$140) | — | Abbott is a defensive, diversified medtech compounder whose stock has fallen ~30% in a year to ~17× forward EPS — cheap for a business with a genuinely great growth engine (FreeStyle Libre CGM, structural heart) — but the growth is modest (~9% top line) and decelerating, and the Synthos expert… |
| ACGL Arch Capital Group Ltd. | Watch | 3 | 6 | 2 | — | +6.5% | $112 ($85–$130) | — | Arch is a genuinely excellent, disciplined P&C/reinsurance/mortgage underwriter trading at just 7.5× earnings and 1.5× book with a 20% ROE and a near-debt-free balance sheet — the problem is you're buying it at the *top* of a hard market, so consensus has FY26–28 EPS drifting *down*, not up; the… |
| MCK McKesson Corporation | Watch | 3 | 6 | 3 | — | -4.1% | $880 ($620–$1050) | — | McKesson is a boring, cash-generative pharmaceutical-distribution utility trading at ~18× forward guidance with a fortress-cheap balance sheet (0.66× net-debt/EBITDA, beta 0.32) and management guiding 13–16% long-term adjusted-EPS growth funded by scale, oncology/biopharma mix-shift and relentless… |
| ACN Accenture plc | Watch | 4 | 6 | 3 | — | -48.8% | $170 ($122–$232) | — | A best-in-class, net-cash, cash-gushing IT-services compounder that the market has re-rated from a growth premium to a ~11× value multiple on fears that generative AI hollows out its people-based model — the numbers still say "high-quality business at a cheap price," but the −55% chart and an… |
| AIZ Assurant, Inc. | Watch | 4 | 6 | 3 | — | +16.0% | $290 ($220–$355) | — | Assurant is a cheap, low-beta, well-managed specialty insurer whose Global Lifestyle engine (phone protection, extended warranties, vehicle plans) compounds steadily and whose Housing arm throws off catastrophe-lumpy but high-return cash — but after a +41% run to a fresh 52-week high with RSI at 78… |
| ALLE Allegion plc | Watch | 4 | 6 | 3 | — | -11.7% | $172 ($125–$205) | — | Allegion is the boring, high-quality locks-and-door-hardware business behind Schlage, Von Duprin and LCN — 45% gross margin, 32% ROE, steady cash — that the market has marked down 22% from its high on soft volumes and an ERP hiccup; at ~19× trailing and ~15× FY27E earnings it offers a reasonable… |
| BKR Baker Hughes Company | Watch | 4 | 6 | 4 | $53 | +15.9% | $60 ($42–$78) | — | Baker Hughes is a cheap, financially-sturdy energy-equipment cyclical that is quietly re-rating from "oilfield services" toward "energy infrastructure" — its IET segment (LNG turbomachinery, gas power-gen, data-center power, CCS) just posted a record $33.1B backlog at a 1.5× book-to-bill, but the… |
| BR Broadridge Financial Solutions, | Watch | 4 | 6 | 3 | — | -35.5% | $187 ($120–$240) | — | Broadridge is a deeply entrenched financial-market infrastructure processor (proxy/investor communications + trade processing) that just fell ~46% from its high while the business kept compounding — FY25 revenue $6.89B (+5.9%), 40% ROE, ~$1.06B free cash flow, and management raising FY26… |
| CRH CRH plc | Watch | 4 | 6 | 3 | — | -13.8% | $128 ($88–$158) | — | CRH is the leading North American building-materials platform (aggregates, cement, asphalt, paving, precast), quietly re-rated by its US listing and infrastructure-spend tailwind: FY25 revenue $37.4B (+9%), Adjusted-EBITDA margin expanding, 23% ROE and a cheap ~8× EV/EBITDA — a genuinely good… |
| DOV Dover Corporation | Watch | 4 | 6 | 3 | — | +9.5% | $235 ($175–$290) | — | Dover is a well-run, low-leverage, five-segment diversified industrial (FY25 revenue $8.09B, adjusted continuing EPS ~$8.01, book-to-bill above one in all five segments) that is quietly re-mixing toward secular-growth end markets — but at ~20× forward earnings on ~5% organic growth it is priced… |
| GRMN Garmin Ltd. | Watch | 4 | 6 | 3 | — | +18.3% | $250 ($175–$320) | — | Garmin is a genuinely excellent, debt-free, high-return niche hardware company (FY25 revenue +15% to $7.25B, 59% gross margin, 20% ROE, $2.1B net cash) — but after a spectacular 2024–25 wearables surge the growth is normalizing back to low-teens, the stock already trades at 27× trailing, and with… |
| ICE Intercontinental Exchange, Inc. | Watch | 4 | 6 | 3 | — | -17.9% | $178 ($110–$215) | — | A wide-moat, cash-gushing exchange-and-data toll road (FY25 net revenue growth double-digit, 51% EBITDA margin, ~$4.3B FCF) that the market has repriced ~30% below its 52-week high on fears that perpetual futures will cannibalize its listed-futures franchise — a fear the one expert in our KB calls… |
| IEX IDEX Corporation | Watch | 4 | 6 | 3 | — | +25.8% | $232 ($175–$285) | — | IDEX is a genuinely high-quality, serially acquisitive niche-industrial compounder — 44% gross margin, ~9% ROIC, fortress-lite balance sheet — but at 26× forward adjusted earnings for roughly 3–4% organic growth the stock already prices in the quality, leaving little margin of safety and no… |
| JKHY Jack Henry & Associates, Inc | Watch | 4 | 6 | 3 | — | -19.5% | $158 ($112–$196) | — | Jack Henry is a genuinely excellent, fortress-balance-sheet vertical-software business — >99% customer retention, net cash, 24% ROE — but it grows earnings at only high-single digits, trades at ~20× earnings, and just printed an overbought RSI 77 after a −24% slide from its highs; we Watch it as a… |
| JPM JPMorgan Chase & Co. | Watch | 4 | 6 | 3 | — | +3.8% | $355 ($250–$430) | — | JPMorgan is the best-run large bank in the world — FY25 net income $57B, 1Q26 ROTCE 23%, a fortress 14.3% CET1 capital ratio — trading at a reasonable ~14× forward earnings, so you are paid to own a genuine quality compounder with heavy capital return; the whole call rests on the credit cycle… |
| MCD McDonald's Corporation | Watch | 4 | 6 | 2 | — | -8.2% | $300 ($225–$375) | — | McDonald's is one of the best-run franchises on earth — 95% franchised, 57% gross / 46% EBIT margins, ~17% ROIC, a fortress moat — but it is a mature ~5%-grower priced at 23× earnings with a ~3.4× PEG, sitting in a multi-quarter downtrend while management itself calls the consumer environment "not… |
| MRSH Marsh & McLennan Companies, | Watch | 4 | 6 | 2 | — | -3.8% | $205 ($155–$238) | — | Marsh & McLennan is one of the best-run, most recession-resilient businesses in the S&P 500 — a global insurance-brokerage and consulting toll-booth with 26% ROE, low beta, and 15+ years of steady compounding — but it is a *mature* mid-single-digit organic grower trading right at fair value, so the… |
| ORLY O'Reilly Automotive, Inc. | Watch | 4 | 6 | 2 | $90 | -1.1% | $94 ($66–$112) | — | O'Reilly is one of the best-run retailers in America — ~34% returns on invested capital, a countercyclical demand base, and a two-decade buyback machine — but at 29× trailing earnings for ~5% revenue and ~9% EPS growth, the price already reflects the quality, and the stock has *lagged* the market… |
| PTC PTC Inc. | Watch | 4 | 6 | 4 | — | -28.5% | $172 ($113–$226) | — | PTC is a high-margin, recurring-revenue industrial-software franchise (Creo CAD, Windchill PLM, Onshape, Arena) that has sold off ~42% from its high on decelerating ARR and a messy divestiture-driven optical picture — leaving a genuinely profitable, cash-generative business trading at ~15× forward… |
| REGN Regeneron Pharmaceuticals, Inc. | Watch | 4 | 6 | 4 | $654 | -15.2% | $785 ($490–$1010) | — | Regeneron is a rare cheap large-cap biotech — 15× trailing earnings, net cash, 84% gross margin — where the market has repriced the stock for a shrinking Eylea franchise (−46% peak-to-trough), while Dupixent (a Sanofi-shared blockbuster still growing double digits) and a broad late-stage pipeline… |
| RJF Raymond James Financial, Inc. | Watch | 4 | 6 | 3 | — | +1.3% | $178 ($128–$214) | — | Raymond James is a well-run, conservatively-financed wealth-management and capital-markets franchise trading at a reasonable ~15× earnings with a net-cash balance sheet and 17% ROE — a quality business at a fair (not cheap) price, which is why the honest call is Watch, not Buy: there is no expert… |
| RMD ResMed Inc. | Watch | 4 | 6 | 3 | — | -13.0% | $255 ($190–$338) | — | ResMed is a dominant, cash-generative, net-cash medical-device franchise (FY25 revenue $5.15B, 24% ROE, ~$1.66B FCF) that has been sold down ~29% from its high on fears that GLP-1 weight-loss drugs will erode its sleep-apnea market — yet it keeps posting ~10–11% revenue growth and margin expansion… |
| RSG Republic Services, Inc. | Watch | 4 | 6 | 2 | — | +2.6% | $224 ($175–$268) | — | Republic Services is a fortress-quality, recession-resistant local-monopoly waste business compounding earnings at a steady high-single-digit clip — genuinely excellent, but at 31× trailing on ~9% EPS growth the stock already prices the quality, and 12 months of flat-to-down price action (−11% vs… |
| STE STERIS plc | Watch | 4 | 6 | 3 | — | -13.9% | $235 ($175–$285) | — | STERIS is a boring-in-a-good-way infection-prevention near-monopoly — FY26 revenue $5.94B (+9% reported / +7% organic), record adjusted EPS $10.17, FCF $983M, net-debt/EBITDA under 1× — but the stock is down ~10% over the past year and still trades at a full ~27× trailing GAAP earnings for only… |
| TEL TE Connectivity plc | Watch | 4 | 6 | 4 | — | -13.2% | $225 ($165–$285) | — | A well-run, cash-generative global connector-and-sensor maker riding a real AI/data-center demand wave (record orders +25% YoY, adjusted EPS +24%) — but it is a mature, cyclical hardware business trading near fair value with zero expert conviction in our KB, so it earns a Watch, not a Buy. |
| UHS Universal Health Services, Inc. | Watch | 4 | 6 | 3 | — | -27.4% | $245 ($150–$330) | — | UHS is a well-run, US-focused hospital and behavioral-health operator trading at ~6.7× earnings and 5.3× EV/EBITDA — a genuine value setup where a big price drop (−35% from the high) has collided with rising earnings ($23.10 EPS in FY25, +37% YoY) and heavy buybacks; the whole call is a re-rating +… |
| ULTA Ulta Beauty, Inc. | Watch | 4 | 6 | 3 | — | -23.7% | $540 ($380–$660) | — | Ulta is the largest US specialty-beauty retailer — 45% ROE, 24% ROIC, no meaningful net leverage, and a 40M+ member loyalty program — now trading at ~16× forward earnings and ~11.6× EV/EBITDA after a 35% drawdown; the setup is a good business on sale, but growth has slowed to mid-single digits and… |
| VLTO Veralto Corporation | Watch | 4 | 6 | 3 | — | -7.2% | $100 ($76–$120) | — | Veralto is a genuinely high-quality, cash-generative razor-and-blade franchise (water quality + product coding/marking) with 61% recurring revenue, 60% gross margins and 33% ROE — but at 24× trailing on ~5% revenue and ~9% EPS growth it is priced like a compounder for a business that grows like a… |
| WMT Walmart Inc. | Watch | 4 | 6 | 3 | $112 | +0.4% | $118 ($88–$145) | — | Walmart is a genuinely fortress-quality, defensive compounder — FY26 revenue $713B (+4.7%), 24% ROE, $41.6B operating cash flow — whose problem is not the business but the *price*: at 39× trailing earnings on a razor-thin 3% net margin, the stock already sells at a rich multiple even after a 17%… |
| WTW Willis Towers Watson Public Limi | Watch | 4 | 6 | 2 | — | -12.9% | $305 ($225–$365) | — | WTW is a high-quality, low-beta global insurance broker and HR-benefits consultant earning a 21% ROE and a rich free-cash-flow yield, but FY25 revenue slipped to $9.71B (−2%), the growth is carried by buybacks and margin rather than demand, and at ~$286 — below its own 200-day average — the stock… |
| XYL Xylem Inc. | Watch | 4 | 6 | 3 | — | -13.3% | $122 ($83–$154) | — | Xylem is a high-quality, defensive, secular-water compounder — clean balance sheet (0.7× net-debt/EBITDA), margins expanding toward ~23%, an enviable install base — but at ~29× trailing EPS on only ~5% organic growth, with the stock in a downtrend below its 200-day average and no expert coverage to… |
| AON Aon plc | Watch | 5 | 6 | 3 | — | +1.3% | $375 ($300–$445) | — | Aon is one of the best businesses in the S&P 500 — a global insurance-broking oligopolist with 45% ROE, 39% adjusted operating margins and sticky recurring fee revenue — but after the ~$13B NFP acquisition inflated the FY25 headline (+9.4%), the *underlying* engine is a ~5% organic grower, the… |
| AZO AutoZone, Inc. | Watch | 5 | 6 | 3 | — | -6.8% | $3690 ($2970–$4255) | — | AutoZone is one of the best-run compounders in retail — 52% gross margin, elite returns on capital, a countercyclical "keep the old car running" business, and a two-decade buyback machine that shrank the share count by ~30% in five years — but the stock is in a downtrend, the multiple is no longer… |
| CBRE CBRE Group, Inc. | Watch | 5 | 6 | 3 | — | -11.9% | $165 ($110–$210) | — | CBRE is the world's largest commercial-real-estate services firm trading at a *reasonable* ~18× forward adjusted earnings as its capital-markets business recovers off a rate-shocked trough — but it is a low-margin, deeply cyclical broker with modest returns on capital, no net-bullish expert support… |
| CMI Cummins Inc. | Watch | 5 | 6 | 4 | — | +29.6% | $700 ($500–$890) | — | Cummins is a best-in-class, cash-generative diesel-and-power franchise that has quietly transformed into a data-center backup-power story (Power Systems is now the profit engine), but after a +101% twelve-month run the stock trades at ~23× forward earnings into a still-cyclical truck market — a… |
| CNP CenterPoint Energy, Inc. | Watch | 5 | 6 | 4 | — | +16.4% | $46 ($36–$56) | — | CenterPoint is a well-run, Houston-centred regulated electric-and-gas utility riding a genuinely unusual tailwind — 12.2 GW of firmly committed industrial load and 8 GW of data-center demand to be energized by 2029 — but at 27× trailing earnings for ~8% growth and a Street target essentially at the… |
| COF Capital One Financial Corporatio | Watch | 5 | 6 | 4 | — | -15.4% | $255 ($175–$315) | — | Capital One just swallowed Discover — the transformational 2025 acquisition roughly doubled the share count, loaded the balance sheet with goodwill, and buried 2025 GAAP EPS under a one-time CECL reserve build — so the stock screens optically expensive on trailing GAAP but sits at only ~10× FY26E… |
| CRM Salesforce, Inc. | Watch | 5 | 6 | 3 | — | -37.3% | $205 ($120–$280) | — | Salesforce is a high-quality, deeply cash-generative franchise (FY26 revenue $41.5B, 78% gross margin, $14.4B free cash flow) trading at a genuinely cheap ~19× earnings / 11× EV-to-free-cash-flow — but the stock has been *cut in half* because the market fears agentic AI erodes the per-seat SaaS… |
| DHR Danaher Corporation | Watch | 5 | 6 | 3 | — | -13.5% | $219 ($160–$260) | — | Danaher is a genuinely elite operator (60%+ gross margin, ~75% recurring revenue, strong free cash flow) that has become a *slow* compounder after its post-COVID bioprocessing hangover — sales grew just +2.9% in FY25 and are modeled at only ~5% forward, so at 23× forward adjusted earnings there is… |
| EMR Emerson Electric Co. | Watch | 5 | 6 | 3 | — | +4.8% | $144 ($100–$167) | — | Emerson has successfully re-shaped itself from a sprawling conglomerate into a focused, higher-margin industrial-automation pure-play (FY25 revenue $18.0B, adjusted segment EBITA margin ~28%, ~$2.7B FCF), and management is now pivoting to shareholder returns — but the stock trades at a fair-to-full… |
| ETR Entergy Corporation | Watch | 5 | 6 | 4 | — | +24.5% | $122 ($90–$148) | — | Entergy is a Gulf-South regulated electric utility that has stumbled into one of the best structural setups in the sector — surging industrial and hyperscaler (data-center) load in Louisiana and Texas is driving ~13% forward EPS growth, roughly double a normal utility — but it is financing that… |
| FDS FactSet Research Systems Inc. | Watch | 5 | 6 | 3 | — | -13.8% | $274 ($200–$352) | — | FactSet is a genuinely elite recurring-revenue business (95%+ subscription retention, 51% gross margin, 27% ROE) that the market has cut nearly in half in a year over two real worries — growth has slowed to ~7% and generative AI could erode the terminal moat — leaving a quality franchise at a… |
| GDDY GoDaddy Inc. | Watch | 5 | 6 | 3 | — | -28.7% | $108 ($70–$150) | — | GoDaddy is a highly cash-generative, low-growth microbusiness-services utility that the market has cut in half — you're paying ~12× forward earnings and getting a 14% free-cash-flow yield for a business buying back ~5% of its stock a year; the debate is whether AI is a tailwind (Airo) or the thing… |
| HUBB Hubbell Incorporated | Watch | 5 | 6 | 3 | — | +9.7% | $510 ($400–$620) | — | Hubbell is a well-run, 138-year-old electrical/utility-grid supplier riding real secular tailwinds (grid modernization, datacenter power, electrification), but after the 2022-24 earnings surge the growth has slowed to high-single-digit sales / low-teens EPS, and at ~28× trailing the stock already… |
| J Jacobs Solutions Inc. | Watch | 5 | 6 | 4 | — | -3.5% | $150 ($95–$175) | — | Jacobs is a post-spin, asset-light engineering and consulting pure-play riding the data-center / semiconductor / water / energy build-out — record $27B backlog (1.4× book-to-bill), management raising FY26 guidance twice, adjusted EPS compounding mid-teens — but the GAAP numbers are muddied by the… |
| JCI Johnson Controls International p | Watch | 5 | 6 | 4 | — | +17.5% | $152 ($105–$180) | — | JCI has become a cleaner, higher-margin pure-play buildings company — thermal management, controls, fire/security, and increasingly data-center HVAC — and a new CEO is running a margin-expansion playbook that is showing up (Q2 FY26 adjusted EPS +45%, orders +30% organic, record $20B backlog). But… |
| NDSN Nordson Corporation | Watch | 5 | 6 | 3 | — | +20.8% | $300 ($225–$360) | — | Nordson is a best-in-class precision-dispensing compounder — 55% gross margin, 31% EBITDA margin, backlog +18% — but the stock already prices in that quality at ~25× forward earnings on only mid-single-digit organic growth, so the honest call is Watch: own the quality on a pullback, don't chase it… |
| OTIS Otis Worldwide Corporation | Watch | 5 | 6 | 2 | — | -16.3% | $82 ($63–$98) | — | Otis is a genuinely high-quality business — a razor-and-blades elevator model where ~65% of revenue is a sticky, recurring service annuity on ~2.5 million maintained units — but the stock is a low-growth, China-exposed, financially-leveraged compounder in a live downtrend, trading only modestly… |
| PLD Prologis, Inc. | Watch | 5 | 6 | 4 | — | +9.2% | $150 ($115–$185) | — | Prologis is the undisputed global leader in logistics real estate — 1.3B square feet, ~6,500 customers, 95%+ occupancy, a fortress balance sheet and a genuinely interesting 5.6GW data-center power option — but at ~22.7× Core FFO and only mid-single-digit forward growth the stock already reflects… |
| TMO Thermo Fisher Scientific Inc. | Watch | 5 | 6 | 3 | — | -9.7% | $560 ($420–$700) | — | Thermo Fisher is the "picks-and-shovels" leader of the life-sciences economy — a wide-moat, cash-generative compounder — but it is currently a ~6% revenue grower trading at ~21× forward earnings, with organic growth stalled near 1% and the stock near a full multiple, so the honest verdict is Watch… |
| TRMB Trimble Inc. | Watch | 5 | 6 | 4 | — | -32.3% | $68 ($42–$88) | — | Trimble has quietly re-shaped itself from a lumpy hardware maker into a higher-margin, recurring-revenue software company (ARR $2.43B, +12%), the stock has been cut ~45% from its high, and it now trades at ~15× forward non-GAAP EPS with the Street ~70% above — but with no expert coverage in our KB… |
| VRSN VeriSign, Inc. | Watch | 5 | 6 | 2 | — | +5.5% | $265 ($185–$316) | — | VeriSign is one of the highest-quality business models in the S&P 500 — a government-sanctioned near-monopoly on .com/.net with 88% gross margins, 50% net margins and 100% pricing discipline — but it grows revenue only ~6-7% a year, the stock already trades at ~28× earnings, and the price lever is… |
| WDAY Workday, Inc. | Watch | 5 | 6 | 3 | $135 | -37.0% | $160 ($95–$225) | — | Workday is a genuinely high-quality, 92%-recurring enterprise-software franchise that has de-rated hard (stock −43% in 12 months) as growth slowed from the 20s to low-teens; on adjusted earnings it is no longer expensive (~12–13× FY27E), but with growth still decelerating and no expert conviction… |
| AVGO Broadcom Inc. | Hold | 6 | 9 | 6 | $360 | +4.1% | $405 ($250–$560) | — | Broadcom has become the second pillar of the AI-infrastructure buildout — custom accelerators (XPUs) and data-center networking — with FY25 revenue +24% to $63.9B, a 67% gross / 56% EBITDA margin, and ~$27B of free cash flow; the fundamentals are elite, but you are paying 58× trailing / 31× forward… |
| APP AppLovin Corporation | Hold | 7 | 9 | 7 | $527 | -21.8% | $590 ($300–$870) | — | AppLovin has transformed from a grab-bag mobile-gaming company into a pure, freakishly profitable advertising-software engine — FY25 revenue $5.48B (+70%), 88% gross margin, 64% net margin, $3.9B free cash flow — but the market already knows it: at 45× trailing and a 2.46 beta, you are paying a… |
| VRT Vertiv Holdings Co | Hold | 7 | 9 | 8 | — | +85.5% | $340 ($190–$470) | — | VRT is the "picks-and-shovels" power-and-cooling supplier to the AI data-center buildout — FY25 revenue +28% to $10.2B, adjusted operating margin expanding 400+ bps, management guiding ~30% organic growth for FY26 and adjusted EPS up ~51% — but the market already knows it (74× trailing, 50×… |
| PLTR Palantir Technologies Inc. | Hold | 8 | 9 | 8 | $129 | -27.3% | $140 ($75–$205) | — | Palantir is one of the highest-quality, fastest-*accelerating* businesses in the Nasdaq-100 — FY25 revenue +56% to $4.48B, 84% gross margin, net cash, commercial revenue +130% — and the expert panel is genuinely enthusiastic; the problem is entirely the price, where 135× trailing / 89× forward… |
| IDXX IDEXX Laboratories, Inc. | Hold | 5 | 8 | 3 | $558 | -17.5% | $565 ($390–$720) | — | IDEXX is a genuinely elite, wide-moat razor-and-blade franchise (62% gross margin, 40% ROIC, 71% ROE, recurring consumable revenue) — but after a −27% drawdown it *still* trades at 41× trailing earnings while growth has settled into the ~10% range, so the quality is real and the price is the… |
| APH Amphenol Corporation | Hold | 6 | 8 | 5 | — | +21.8% | $175 ($110–$217) | — | Amphenol is a genuinely elite, serial-compounding connector manufacturer riding an AI-datacom boom — Q1'26 sales grew 58% (33% organic) with a 1.24 book-to-bill — but after a 69% twelve-month run the stock trades at 45× trailing / 34× forward earnings, so our base-case fair value (~$175) sits only… |
| CTAS Cintas Corporation | Hold | 6 | 8 | 3 | $181 | -3.6% | $176 ($130–$232) | — | Cintas is a genuinely elite, wide-moat route-density compounder (FY25 revenue $10.34B, record 51% gross margin, 41% ROE) — but the market already knows it, the stock trades at ~37× trailing on high-single-digit organic growth, and it has de-rated ~20% from its high. Great business, full-to-rich… |
| FICO Fair Isaac Corporation | Hold | 6 | 8 | 5 | — | -24.8% | $1510 ($830–$1970) | — | FICO owns one of the best business models on the planet — a credit-score monopoly with ~84% gross margins and ~53% return on invested capital that just raised FY26 guidance twice — but the stock has fallen ~31% in a year as the market frets that the aggressive mortgage-score price increases… |
| FIX Comfort Systems USA, Inc. | Hold | 6 | 8 | 6 | — | +86.6% | $1850 ($1050–$2450) | — | FIX is the "picks-and-shovels" mechanical and electrical contractor building the guts of AI datacenters, and the fundamentals are extraordinary right now — FY25 revenue +29.5% to $9.10B, Q1'26 organic revenue +51%, EPS more than doubled, backlog $12.45B (nearly 2× YoY), a net-cash balance sheet and… |
| GE GE Aerospace | Hold | 6 | 8 | 3 | — | +22.6% | $362 ($234–$437) | — | GE Aerospace is a genuinely elite, aftermarket-heavy engine franchise — 87% order growth, a $170B commercial-services backlog, and management "trending toward the high end" of 2026 guidance — but at $377.52 the stock trades *above* both our $362 base-case fair value and, on price, its own street… |
| HWM Howmet Aerospace Inc. | Hold | 6 | 8 | 4 | — | +31.9% | $181 ($117–$224) | — | Howmet is a genuinely elite aerospace-components franchise — record backlogs, 32% adjusted-EBITDA margins, ~17% ROIC, a fortress balance sheet and management raising guidance every quarter — but at 53× FY26E / 45× FY27E the market is already paying up for years of flawless execution, so our… |
| ISRG Intuitive Surgical, Inc. | Hold | 6 | 8 | 5 | $426 | -24.8% | $430 ($300–$640) | — | Intuitive is one of the highest-quality medical-device franchises on the market — a razor-and-blade robotic-surgery near-monopoly with a fortress net-cash balance sheet and ~13.5–15.5% guided procedure growth — but the stock has already fallen ~30% from its high while still trading at 51× earnings… |
| KLAC KLA Corporation | Hold | 6 | 8 | 4 | $236 | +93.9% | $205 ($135–$290) | — | KLA owns a near-monopoly in semiconductor process control (defect inspection + metrology) with 61% gross margins and ~89% ROE — a genuinely elite business — but after a +162% 12-month run the stock trades at 66× trailing / 46× forward earnings into an elevated wafer-fab-equipment (WFE) cycle, so… |
| MPWR Monolithic Power Systems, Inc. | Hold | 6 | 8 | 6 | $1,288 | +42.1% | $1385 ($885–$1770) | — | MPWR is a best-in-class, net-cash, ~55%-gross-margin power-semiconductor compounder growing ~20%+ into the data-center/AI power build-out — but at 92× trailing / 54× forward earnings the price already assumes the growth, so our base case pegs fair value only modestly above spot and we rate it Watch… |
| NOW ServiceNow, Inc. | Hold | 6 | 8 | 5 | — | -30.6% | $142 ($83–$180) | — | ServiceNow is a genuinely elite enterprise-software compounder — FY25 revenue $13.3B (+21%), 77% gross margin, $4.6B free cash flow — whose stock has been *cut in half* (−47% in 12 months, −55% from peak) on fears that agentic AI disrupts seat-based SaaS and on a real complaint that stock-based… |
| PWR Quanta Services, Inc. | Hold | 6 | 8 | 6 | — | +58.3% | $720 ($430–$980) | — | PWR is the pick-and-shovel prime contractor for the electric-grid, generation and data-center "large-load" buildout — FY25 revenue grew ~20% to $28.4B with a record $48.5B backlog and management guiding adjusted EPS to *more than double* by 2030 — but you pay ~48× forward adjusted EPS for a… |
| TDG TransDigm Group Incorporated | Hold | 6 | 8 | 4 | — | +1.4% | $1360 ($960–$1680) | — | TransDigm is a genuinely elite business — a "public private-equity firm" that buys sole-source, proprietary aerospace aftermarket parts and raises prices for decades — but the stock is up against a full 42× multiple, a stretched RSI, a heavy 5.9× debt load, and 12-month price *underperformance*… |
| AMAT Applied Materials, Inc. | Hold | 7 | 8 | 5 | $603 | +134.7% | $540 ($360–$780) | — | Applied Materials is the largest, most diversified wafer-fabrication-equipment maker on earth — a genuine picks-and-shovels toll on the AI build-out with 49% gross margins, 40% ROE and a net-cash balance sheet — but after a +228% twelve-month run the stock trades at 49× forward earnings on a… |
| CDNS Cadence Design Systems, Inc. | Hold | 7 | 8 | 5 | $373 | +19.4% | $400 ($270–$500) | — | Cadence is one half of a genuinely mission-critical EDA duopoly with a fortress balance sheet (net cash), 89% gross margins and a record $8.0B backlog — a wonderful business whose stock already prices in years of flawless execution, so the honest call is Watch and wait for a better entry, not chase… |
| CIEN Ciena Corporation | Hold | 7 | 8 | 7 | — | +80.6% | $435 ($250–$615) | — | Ciena is the picks-and-shovels optical-networking supplier that is now a direct beneficiary of the AI-datacenter interconnect buildout: fiscal-Q2'26 revenue grew 40% YoY, adjusted EPS nearly quadrupled, and management *raised* full-year revenue guidance to ~$6.3B (+32%). The stock has already… |
| DASH DoorDash, Inc. | Hold | 7 | 8 | 7 | $192 | -15.2% | $205 ($120–$320) | — | DoorDash has quietly crossed into durable profitability — FY25 revenue +28% to $13.7B, first full-year GAAP profit ($935M), $2.2B free cash flow, net cash — and volumes are still *accelerating* (orders +27% YoY, GOV +37%). The problem is price: at 89× trailing / 76× FY26E earnings with an 81 RSI… |
| DDOG Datadog, Inc. | Hold | 7 | 8 | 6 | $260 | +91.5% | $235 ($150–$340) | — | Datadog is a genuinely elite software business — 80% gross margins, ~19% forward revenue compounding, $1B of free cash flow and best-in-class land-and-expand — but at 107× forward non-GAAP EPS after a +97% twelve-month run, the market has already paid for years of flawless execution; the only KB… |
| HOOD Robinhood Markets, Inc. | Hold | 7 | 8 | 7 | — | -0.3% | $118 ($58–$175) | — | Robinhood has crossed the line from meme-stock brokerage to a genuinely profitable, fast-compounding financial super-app (FY25 revenue $4.47B +52%, net income $1.88B, 41% net margin, ROE 22%) — the growth and product velocity are real, but you are paying 53× trailing for a business whose top line… |
| LRCX Lam Research Corporation | Hold | 7 | 8 | 5 | $351 | +105.3% | $300 ($185–$370) | — | Lam is a genuinely elite, oligopoly semiconductor-equipment franchise riding a real AI-driven capex wave (FY-ending-June-25 revenue $18.4B, 50% gross margin, 66% ROE, net cash) — but after a +263% twelve-month run the stock trades at 66× trailing earnings and sits *above* our base-case fair value… |
| ORCL Oracle Corporation | Hold | 7 | 8 | 7 | — | -28.0% | $205 ($95–$300) | — | Oracle re-invented itself from a mature database company into the fastest-growing large-scale AI-cloud provider — FY26 revenue +17% to $67.4B, cloud infrastructure +77%, and a $638B RPO backlog that grew 363% — but the stock has been cut in half from its high because building those datacenters is… |
| PANW Palo Alto Networks, Inc. | Hold | 7 | 8 | 5 | $348 | +89.0% | $296 ($173–$415) | — | Palo Alto is the highest-quality platform in cybersecurity — ~$9.2B FY25 revenue growing mid-teens, 72% gross margin, net-cash balance sheet, and a genuine AI-security tailwind — but at ~85–92× forward earnings and RSI 84 it is priced for flawless execution, and our disciplined base-case fair value… |
| TPL Texas Pacific Land Corporation | Hold | 7 | 8 | 6 | — | +41.8% | $380 ($250–$560) | — | TPL is a genuinely extraordinary business — a debt-free, ~880,000-acre Permian land-and-royalty machine with 97% gross margins, ~30% ROIC and essentially no capital needs — but the stock at 56× trailing / 40× EV-EBITDA already prices in the emerging data-center and desalination optionality, so the… |
| AMD Advanced Micro Devices, Inc. | Hold | 8 | 8 | 8 | $518 | +141.8% | $545 ($300–$800) | — | AMD is the clearest #2 in the biggest secular buildout of the decade: data-center revenue ($16.6B FY25) is now its largest segment and total revenue is estimated to nearly *quintuple* to ~$171B by FY30 — but you pay 168× trailing / 69× forward earnings for a business at ~50% gross margin and 13%… |
| AXON Axon Enterprise, Inc. | Hold | 8 | 8 | 7 | $597 | +5.1% | $617 ($340–$750) | — | Axon is a genuinely elite public-safety compounder — a TASER hardware monopoly that has flywheeled into 95%-sticky evidence software (ARR $1.5B, +35%; net revenue retention 125%) with counter-drone and AI now inflecting at 300–700% growth — but at 56× FY27E non-GAAP EPS with a beta of 1.42 and RSI… |
| CRWD CrowdStrike Holdings, Inc. | Hold | 8 | 8 | 5 | $194 | +65.5% | $134 ($66–$203) | — | CrowdStrike is a genuinely elite, category-leading cybersecurity platform whose fundamentals are re-accelerating (net-new ARR +32% in Q1'27, FY27 ARR-growth guide *raised*), but the stock has run +97% in three months to 41× sales and ~157× forward non-GAAP EPS — a price at which even a strong bull… |
| FAST Fastenal Company | Hold | 4 | 7 | 2 | $49 | +21.1% | $48 ($34–$58) | — | Fastenal is a genuinely elite business — ~29% return on invested capital, a fortress balance sheet, and a widening vending/Onsite distribution moat — but at 42.6× trailing earnings for high-single-digit, *decelerating* growth in a cyclical end-market, the price already reflects the quality; the… |
| TJX The TJX Companies, Inc. | Hold | 4 | 7 | 3 | — | +0.3% | $138 ($96–$163) | — | TJX is one of the best-run retailers on earth — FY27 (Jan-year) is tracking record comps, a ~12% pretax margin and 29% Q1 EPS growth on an unbreakable off-price model — but at ~30× earnings for ~9% forward EPS growth the stock already prices the excellence, so the operator earns an A while the… |
| AME AMETEK, Inc. | Hold | 5 | 7 | 3 | — | +14.3% | $232 ($183–$276) | — | AMETEK is a genuinely elite serial-acquirer industrial compounder — 37% gross margin, 26% operating margin, a fortress balance sheet and a decades-long record of buying niche instrument businesses and never taking a goodwill write-off — but at 35× trailing earnings on only mid-single-digit organic… |
| ROL Rollins, Inc. | Hold | 5 | 7 | 3 | — | -27.7% | $41 ($29–$52) | — | Rollins is one of the highest-quality recurring-revenue compounders in the S&P 500 — Orkin pest control, 2.8M customers, 37% ROE, light debt, ~90% U.S. — but even after a 34% drawdown it trades at ~35× forward earnings for ~10% EPS growth, so the price still has to catch down to the (excellent)… |
| TT Trane Technologies plc | Hold | 5 | 7 | 3 | — | +22.8% | $460 ($355–$590) | — | Trane is a genuinely excellent, secular-tailwind-backed compounder — record $10.7B backlog, ~40% Commercial HVAC bookings growth, ~20% ROIC, fortress balance sheet — but at 37× trailing on a ~9% revenue grower with cyclical end-markets, the quality is already in the price; we rate it Watch and… |
| BX Blackstone Inc. | Hold | 6 | 7 | 5 | — | -20.4% | $127 ($83–$164) | — | Blackstone is the world's largest alternative asset manager (~$1.3T AUM, record inflows) with a genuine fee-related-earnings moat — but the stock is down ~20% over the past year, GAAP optics (31× P/E) overstate the valuation, and the honest read is a high-quality *cyclical* trading near mid-cycle… |
| COST Costco Wholesale Corporation | Hold | 6 | 7 | 3 | $952 | +10.4% | $955 ($726–$1044) | — | Costco is one of the highest-quality businesses in the S&P 500 — an 89.7% membership renewal rate, 28% ROE, a net-cash balance sheet, and utterly durable comps — but the stock discounts all of that and more at 48× trailing / 42× forward earnings for a ~9% EPS grower, so our base-case fair value… |
| DXCM DexCom, Inc. | Hold | 6 | 7 | 4 | $71 | +7.4% | $72 ($48–$100) | — | DexCom is the most accurate continuous glucose monitor and owns the insulin-intensive diabetes segment with a long penetration runway — but growth has decelerated from ~25%+ to management's own ~11–13% FY26 guide, the stock still trades at ~30× earnings after a −56% peak-to-trough drawdown, and the… |
| ETN Eaton Corporation plc | Hold | 6 | 7 | 5 | — | +25.1% | $415 ($300–$545) | — | Eaton is a best-in-class electrical-equipment compounder riding a real electrification/data-center order wave (Electrical Americas orders +42%, total electrical backlog +48%, FY26 organic guide *raised* to ~10%), but at ~30× forward adjusted earnings on ~10% organic revenue growth the good news is… |
| FSLR First Solar, Inc. | Hold | 6 | 7 | 5 | — | -14.0% | $260 ($130–$400) | — | First Solar is a genuinely cheap (14× earnings), net-cash, US-champion solar-module maker with a 47.9 GW contracted backlog and 42% gross margins — but a large slice of those margins is a government subsidy (Section 45X), the stock is deeply cyclical (beta 1.7) and has just sold off 29% into… |
| FTNT Fortinet, Inc. | Hold | 6 | 7 | 4 | $156 | +96.8% | $120 ($84–$165) | — | Fortinet is a genuinely elite cybersecurity franchise — 81% gross margin, 34% ROIC, net cash, a rising subscription/SASE mix and $2.2B of free cash flow — but after a +52% twelve-month run the stock trades at ~50× forward earnings on only low-teens, decelerating revenue growth, and the entire… |
| GEV GE Vernova Inc. | Hold | 6 | 7 | 6 | — | +70.3% | $1130 ($640–$1420) | — | GE Vernova is a real, improving energy-transition franchise riding an AI-driven power-demand supercycle — $163B backlog, guidance raised, a net-cash balance sheet — but after a +120% 12-month run the stock already prices in the good news, so we rate it Watch: a high-quality name to own on weakness… |
| HLT Hilton Worldwide Holdings Inc. | Hold | 6 | 7 | 3 | — | +17.7% | $340 ($250–$430) | — | Hilton is a genuinely elite, capital-light hotel-franchising machine — ~45% adjusted-EBITDA margins, 6–7% unit growth, and a buyback engine that turns high-single-digit fee growth into ~16% EPS growth — but at 37× forward earnings the market already knows it, and with RevPAR decelerating to 2–3%… |
| KEYS Keysight Technologies, Inc. | Hold | 6 | 7 | 4 | — | +54.5% | $300 ($210–$405) | — | Keysight is a genuinely high-quality, wide-moat electronic test-and-measurement franchise firing on all cylinders right now (record H1 FY26, orders topping $2B/quarter, full-year outlook raised) — but after a ~90% twelve-month run the stock trades at 52× trailing / 31× forward earnings for a… |
| KKR KKR & Co. Inc. | Hold | 6 | 7 | 6 | — | -26.4% | $118 ($70–$165) | — | KKR is a genuinely elite alternative-asset compounder (fee-related earnings and adjusted EPS growing ~20% YoY) whose stock has been cut ~39% from its high on private-credit-cycle fears — so the debate is *cyclical dip vs. cracking cycle*, and the honest answer is that the fundamentals say buy while… |
| MCO Moody's Corporation | Hold | 6 | 7 | 3 | — | -4.0% | $500 ($385–$610) | — | Moody's is one of the highest-quality franchises in the S&P 500 — a ratings duopoly with 67% MIS margins plus a growing subscription-analytics annuity (MA ARR +8%) — but at 35× trailing on ~11% forward EPS growth the stock is priced for perfection while the shares have gone nowhere for a year (−2%… |
| NRG NRG Energy, Inc. | Hold | 6 | 7 | 4 | — | -14.2% | $160 ($95–$215) | — | NRG is a cheap, cash-generative Texas-centric power retailer-plus-generator riding a genuine electricity-demand tailwind (data centers, electrification, its own 1.5 GW Texas Energy Fund buildout), reaffirming ~$8.90 midpoint adjusted EPS and ~$3B free-cash-flow guidance for 2026 — but it carries… |
| SNPS Synopsys, Inc. | Hold | 6 | 7 | 5 | $437 | -6.9% | $515 ($320–$630) | — | Synopsys is one half of the EDA duopoly that every chip on earth is designed through — a genuinely wide-moat, recurring-revenue franchise now trading ~30× forward after a brutal −32% drawdown, but the story is complicated by a debt-funded, margin-diluting Ansys acquisition that inflates FY26 growth… |
| TMUS T-Mobile US, Inc. | Hold | 6 | 7 | 3 | $178 | -12.6% | $215 ($150–$265) | — | T-Mobile is a cash-gushing wireless leader (FY25 revenue $88.3B, EBITDA $31.3B, FCF $18.0B) whose stock has fallen ~31% from its 2025 peak to 18.8× trailing / 17× forward earnings — a rare "quality on sale" setup where the Street sees +42% upside, but the debt load (4.1× net-debt/EBITDA) and a… |
| TTWO Take-Two Interactive Software, I | Hold | 6 | 7 | 6 | $255 | -0.4% | $250 ($150–$360) | — | Take-Two owns two of the most valuable franchises in entertainment (Grand Theft Auto and NBA 2K) and is one of the few gaming pure-plays with a genuine, near-term step-change coming — but at ~$255 the market already prices Grand Theft Auto VI as a near-certainty, the company is still posting GAAP… |
| VST Vistra Corp. | Hold | 6 | 7 | 5 | — | -6.4% | $185 ($95–$265) | — | Vistra is a large integrated Texas/East merchant power generator + retailer trading at ~16× FY26E and ~13× FY27E EPS after a −31% drawdown, with genuine AI-datacenter demand behind it (Meta nuclear PPAs, the pending 5,500-MW Cogentrix gas buy) and a freshly minted investment-grade balance sheet… |
| WELL Welltower Inc. | Hold | 6 | 7 | 4 | — | +27.1% | $220 ($165–$270) | — | Welltower is the best-executing large-cap healthcare REIT in the market right now — Q1'26 normalized FFO/share grew 23% and Seniors-Housing same-store NOI grew 22% on an aging-demographics tailwind — but the stock sits at an all-time high, overbought, at ~37× forward FFO, so the *business* is a Buy… |
| WST West Pharmaceutical Services, In | Hold | 6 | 7 | 4 | — | +32.9% | $316 ($225–$395) | — | West is a genuinely elite "picks-and-shovels" franchise — the dominant maker of the rubber stoppers, seals and delivery components that go into virtually every injectable drug, with a fortress net-cash balance sheet and best-in-class returns on capital — but after a +64% twelve-month rally to a… |
| ARES Ares Management Corporation | Hold | 7 | 7 | 5 | — | -27.7% | $176 ($96–$240) | — | Ares is a top-tier alternative-asset manager ($644B AUM, growing fee-related earnings) whose stock has been cut ~40% on fears that the $1.7T private-credit boom is turning — leaving it cheap on *forward adjusted* earnings (~16× FY27E) but squarely a bet on the credit cycle, which is exactly why our… |
| COHR Coherent Corp. | Hold | 7 | 7 | 6 | — | +80.6% | $375 ($200–$500) | — | Coherent is a merger-built photonics leader (II-VI + the old Coherent) that has become a front-line AI-datacenter optics supplier — revenue is re-accelerating (Q3 FY26 +21% Y/Y, non-GAAP operating margin 20.3%) and estimates imply ~30% forward revenue growth, but you are paying 61× this-year… |
| GLW Corning Incorporated | Hold | 7 | 7 | 6 | — | +124.6% | $205 ($120–$300) | — | Corning is a 175-year-old glass and materials company that has genuinely re-invented itself as the picks-and-shovels optical-fiber supplier to the AI data-center buildout — the fundamentals are inflecting (FY25 revenue +19% to $15.6B, core EPS growing 30% YoY, Meta plus two more multi-billion… |
| MRVL Marvell Technology, Inc. | Hold | 7 | 7 | 8 | $245 | +188.6% | $250 ($140–$360) | — | Marvell has transformed from a sleepy diversified chip vendor into a nearly-pure AI data-center interconnect and custom-silicon play (Data Center is now $6.1B of $8.19B FY26 revenue), and the growth is both fast and still accelerating — but the stock already discounts a lot of that, trades at 83×… |
| TER Teradyne, Inc. | Hold | 7 | 7 | 7 | $369 | +90.7% | $400 ($250–$560) | — | Teradyne is the #2 name in the automated-test-equipment duopoly, riding a genuine AI-compute and high-bandwidth-memory test surge (FY26E revenue +42%, EPS +114% *estimated*) with a net-cash balance sheet — but the stock has already tripled in twelve months, trades at ~49× FY26E earnings with a 1.79… |
| CVNA Carvana Co. | Hold | 8 | 7 | 6 | — | -18.7% | $72 ($34–$118) | — | Carvana is a genuine, well-executed turnaround — FY25 revenue +49% to $20.3B, Adjusted EBITDA margin now double-digit, net debt gone — but after a ~10× run off the 2022–23 bankruptcy scare the stock is a 3.4-beta cyclical priced for years of flawless 40% unit growth, so our honest base case sits… |
| LITE Lumentum Holdings Inc. | Hold | 8 | 7 | 8 | $728 | +97.6% | $780 ($300–$1120) | — | Lumentum is a real winner of the AI build-out — datacenter optical demand has taken quarterly revenue from $337M (FQ1'25) to $808M (FQ3'26) and analysts model revenue nearly quadrupling to ~$12.8B by FY29 — but after a ~700% twelve-month run the stock already prices in a lot of that, on a cyclical… |
| WDC Western Digital Corporation | Hold | 8 | 7 | 6 | $539 | +212.9% | $430 ($210–$640) | — | WDC is riding a genuine AI-datacenter storage boom — post-SanDisk it is a pure-play nearline-HDD maker whose revenue is set to re-accelerate ~28%/yr and whose margins are inflecting — but the stock has already risen 744% in twelve months, the trailing P/E is flattered by a one-time separation gain… |
| CB Chubb Limited | Hold | 3 | 6 | 3 | — | +15.7% | $355 ($270–$430) | — | Chubb is one of the best-underwritten, most disciplined global P&C insurers on earth — fortress balance sheet, ~20% core operating return on tangible equity, low beta — but it's a mature, cyclical compounder trading *above* its own Street price target at a 52-week high with an overbought tape, so… |
| WRB W. R. Berkley Corporation | Hold | 3 | 6 | 2 | — | +2.8% | $74 ($58–$88) | — | WRB is one of the best-run specialty commercial insurers in the market — 21% ROE, a record-low underwriting combined ratio, a fortress balance sheet and 0.31 beta — but at 16× earnings and 2.9× book near the top of a hard pricing cycle, the price already reflects the quality; it is a Watch until… |
| ATO Atmos Energy Corporation | Hold | 4 | 6 | 2 | — | +5.5% | $179 ($150–$210) | — | Atmos is a textbook, well-run regulated natural-gas distributor — steady ~8-9% EPS growth funded by a multi-year rate-base build, low beta, a 40-year dividend-raise culture — but at ~23× earnings and a price essentially on top of the Street target, you are paying a full multiple for a modest… |
| AWK American Water Works Company, In | Hold | 4 | 6 | 2 | — | +4.9% | $138 ($110–$168) | — | American Water is the highest-quality, most defensive water utility in the US — a rate-regulated monopoly compounding EPS ~7–9% on relentless rate-base growth — but at ~22× forward earnings against that mid-single-digit growth it offers a bond-like return with equity risk, so we rate it Watch: a… |
| AXP American Express Company | Hold | 4 | 6 | 3 | — | -4.9% | $360 ($270–$445) | — | American Express is a best-in-class, self-funded premium-consumer franchise — 35% ROE, fortress CET1 10.5%, double-digit billed-business growth, ~13% forward EPS CAGR — but at 22× trailing / 20× forward with the stock overbought (RSI 84) and lagging the market, the risk/reward is roughly balanced.… |
| GD General Dynamics Corporation | Hold | 4 | 6 | 3 | — | +11.0% | $384 ($300–$460) | — | General Dynamics is a fortress-balance-sheet defense prime with a record ~$188B total backlog and a 2-to-1 book-to-bill, compounding earnings at a steady high-single-digit clip — but at 23× trailing and 22× forward on ~7% EPS growth, near its all-time high, the stock already reflects the good news… |
| GWW W.W. Grainger, Inc. | Hold | 4 | 6 | 2 | — | +33.1% | $1210 ($820–$1470) | — | Grainger is a genuinely elite business — 48% ROE, a widening distribution moat, and management that keeps raising guidance — but the market already knows it: at 36× trailing earnings on ~7% revenue growth, the quality is fully paid for, so we rate it Watch and wait for a cheaper entry rather than… |
| LIN Linde plc | Hold | 4 | 6 | 2 | $547 | +28.2% | $545 ($430–$660) | — | Linde is the world's largest and highest-quality industrial-gas company — a genuine wide-moat compounder (FY25 revenue $34.0B, 46% gross margin, 38% EBITDA margin, contracted take-or-pay volumes) — but the market already knows it: at 36× trailing earnings for ~5% revenue growth the stock is priced… |
| PGR The Progressive Corporation | Hold | 4 | 6 | 3 | — | +2.0% | $232 ($155–$272) | — | Progressive is one of the best-run insurers on earth — 39.6M policies in force (+9% YoY), a sub-87% combined ratio, and a 35% ROE — but you are buying it after a cycle-peak underwriting year, the shares are −12% over the past year despite the S&P +21%, RSI is 79 (overbought), and the Street's own… |
| ROST Ross Stores, Inc. | Hold | 4 | 6 | 2 | $213 | +18.5% | $215 ($150–$250) | — | Ross is a genuinely elite off-price operator — 38% ROE, 19% ROIC, a fortress balance sheet, and a moat built on treasure-hunt buying — but at 30× trailing earnings on ~7% forward EPS growth the stock already prices in the quality, so we rate it Watch and would want a better entry (or faster growth)… |
| CASY Casey's General Stores, Inc | Hold | 5 | 6 | 3 | — | +44.3% | $820 ($610–$1010) | — | Casey's is one of the best-run businesses in American retail — a small-town convenience/fuel roll-up that just closed a three-year plan with record FY26 results (revenue $17.6B, EPS $19.16 +31%, EBITDA ~$1.48B, 27th straight dividend raise) — but the stock now trades at ~42× trailing / ~38× forward… |
| ITW Illinois Tool Works Inc. | Hold | 5 | 6 | 2 | — | +10.7% | $265 ($205–$320) | — | ITW is a genuinely elite operator — 26.5% operating margins, ~25% ROIC, a 60-plus-year dividend record and the famous "ITW Business Model" — but it is a mature, cyclically exposed, ~1%-organic-growth multi-industrial trading at ~25× earnings and 18.7× EV/EBITDA, i.e. a premium price for a… |
| LHX L3Harris Technologies, Inc. | Hold | 5 | 6 | 3 | — | +2.9% | $290 ($210–$345) | — | L3Harris is a well-run, mid-cap prime defense contractor riding a genuine demand tailwind (record $40.7B backlog, 1.4× book-to-bill, management raising FY26 EPS guidance) — but at 28× forward earnings, single-digit revenue growth, 2.8× leverage and mediocre returns on capital, the price already… |
| MNST Monster Beverage Corporation | Hold | 5 | 6 | 3 | $98 | +27.3% | $91 ($64–$110) | — | Monster is a pristine business — 55% gross margin, 25% ROE, zero debt, ~$2B net cash, decades of share gains in energy drinks — but after a +54% twelve-month run it trades at ~42× forward earnings for a company now growing revenue around 10%, so the price already discounts the quality; we rate it… |
| MS Morgan Stanley | Hold | 5 | 6 | 3 | — | +20.5% | $218 ($150–$275) | — | Morgan Stanley is a genuinely better business than it was a decade ago — the Gorman-built, fee-annuity wealth franchise (~$2.8T fee-based assets, +$118B net new assets in a single quarter) now steadies the cyclical institutional-securities engine — but after a record 2025–26 the stock trades at… |
| RL Ralph Lauren Corporation | Hold | 5 | 6 | 3 | — | +12.6% | $400 ($280–$515) | — | Ralph Lauren has executed a genuinely impressive brand-elevation turnaround — FY26 revenue crossed $8B for the first time (+15%), gross margin ~70%, ROE ~35%, net-debt/EBITDA 0.7× — but management itself now guides to only mid-single-digit revenue growth, and after a +46% year the stock already… |
| RTX RTX Corporation | Hold | 5 | 6 | 3 | — | +8.6% | $205 ($140–$250) | — | RTX is a top-tier defense/aerospace prime riding a record $271B backlog and a genuine post-GTF earnings recovery (FY25 revenue +9.7% to $88.6B, adjusted EPS climbing double-digits), but at 37× trailing / 29× forward with only ~6% forward revenue growth, the multiple already prices the recovery — so… |
| UNP Union Pacific Corporation | Hold | 5 | 6 | 3 | — | +22.0% | $289 ($218–$334) | — | Union Pacific is one of the highest-quality, widest-moat businesses in the S&P 500 — a two-railroad continental duopoly with a sub-60% operating ratio, ~40% net margin and 40% ROE — but at 23× earnings on ~10% forward EPS growth the stock is priced for perfection, and the pending Norfolk Southern… |
| WAB Westinghouse Air Brake Technolog | Hold | 5 | 6 | 3 | — | +22.8% | $268 ($200–$330) | — | Wabtec is a genuinely high-quality, wide-moat rail-equipment compounder — record $9.25B backlog, margins grinding higher, mid-teens forward EPS growth — but at 37× trailing and ~25× forward on a low-single-digit-growth, cyclical end market, the stock already prices in the good news; we rate it… |
| YUM Yum! Brands, Inc. | Hold | 5 | 6 | 3 | — | +8.9% | $168 ($128–$205) | — | Yum! is a genuinely good, capital-light global franchise machine — Taco Bell is firing (Q1'26 same-store +8%), KFC is expanding units fast, and 94% of the system is franchised so cash converts cleanly — but at ~26× trailing earnings for a high-single-digit-topline, 3.9×-levered business with a… |
| AAPL Apple Inc. | Hold | 6 | 6 | 3 | $309 | +13.5% | $300 ($215–$400) | — | Apple is one of the best businesses on earth — 48% gross margin, ~$99B free cash flow, a 2.3B-device installed base and a Services engine at a record $109B — but at 37× trailing earnings for ~11% forward EPS growth you are paying a premium price for a decelerating mega-cap whose AI position is a… |
| ABBV AbbVie Inc. | Hold | 6 | 6 | 3 | — | +14.3% | $275 ($205–$330) | — | AbbVie has done the hard thing — replaced its $21B Humira monopoly with Skyrizi + Rinvoq ($25.9B combined in FY25 and still growing 20–30%) — so the growth cliff everyone feared is now behind it; but the stock sits at an all-time high on ~18× forward adjusted earnings with 3.8× net leverage and… |
| ABNB Airbnb, Inc. | Hold | 6 | 6 | 4 | $149 | +9.7% | $158 ($94–$210) | — | Airbnb is a genuinely elite, net-cash, high-margin marketplace (FY25 revenue $12.24B, 83% gross margin, $4.65B free cash flow, 31% ROE) — but top-line growth has cooled to ~10%, the stock trades at ~36× trailing right *at* its 52-week high, and the freshest expert conviction in our KB is a… |
| ADI Analog Devices, Inc. | Hold | 6 | 6 | 4 | $377 | +39.1% | $400 ($300–$500) | — | ADI is a genuinely elite analog/mixed-signal franchise — 64% gross margins, $4.3B free cash flow, and a diversified industrial/auto book — now emerging from a deep chip-cycle trough (FY25 revenue +17%), but the stock at ~56× GAAP / ~31× forward earnings already discounts a clean recovery, so the… |
| APO Apollo Global Management, Inc. | Hold | 6 | 6 | 4 | — | -18.1% | $144 ($96–$171) | — | Apollo screens genuinely cheap on the earnings the Street actually underwrites (~11–13× forward adjusted EPS vs a ~16% growth path), and its Athene-driven perpetual-capital engine is a real structural moat — but the stock is in a clean downtrend, the balance sheet is an opaque insurance book, and… |
| BRO Brown & Brown, Inc. | Hold | 6 | 6 | 3 | — | -12.2% | $84 ($60–$106) | — | Brown & Brown is a high-quality, low-beta, serially-acquisitive insurance broker that just made its largest-ever acquisition (Accession/RSC, ~$7.8B) — the deal doubled goodwill and pushed net-debt/EBITDA to ~3.3×, and it landed exactly as organic growth fell to zero; the stock has already de-rated… |
| CAT Caterpillar Inc. | Hold | 6 | 6 | 4 | — | +68.2% | $845 ($540–$1155) | — | Caterpillar is a genuinely excellent, well-run cyclical that has been re-rated by the market into an AI-infrastructure/data-center-power proxy — the fundamentals are real (FY25 revenue $67.6B, ROE 47.5%, FCF $10.3B), but at 32× FY27E earnings the stock is priced for a secular growth story on top of… |
| DLR Digital Realty Trust, Inc. | Hold | 6 | 6 | 5 | — | +12.0% | $185 ($140–$225) | — | Digital Realty is a real, front-line beneficiary of the AI/cloud data-center buildout — record bookings, a $1.8B backlog and a 6 GW development pipeline — but the stock already discounts most of that at ~21× forward Core FFO, the growth shows up in FFO/share (not GAAP earnings), and the model runs… |
| ECL Ecolab Inc. | Hold | 6 | 6 | 3 | — | +7.9% | $285 ($215–$355) | — | Ecolab is one of the highest-quality industrial compounders in the S&P 500 — a genuine switching-cost moat, 22% ROE, and a steady margin-expansion story — but at 38× trailing earnings on mid-single-digit organic sales growth the price already reflects the quality, leaving little margin of safety. A… |
| EFX Equifax Inc. | Hold | 6 | 6 | 4 | — | -20.7% | $205 ($150–$275) | — | Equifax is a wide-moat, oligopoly credit-and-workforce data business whose earnings are re-accelerating as new products and a cloud rebuild kick in — but it sits at the mercy of the U.S. mortgage cycle, carries real leverage, and the stock has already de-rated 35% from its high, so this is a Watch… |
| EW Edwards Lifesciences Corporation | Hold | 6 | 6 | 4 | — | +10.7% | $90 ($66–$116) | — | Edwards is a genuinely excellent, focused structural-heart franchise — 78% gross margin, net-cash balance sheet, category leadership in transcatheter aortic valves (TAVR) — but at ~50× trailing / 31× forward EPS on a business the Street models growing revenue ~10% a year, the price already reflects… |
| HAS Hasbro, Inc. | Hold | 6 | 6 | 4 | — | -2.3% | $96 ($58–$128) | — | Underneath a headline GAAP loss (a one-time 2025 goodwill write-down) sits a leaner, cash-generative Hasbro throwing off ~$830M of free cash flow, trading at ~13× forward earnings, with one truly excellent growth engine — Magic: The Gathering — doing the heavy lifting; it's cheap enough and… |
| HCA HCA Healthcare, Inc. | Hold | 6 | 6 | 3 | — | -12.1% | $500 ($360–$578) | — | HCA is the largest for-profit hospital operator in the US — a genuinely cheap (13.6× FY26E), high-return (~19% ROIC), prodigious cash generator that shrinks its share count aggressively — but it carries heavy leverage (3.1× net-debt/EBITDA, negative book equity) and sits directly in the path of two… |
| IQV IQVIA Holdings Inc. | Hold | 6 | 6 | 3 | — | -8.1% | $227 ($156–$270) | — | IQVIA is the dominant global data-and-clinical-research franchise (FY25 revenue $16.3B, +5.9%; adjusted EPS re-accelerating; FCF ~100% of adjusted net income) trading at a reasonable ~16× forward adjusted earnings — the catch is 4× net leverage, a 1.2 beta, and an order book that lives and dies on… |
| IR Ingersoll Rand Inc. | Hold | 6 | 6 | 3 | — | +1.7% | $82 ($58–$104) | — | Ingersoll Rand is a genuinely well-run, aftermarket-rich compressor and flow-control compounder (FY25 revenue $7.65B, 21% EBITDA margin, strong FCF) whose IRX operating system and serial M&A have compounded value for years — but at ~54× GAAP earnings and ~21× EV/EBITDA on roughly 5% forward revenue… |
| JBL Jabil Inc. | Hold | 6 | 6 | 5 | — | +49.7% | $351 ($218–$420) | — | Jabil is a well-run, newly AI-levered contract manufacturer executing beautifully (FY26 core EPS guided to $12.70, revenue reaccelerating on AI-infrastructure demand), but the stock has already priced most of that in — our base-case fair value of ~$351 is barely above today's $341, so we rate it… |
| LII Lennox International Inc. | Hold | 6 | 6 | 3 | — | +17.4% | $610 ($390–$755) | — | Lennox is a genuinely high-quality HVAC franchise — 72% ROE, 33% gross margin, a fat replacement-demand tailwind from the refrigerant-regulation cycle — but FY25 revenue actually *fell* 2.7%, the residential segment is still working through a construction downturn, and at 26× trailing / 23× forward… |
| LYV Live Nation Entertainment, Inc. | Hold | 6 | 6 | 4 | — | +30.9% | $185 ($123–$225) | — | Live Nation is the structurally dominant global live-entertainment flywheel — Concerts + Ticketmaster + Sponsorship — with a record deferred-revenue backlog and genuine double-digit adjusted-operating-income growth, but at ~$187 the stock sits right on its 52-week high, at Street's own price… |
| MAR Marriott International, Inc. | Hold | 6 | 6 | 3 | $373 | +20.2% | $360 ($265–$450) | — | Marriott is a genuinely excellent asset-light hotel-franchise machine — high returns on capital, a durable brand-and-loyalty moat, and relentless buybacks — but the top line barely grows (FY25 revenue +4.3%, ~2%/yr forward), the earnings growth is engineered by margin and share count, and at 39×… |
| MTD Mettler-Toledo International Inc | Hold | 6 | 6 | 3 | — | -6.2% | $1290 ($980–$1620) | — | Mettler-Toledo is one of the highest-quality industrial-instruments businesses on the market — 58% gross margins, ~36% ROIC, relentless buybacks — but it grows revenue only mid-single-digits, the multiple already embeds that quality, and the stock is technically stretched (RSI 82) below its… |
| NEE NextEra Energy, Inc. | Hold | 6 | 6 | 4 | — | +10.0% | $95 ($67–$106) | — | NextEra is two businesses stapled together — America's largest regulated utility (Florida Power & Light) and the largest US clean-energy developer (NextEra Energy Resources) — that together offer a visible, management-guided 8%+ adjusted-EPS CAGR through 2032 funded by heavy capex and heavy debt… |
| ODFL Old Dominion Freight Line, Inc. | Hold | 6 | 6 | 3 | $218 | +38.8% | $205 ($150–$265) | — | Old Dominion is the best-run less-than-truckload (LTL) carrier in North America — a genuine fortress balance sheet, an industry-leading sub-73 operating ratio and ~20% returns on capital — but revenue has now fallen three straight years in a freight downturn, and at 45× trailing / 40× forward EPS… |
| PH Parker-Hannifin Corporation | Hold | 6 | 6 | 3 | — | +9.5% | $1010 ($760–$1180) | — | Parker-Hannifin is a best-in-class diversified-industrial compounder — record 23%+ segment margins, 70 straight years of dividend increases, a record $12.5B backlog and an accelerating aerospace franchise — but at $963 it already trades near our base-case fair value (~$1,010) and slightly *above*… |
| SHW The Sherwin-Williams Company | Hold | 6 | 6 | 3 | — | +8.8% | $350 ($255–$450) | — | Sherwin-Williams is a genuinely elite, wide-moat compounder — dominant US paint distribution, ~58% ROE, decades of dividend growth — but at 33× trailing earnings on ~2% revenue growth and ~9% forward EPS growth, with a 3.0× levered balance sheet and an overbought chart that has *lagged* the S&P by… |
| TRGP Targa Resources Corp. | Hold | 6 | 6 | 4 | — | +40.3% | $270 ($178–$336) | — | Targa is a genuinely well-run Permian-centric midstream operator riding real NGL volume growth (FY25 revenue $17.1B, record adjusted EBITDA, management guiding FY26 adjusted EBITDA to $5.7–5.9B, +17%) — but the stock has already re-rated to ~24× forward EPS and 15× EV/EBITDA on ~13% top-line… |
| TTD The Trade Desk, Inc. | Hold | 6 | 6 | 4 | — | -49.7% | $25 ($15–$38) | — | The Trade Desk is still a high-margin, cash-generative leader of the independent (non-walled-garden) ad-buying market, but the stock has been cut ~75% in a year as revenue growth collapsed from ~40% to ~12% and competition intensified — the valuation is finally *reasonable* (21× earnings, 9% FCF… |
| TXN Texas Instruments Incorporated | Hold | 6 | 6 | 4 | $293 | +68.9% | $270 ($175–$360) | — | Texas Instruments is one of the highest-quality franchises in all of semis — 57% gross margin, 32% ROE, a fortress distribution moat in analog/embedded chips — but after a +39% twelve-month run it trades at ~50× trailing and ~38× forward earnings while free cash flow is still squeezed by a historic… |
| URI United Rentals, Inc. | Hold | 6 | 6 | 3 | — | +35.7% | $1090 ($720–$1450) | — | United Rentals is the North American equipment-rental leader — a genuinely well-run, cash-generative cyclical (44% adjusted-EBITDA margin, 28% ROE, disciplined buybacks) — but revenue growth has cooled to the mid-single digits, the stock sits near an all-time high at a fair-to-full ~28× earnings… |
| VMC Vulcan Materials Company | Hold | 6 | 6 | 3 | — | +6.3% | $300 ($225–$375) | — | Vulcan is the highest-quality way to own US construction aggregates — a genuine local-monopoly, pricing-power franchise (FY25 revenue $7.93B, ~16% ROIC, EBITDA margins expanding on price) — but at 36× trailing earnings and 17× EV/EBITDA on a ~6% top-line grower whose demand is cyclical, the stock… |
| WAT Waters Corporation | Hold | 6 | 6 | 4 | — | -0.1% | $400 ($300–$500) | — | Waters is a best-in-class "razor-and-blades" analytical-instruments franchise — sticky consumables and service on top of high-end liquid-chromatography and mass-spec hardware — that just doubled its revenue base by acquiring BD's Biosciences and Diagnostic Solutions units (closed Feb 9, 2026); the… |
| WSM Williams-Sonoma, Inc. | Hold | 6 | 6 | 3 | — | +27.4% | $210 ($150–$275) | — | Williams-Sonoma is one of the best-run specialty retailers in America — 46% gross margin, 53% ROE, a net-cash-like balance sheet and a real omni-channel moat — but it is a mature, cyclical business whose revenue has been essentially flat for four years ($7.75B FY23 → $7.81B FY25), so at 25×… |
| CCL Carnival Corporation & plc | Hold | 7 | 6 | 3 | — | -8.6% | $33 ($18–$44) | — | Carnival is a genuinely cheap (12× EPS, 8.7× EV/EBITDA), record-demand cruise operator methodically paying down a mountain of COVID-era debt — the base-case return comes from deleveraging and multiple normalization, not from fast growth, and the whole call is hostage to the consumer cycle because a… |
| FLEX Flex Ltd. | Hold | 7 | 6 | 5 | — | +126.5% | $117 ($60–$154) | — | Flex is a genuinely improving contract manufacturer riding a real AI-infrastructure tailwind (power, cooling, data-center IT), and just announced a spin-off of its Cloud & Power Infrastructure segment — but after a +182% 12-month run the stock trades at ~41× adjusted earnings for a business that… |
| GNRC Generac Holdings Inc. | Hold | 7 | 6 | 5 | — | +85.3% | $278 ($175–$360) | — | Generac is a high-quality franchise (the dominant US home-standby generator brand) trapped in a genuinely cyclical demand pattern: FY25 revenue actually *fell* 2% to $4.21B and GAAP EPS collapsed to $2.69 on a Q4 loss, yet the stock trades at 78× trailing and near all-time highs on hopes for a… |
| IRM Iron Mountain Incorporated | Hold | 7 | 6 | 4 | — | +41.2% | $122 ($88–$158) | — | Iron Mountain is executing a genuine pivot from a boring paper-records storage REIT into a data-center + asset-lifecycle growth story (growth lines +50% YoY, FY26 guidance raised), but it funds that pivot with heavy debt (8.4× net-debt/EBITDA, negative book equity, negative free cash flow) and pays… |
| MU Micron Technology, Inc. | Hold | 7 | 6 | 7 | $976 | +241.8% | $1150 ($620–$1830) | — | This is the purest liquid way to own the AI-memory (HBM) super-cycle: revenue went from $9.3B to $41.5B a quarter in a year and EPS from $1.69 to $25.04, HBM is sold out through 2026, and the stock is *statistically cheap* on forward EPS — but that cheapness exists precisely because memory is a… |
| BA The Boeing Company | Hold | 8 | 6 | 3 | — | +4.3% | $235 ($130–$330) | — | Boeing is a genuine recovery story — a record $695B backlog, deliveries and revenue climbing, and losses narrowing toward breakeven — but it is still burning cash (FY25 FCF −$1.9B), carrying $43.5B net debt at 5.2× EBITDA, and trading at ~55× FY27 estimated EPS, so the market is already paying for… |
| STX Seagate Technology Holdings plc | Hold | 8 | 6 | 4 | $820 | +197.8% | $600 ($220–$864) | — | Seagate is executing a genuine boom — TTM revenue up ~42% and net margin more than doubled as AI-driven "mass-capacity" nearline HDD demand tightens supply — but the stock has already risen +465% in twelve months into that boom, trades at ~30× FY27E EPS on a deeply cyclical business with a 2.08… |
| HIG The Hartford Insurance Group, In | Hold | 3 | 5 | 2 | — | +0.0% | $150 ($110–$178) | — | The Hartford is a disciplined, cheap (9.5× earnings), low-beta P&C-plus-benefits insurer earning a 20% core ROE — a genuinely high-quality operator, but it trades right on top of the Street's target with only single-digit upside, so it is a Watch: own it for ballast and yield if you already do, but… |
| SNA Snap-on Incorporated | Hold | 3 | 5 | 2 | — | +19.6% | $420 ($305–$505) | — | Snap-on is a genuinely elite, wide-moat cash machine — ~60% van-market share, 51% gross margin, 17% ROE, a net-*cash* balance sheet — but it is a low-single-digit grower trading at ~21× with the stock pinned at its 52-week high on an overbought RSI, so the quality is real and the price already… |
| AEE Ameren Corporation | Hold | 4 | 5 | 2 | — | +15.2% | $118 ($87–$133) | — | Ameren is a high-quality, low-beta Missouri/Illinois regulated electric-and-gas utility compounding earnings at a dependable ~6–8% off a growing rate base — but at 21× earnings and ~$121 street consensus the market already pays for that steadiness, so there is no discount to buy and the verdict is… |
| AOS A. O. Smith Corporation | Hold | 4 | 5 | 2 | — | -6.2% | $64 ($46–$84) | — | AOS is a genuinely well-run, cash-generative water-technology franchise (28% ROE, 39% gross margin, net-debt/EBITDA 0.6×) trading at a reasonable 16.7× — but it is barely growing (FY25 revenue +0.3%, management just *lowered* FY26 guidance on China and North-American softness), the stock is below… |
| BNY The Bank of New York Mellon Corp | Hold | 4 | 5 | 3 | — | +26.3% | $150 ($110–$185) | — | BNY is the world's largest custodian ($59.4T of assets under custody/administration) running at record efficiency — 1Q26 ROTCE ~29%, +42% EPS growth, a fresh $10B buyback — but after a +62% twelve-month run the stock sits right on the Street's consensus, so it is a quality utility to own for… |
| CAH Cardinal Health, Inc. | Hold | 4 | 5 | 2 | — | +16.3% | $256 ($165–$330) | — | Cardinal Health is a boring, essential, low-margin drug-distribution oligopolist that has quietly executed a genuine turnaround (non-GAAP EPS guided +30% to ~$10.75 in FY26, leverage cut to 3.0×, $1B bought back) — but the market has *already* rewarded it, running the stock to a fresh 52-week high… |
| CHD Church & Dwight Co., Inc. | Hold | 4 | 5 | 2 | — | +17.6% | $96 ($72–$116) | — | Church & Dwight is a best-in-class consumer-staples compounder — 45% gross margin, ~17% ROE, a low-0.47 beta, and 5% organic growth on strong innovation — but at 32× trailing EPS for a low-single-digit reported grower the stock already prices in the quality, leaving a modest negative to fair value… |
| CMS CMS Energy Corporation | Hold | 4 | 5 | 2 | — | +11.2% | $77 ($63–$86) | — | CMS is a textbook low-beta regulated Michigan utility — reliable ~7–8% EPS growth, a 2.9% dividend, management reaffirming $3.83–$3.90 FY26 adjusted EPS — that is trading at roughly its own fair value, so the risk/reward is balanced rather than compelling. Nothing is broken; nothing is cheap. Watch. |
| COR Cencora, Inc. | Hold | 4 | 5 | 3 | — | -12.2% | $340 ($255–$400) | — | Cencora is a defensive, low-beta pharmaceutical-distribution utility moving $321B of drugs a year at a ~3.5% gross margin and <1% net margin; the stock has de-rated ~21% off its high and trades at ~16.7× forward adjusted EPS with a mid-teens adjusted-EPS growth path driven by buybacks, mix… |
| CSCO Cisco Systems, Inc. | Hold | 4 | 5 | 4 | $113 | +46.3% | $118 ($82–$148) | — | Cisco is a mature, cash-gushing networking incumbent that the market has re-rated as an AI-infrastructure beneficiary (stock +63% in 12 months, near all-time highs); the business is genuinely good — 64% gross margin, 25% ROE, ~$13B free cash flow — but at 37× trailing GAAP earnings and ~26× forward… |
| CTVA Corteva, Inc. | Hold | 4 | 5 | 2 | — | +28.0% | $92 ($70–$108) | — | Corteva is a well-run, net-cash, #1/#2 global seed-and-crop-protection franchise trading at a full ~23× forward operating earnings on only low-single-digit revenue growth — a defensible compounder whose main 2026 story is a value-unlocking split into two companies, but with the stock already at a… |
| DGX Quest Diagnostics Incorporated | Hold | 4 | 5 | 2 | — | +24.3% | $220 ($165–$265) | — | Quest is a well-run, defensive US clinical-lab duopolist growing high-single-digit revenue (FY25 +11.8% to $11.0B, mostly M&A-assisted) with reliable cash flow and a 1.5% dividend — but at 24× trailing earnings and 3.1× net-debt/EBITDA on ~11% EPS growth, the stock already reflects the good news… |
| DRI Darden Restaurants, Inc. | Hold | 4 | 5 | 2 | — | +11.0% | $210 ($165–$260) | — | Darden is a best-in-class restaurant operator (Olive Garden, LongHorn, Ruth's Chris) throwing off ~$1.1B of free cash flow and a ~3% dividend, but it grows revenue only mid-single-digits, trades roughly in line with fair value, and has zero expert coverage in our KB — a Watch: own it for defensive… |
| EXPD Expeditors International of Wash | Hold | 4 | 5 | 2 | — | +12.5% | $158 ($120–$195) | — | Expeditors is a genuinely elite, capital-light freight forwarder — 37% ROE, net cash, decades of shareholder-friendly buybacks — but it is a cyclical, low-single-digit grower now trading at 28× earnings and *above* the Street's own price target, so the quality is real and the entry price is not… |
| FFIV F5, Inc. | Hold | 4 | 5 | 3 | — | +59.9% | $390 ($280–$505) | — | F5 is a genuinely good, cash-generative infrastructure-software business that has quietly turned an AI-inference and hybrid-multicloud story into seven straight quarters of double-digit product growth — but the stock has already re-rated from ~$224 to ~$408 in a year (mostly multiple, not… |
| JNJ Johnson & Johnson | Hold | 4 | 5 | 2 | — | +27.1% | $258 ($205–$300) | — | Johnson & Johnson is a fortress: AAA-caliber balance sheet, 0.26 beta, 69% gross margin, two diversified franchises (Innovative Medicine + MedTech), and a raised FY26 outlook — but after a +69% twelve-month run it trades at 30× trailing / 22.7× forward for only mid-single-digit revenue growth, so… |
| KO The Coca-Cola Company | Hold | 4 | 5 | 2 | — | +20.4% | $82 ($64–$96) | — | Coca-Cola is one of the highest-quality, most durable businesses on earth — 62% gross margin, 44% ROE, a beta of 0.35, a fortress brand-and-bottler moat — but at ~26× earnings for only mid-single-digit EPS growth the stock is priced for perfection, so we rate it Watch: a superb defensive holding to… |
| LDOS Leidos Holdings, Inc. | Hold | 4 | 5 | 3 | — | -39.7% | $138 ($88–$178) | — | Leidos is a defensive, US-government IT and services prime that grew FY25 revenue only ~3% to $17.2B but throws off ~$1.6B of free cash flow and trades at just 9.9× earnings after a −46% drawdown driven by federal-budget fear — a cheap, low-beta value/mean-reversion setup where management just… |
| LMT Lockheed Martin Corporation | Hold | 4 | 5 | 2 | — | +12.8% | $560 ($430–$690) | — | A cheap, low-beta, dividend-paying defense prime with a fortress backlog and an irreplaceable franchise (F-35, missile defense, Space) — but 2025 was a *margin-shock* year (net income fell to $5.0B on program charges), growth is low-single-digit, and at only +3% to our base-case fair value the… |
| MET MetLife, Inc. | Hold | 4 | 5 | 3 | — | +14.1% | $99 ($72–$122) | — | MetLife is a large, cheap, conservatively-capitalized global life insurer trading at ~9× forward adjusted EPS with a ~2.5% dividend and steady buybacks; the numbers support a modest Buy — Tactical on valuation and capital return, but this is a low-growth, rate-sensitive balance-sheet business with… |
| NOC Northrop Grumman Corporation | Hold | 4 | 5 | 2 | — | -3.7% | $560 ($420–$640) | — | A blue-chip defense prime trading at a reasonable ~17× trailing / 12× EV-EBITDA after a ~28% drawdown, with a negative beta, a $96B backlog, and reaffirmed 2026 guidance — but the growth is genuinely modest (~5% EPS CAGR) and the fixed-price B-21/Sentinel programs have already burned shareholders… |
| NTRS Northern Trust Corporation | Hold | 4 | 5 | 3 | — | +29.2% | $182 ($128–$226) | — | Northern Trust is a rock-solid, deposit-funded custody-and-wealth franchise trading at a modest ~16× forward earnings after a strong 2025–26 recovery in return-on-equity; the earnings recovery is real but is driven by cost discipline, buybacks and a friendly rate/market backdrop rather than an… |
| NVR NVR, Inc. | Hold | 4 | 5 | 2 | — | -7.4% | $6900 ($4900–$8800) | — | NVR runs the best-designed business model in US homebuilding — asset-light land options, pre-sold homes, no land-development risk, 33% ROE and a net-cash balance sheet — but the cycle has turned against it: FY25 revenue fell 2%, net income fell 20%, Q1'26 EPS fell 29%, and gross margin is… |
| NWS News Corporation | Hold | 4 | 5 | 3 | — | +1.8% | $33 ($23–$42) | — | News Corp is a cheap-on-cash-flow (EV/EBITDA 11.7×) collection of a few genuinely good digital businesses — Dow Jones (WSJ/Barron's/Factiva), REA Group (Australian real estate), and Realtor.com — bolted to slow-declining legacy print and book publishing, wrapped in a dual-class structure the… |
| NWSA News Corporation | Hold | 4 | 5 | 3 | — | +2.0% | $29 ($20–$35) | — | News Corp is a genuine sum-of-the-parts story — a crown-jewel Digital Real Estate stake (REA Group) and a growing, high-margin Dow Jones (Wall Street Journal, Barron's, professional data) bolted to a shrinking, low-multiple print/News Media business — trading at roughly fair value near the Street… |
| PAYX Paychex, Inc. | Hold | 4 | 5 | 2 | $106 | -5.2% | $108 ($82–$135) | — | Paychex is a best-in-class, cash-gushing payroll/HCM utility (46% EBITDA margin, 45% ROE, 4.2% dividend) that just absorbed Paycor — but the stock is down 28% on the year, the multiple still isn't cheap for mid-single-digit organic growth, and there is zero expert conviction in the Synthos KB, so… |
| PEP PepsiCo, Inc. | Hold | 4 | 5 | 2 | $144 | +0.5% | $159 ($126–$182) | — | PepsiCo is a fortress-quality, low-beta consumer staple throwing off ~$7.7B of free cash flow and a ~4% dividend — but FY25 revenue grew only ~2% and GAAP EPS actually *fell*, the stock is down ~15% from its high while the market ran, and there is no Synthos expert conviction behind it; it is a… |
| PG The Procter & Gamble Company | Hold | 4 | 5 | 2 | — | +5.6% | $162 ($130–$180) | — | P&G is a best-in-class, fortress-balance-sheet consumer-staples compounder — 50% gross margin, 31% ROE, a 70-year dividend-raise streak — but it is growing revenue only low-single-digits and trades at ~22× earnings, so the quality is real and the price already reflects it; we rate it Watch and… |
| PYPL PayPal Holdings, Inc. | Hold | 4 | 5 | 3 | $45 | -22.1% | $58 ($32–$85) | — | PayPal is a cash-machine at a distressed price — 8.5× earnings, ~14% free-cash-flow yield, a fortress-lite balance sheet and $6B/yr of buybacks shrinking the share count — but the market is (rightly) worried that its high-margin branded-checkout franchise is losing share to Apple Pay, Shop Pay and… |
| SO The Southern Company | Hold | 4 | 5 | 2 | — | +12.4% | $100 ($78–$114) | — | Southern is a best-in-class regulated Southeastern utility riding real data-center-driven load growth, but at ~25× trailing earnings for ~9% EPS growth and a 3% yield, the stock already prices the good news — a hold-for-income name, not a total-return buy at today's price. |
| TDY Teledyne Technologies Incorporat | Hold | 4 | 5 | 3 | — | +27.7% | $660 ($500–$820) | — | Teledyne is a superbly-run, Danaher-style serial acquirer of niche sensing, imaging and defense-electronics businesses (FY25 revenue $6.12B +7.9%, GAAP EPS $18.88, FCF $1.07B), but at 33× trailing on ~5% organic revenue growth the stock already reflects the quality — so it earns a Watch, not a Buy… |
| TRV The Travelers Companies, Inc. | Hold | 4 | 5 | 2 | — | +18.0% | $330 ($255–$400) | — | Travelers is a genuinely elite P&C underwriter — 88.6% combined ratio, 22.7% trailing core ROE, 22 straight years of dividend hikes, a fortress balance sheet — but the stock is at its 52-week high, RSI 89, trading *above* the Street's $310 target, and Wall Street's own EPS estimates show earnings… |
| TXT Textron Inc. | Hold | 4 | 5 | 3 | — | +6.1% | $98 ($72–$124) | — | A cheap, well-run, low-beta multi-industrial (business jets, Bell helicopters, defense systems, and an Industrial segment now slated for separation) trading at ~15× forward earnings — the value is real but so is the ceiling: ~3% revenue growth means the whole upside case rests on the announced… |
| WEC WEC Energy Group, Inc. | Hold | 4 | 5 | 2 | — | +12.7% | $120 ($98–$138) | — | WEC is a best-in-class Midwest regulated utility — 4.8M customers, a $28B capital plan, a 22-year dividend-growth streak, and a low 0.47 beta — but at ~21× forward earnings for ~7% EPS growth it is priced like a premium bond proxy with little margin of safety, so we rate it Watch: own it for… |
| AEP American Electric Power Company, | Hold | 5 | 5 | 3 | $139 | +20.1% | $137 ($110–$168) | — | AEP is a large, low-beta regulated electric utility riding a genuine once-in-a-generation demand tailwind (63 GW of signed/pending data-center and industrial load by 2030 driving an $78B capital plan and ~11% rate-base growth), but the earnings growth this converts to is a steady 7–9% — good for a… |
| AVY Avery Dennison Corporation | Hold | 5 | 5 | 2 | — | -8.2% | $178 ($130–$225) | — | Avery Dennison is a high-quality, wide-moat label-materials leader trading at a reasonable ~19× earnings with a 2.3% dividend and a real RFID growth kicker — but it is a mature, cyclical ~4%-top-line business with no expert conviction behind it and a stock that has *lagged the market by ~28 points… |
| CDW CDW Corporation | Hold | 5 | 5 | 3 | — | -2.1% | $150 ($110–$195) | — | CDW is a well-run, cash-generative IT reseller trading at a modest ~16× earnings and a ~1.9% dividend, but it is a thin-margin, cyclical middleman growing revenue in the mid-single digits — a reasonable value-and-income holding, not a compounder or an exponential, and with no expert conviction in… |
| CFG Citizens Financial Group, Inc. | Hold | 5 | 5 | 3 | — | +21.5% | $72 ($52–$90) | — | Citizens is a well-run, cheaply-priced US super-regional bank in the early innings of a self-help earnings recovery (NIM expanding to 3.14%, ROTCE back to 12.2%, a fast-growing Private Bank), but it is a rate- and credit-cycle business with a fixed deposit footprint — the stock has already run +54%… |
| CL Colgate-Palmolive Company | Hold | 5 | 5 | 2 | — | +20.4% | $92 ($72–$112) | — | Colgate is one of the highest-quality consumer-staples franchises on earth — 41% global toothpaste share, ~60% gross margins, 30%+ return on invested capital, a 0.32 beta — but at 37× trailing / ~24× forward earnings for roughly 4% revenue and 5–6% EPS growth, the price already reflects the… |
| CTSH Cognizant Technology Solutions C | Hold | 5 | 5 | 3 | — | -49.4% | $74 ($47–$104) | — | A profitable, net-cash, cash-generative IT-services leader has been cut roughly in half (−48% in 12 months) on fears that generative AI guts the offshore labor-arbitrage model — leaving it at ~7× forward earnings with a ~12% free-cash-flow yield and 21% quarterly bookings growth; the tactical bet… |
| DIS The Walt Disney Company | Hold | 5 | 5 | 3 | — | -12.6% | $118 ($78–$150) | — | Disney is a cheap ($99, ~15× trailing, ~13× FY27E) turnaround where an irreplaceable IP flywheel and a genuinely high-return Experiences (parks/cruises) business are being masked by the melting linear-TV franchise and a wounded chart (−20% off the high, −19% over 12 months vs SPY +21%) — a Tactical… |
| DLTR Dollar Tree, Inc. | Hold | 5 | 5 | 3 | — | +0.8% | $128 ($80–$170) | — | A newly-simplified, single-banner Dollar Tree (Family Dollar divested) is executing a credible margin turnaround — Q1 FY26 adjusted EPS +38%, comps +3.5%, guiding FY26 adjusted EPS to $6.70–$7.10 — at a genuinely undemanding ~18× forward earnings; but it's a low-growth, US-saturated discounter with… |
| DTE DTE Energy Company | Hold | 5 | 5 | 2 | — | +19.4% | $152 ($128–$170) | — | DTE Energy is a well-run, low-beta Michigan regulated electric-and-gas utility compounding earnings at a steady ~7–8% off a growing rate base — but at ~$154 it trades near its own fair value and the Street's, carries ~6.6× net-debt/EBITDA and structurally negative free cash flow (a normal utility… |
| EBAY eBay Inc. | Hold | 5 | 5 | 3 | — | +31.8% | $118 ($82–$150) | — | eBay is a cash-generative, cheaply-valued marketplace that has genuinely re-accelerated (Q1'26 GMV +18%, revenue +19%) on Focus Categories, collectibles and advertising — but it is a mature $51B business with a mid-single-digit structural growth ceiling and a rich beta, so the honest call is Watch… |
| EQT EQT Corporation | Hold | 5 | 5 | 3 | — | -1.8% | $52 ($33–$72) | — | EQT is the largest and among the lowest-cost natural-gas producers in the US, now de-levered and gushing free cash flow at high gas prices — but it is fundamentally a commodity price bet: at ~$53 the stock already discounts a healthy gas strip, the Street's $41 consensus sits *below* today's price… |
| ERIE Erie Indemnity Company | Hold | 5 | 5 | 3 | — | -9.6% | $255 ($180–$320) | — | Erie Indemnity is a capital-light, zero-debt fee machine with ~25% ROE — a genuinely high-quality toll-taker — but the stock sits at 21× earnings on EPS that has *stopped* accelerating (2025 EPS actually fell), after a −52% peak-to-trough drawdown, so at ~$259 we see it as roughly fairly valued and… |
| EVRG Evergy, Inc. | Hold | 5 | 5 | 3 | — | +21.6% | $91 ($72–$106) | — | Evergy is a slow, dependable Kansas–Missouri regulated electric monopoly whose earnings grow at a mid-single-digit clip that data-center "large-load" demand could nudge toward 8%+ late this decade — but at the 52-week high, a full valuation, a 3.1% dividend and a Watch-grade balance sheet, the… |
| FITB Fifth Third Bancorp | Hold | 5 | 5 | 3 | — | +22.1% | $60 ($44–$74) | — | Fifth Third is a cleanly-run, cheap ($57, ~11.6× FY27E, 2.8% yield) super-regional that just bought Comerica in a ~$12.7B all-stock deal — the numbers are fine and the stock is near highs, but there is no expert conviction behind it and no exponential story, so it is a Watch: a reasonable… |
| FRT Federal Realty Investment Trust | Hold | 5 | 5 | 2 | — | +20.7% | $124 ($95–$148) | — | Federal Realty is the highest-quality open-air retail landlord in the US — 54 straight years of dividend increases, record 13% cash re-leasing spreads, coastal supply-constrained locations — but at ~16× Core FFO with mid-single-digit FFO growth it is priced for what it is: a durable income… |
| FTV Fortive Corporation | Hold | 5 | 5 | 3 | — | +13.5% | $62 ($46–$78) | — | Fortive is a freshly slimmed-down, higher-quality industrial-technology compounder — the June 2025 spin of Precision Technologies (Ralliant) left a two-segment, software-and-healthcare-tilted business with 62% gross margins and 29% adjusted-EBITDA margins — but it trades at a full 21× forward… |
| GEHC GE HealthCare Technologies Inc. | Hold | 5 | 5 | 3 | $66 | -20.1% | $75 ($52–$95) | — | GE HealthCare is a global imaging and diagnostics leader trading at a genuinely undemanding valuation (13× forward earnings, 1.9× sales), backed by a rock-solid installed base and a helpful cluster of insider buying — but it grows revenue at only mid-single-digits, carries moderate leverage, and… |
| GL Globe Life Inc. | Hold | 5 | 5 | 2 | — | +29.1% | $175 ($120–$225) | — | Globe Life is a cheap, low-beta, buyback-driven life & supplemental-health insurer to lower-middle-income US households — a real ~20%-ROE cash machine trading at ~12× earnings — but it grows slowly (~5% revenue), carries an unresolved agent-misconduct/short-seller overhang, and just ran +44% into a… |
| HD The Home Depot, Inc. | Hold | 5 | 5 | 2 | — | +4.0% | $360 ($270–$445) | — | Home Depot is a fortress retailer with elite returns on capital and a wide moat, but it is a mature, cyclical, low-single-digit grower trading at ~25× earnings — you are paying a quality-and-cycle-recovery premium, so the honest call is Watch until either the price comes in or the housing cycle… |
| HII Huntington Ingalls Industries, I | Hold | 5 | 5 | 3 | — | -14.3% | $330 ($225–$430) | — | HII owns an essentially unassailable monopoly building America's aircraft carriers and submarines with a $54B backlog (>4× annual revenue), but the business runs at ~5% operating margins, guides to only ~6% revenue growth, carries 2.3× net-debt/EBITDA, and has burned through a 36% drawdown on… |
| HON Honeywell International Inc. | Hold | 5 | 5 | 3 | $230 | -41.1% | $235 ($175–$300) | — | Honeywell is a cheap, low-beta, cash-generative industrial conglomerate in the middle of splitting itself into three — a classic "sum-of-the-parts" value setup where the reward (re-rating of Aerospace) is real but so is the execution risk, and with zero expert coverage and only mid-single-digit… |
| KDP Keurig Dr Pepper Inc. | Hold | 5 | 5 | 3 | $33 | +18.9% | $34 ($26–$44) | — | KDP is a well-run, low-beta beverage staple that gushes cash and pays a ~2.8% dividend, but it is only *fairly* priced, its returns on capital are pedestrian (ROIC ~4%), and its next chapter is a debt-funded coffee mega-deal and corporate split — so the honest verdict is Watch: own it for income… |
| LNT Alliant Energy Corporation | Hold | 5 | 5 | 4 | — | +20.0% | $79 ($63–$92) | — | Alliant is a well-run Midwest regulated electric-and-gas utility riding a real data-center demand wave (3.4 GW of contracted load, five executed agreements) that supports its decade-plus ~6% EPS growth track record — but at ~23× forward earnings, near a 52-week high, on 5.7× net-debt/EBITDA… |
| LOW Lowe's Companies, Inc. | Hold | 5 | 5 | 2 | — | -5.7% | $245 ($185–$295) | — | Lowe's is a well-run, cash-generative #2 home-improvement retailer trading at a reasonable ~19× earnings, but revenue is barely growing (~5% forward) in a mature, housing-cycle-dependent US market — a solid dividend compounder to own on weakness, not a name with the growth or the expert conviction… |
| MLM Martin Marietta Materials, Inc. | Hold | 5 | 5 | 3 | — | -3.7% | $620 ($470–$760) | — | Martin Marietta is a genuinely elite aggregates franchise — irreplaceable, permitted stone reserves with durable pricing power — but at ~$599 (~31× FY26E EPS, EV/EBITDA 19×) the market already pays a premium for a cyclical whose organic volume grows low-single-digits; the honest call is Watch and… |
| NI NiSource Inc. | Hold | 5 | 5 | 4 | — | +14.5% | $49 ($38–$60) | — | NiSource is a well-run, fully-regulated gas-and-electric utility whose new twist is a data-center growth engine — GenCo collaborations with Alphabet and Amazon in Indiana that let management *raise* its 2026–2033 adjusted-EPS CAGR guidance to 9–10%. The stock already trades near the Street target… |
| NSC Norfolk Southern Corporation | Hold | 5 | 5 | 3 | — | +11.8% | $330 ($250–$415) | — | Norfolk Southern is a high-quality, wide-moat Eastern US railroad executing a credible self-help operating-ratio story (adjusted OR ~68–69%), but it trades at ~27× trailing / 26× forward for only ~5% revenue and ~7% EPS growth, carries 2.85× net-debt/EBITDA, and its risk/reward is now dominated by… |
| NTAP NetApp, Inc. | Hold | 5 | 5 | 3 | — | +44.0% | $150 ($110–$200) | — | NetApp is a well-run, cash-generative, all-flash-and-cloud storage leader trading at a fair-to-full ~19× forward non-GAAP earnings, but its FY26 revenue grew only 5% and management guides FY27 to ~7–9% — this is a high-quality *compounder-at-a-fair-price*, not a mispriced growth story, so we rate… |
| PKG Packaging Corporation of America | Hold | 5 | 5 | 3 | — | +15.5% | $235 ($160–$275) | — | PKG is a genuinely well-run, low-cost containerboard producer that just bought Greif's containerboard business (~$1.8B) to add scale — but it is a mature, cyclical commodity company trading at ~29× trailing earnings, roughly at our fair value, with an overbought chart and no expert conviction… |
| PNC The PNC Financial Services Group | Hold | 5 | 5 | 3 | — | +19.5% | $255 ($180–$293) | — | PNC is a high-quality, US-super-regional bank trading at a fair-to-slightly-cheap ~14.5× earnings with a 2.7% dividend; the numbers are solid (12% ROE, 12% forward EPS growth, low beta) but there is no expert conviction and no exponential story here — it's a Watch: own it for income and stability… |
| PNR Pentair plc | Hold | 5 | 5 | 2 | — | -26.3% | $88 ($58–$112) | — | Pentair is a well-run, cash-generative water and pool business trading at a reasonable (not cheap) ~14× forward earnings, but revenue barely grows (~3–4%/yr), the end markets are cyclical and mid-downturn, and the stock is in a 32% drawdown — a fine *Watch*/value-satellite candidate, not a… |
| PNW Pinnacle West Capital Corporatio | Hold | 5 | 5 | 3 | — | +23.3% | $100 ($76–$115) | — | Pinnacle West is a well-run, single-state Arizona regulated electric utility riding a genuine data-center/AI load boom (management guides 4–6% weather-normalized sales growth), but it is a capex-heavy, negative-free-cash-flow, rate-base-bound monopoly trading at a 52-week high with an overbought… |
| STT State Street Corporation | Hold | 5 | 5 | 2 | — | +32.3% | $176 ($120–$220) | — | State Street is a cheap, well-capitalized, 233-year-old custody bank and index-fund manager (SPDR) with a fortress franchise ($53.8T assets under custody, $5.67T AUM) — but its revenue rides equity markets and interest rates rather than a growth engine, so at ~13× forward earnings it is a… |
| WM Waste Management, Inc. | Hold | 5 | 5 | 2 | — | +4.9% | $235 ($185–$285) | — | WM is a genuinely elite, recession-proof toll road on North American waste — 29% EBITDA margins, 29% ROE, wide moat, low beta — but at 33× trailing earnings and 3.1× net-debt/EBITDA the price already reflects the quality, leaving a ~5% revenue / ~12% EPS grower with little valuation cushion and no… |
| XEL Xcel Energy Inc. | Hold | 5 | 5 | 3 | $82 | +11.0% | $84 ($66–$100) | — | Xcel is a well-run, low-beta regulated electric-and-gas monopoly riding a genuine multi-year rate-base and data-center demand tailwind — but it funds that growth with heavy debt and equity issuance, generates *negative* free cash flow through the buildout, earns a capped regulated return, and… |
| ZTS Zoetis Inc. | Hold | 5 | 5 | 3 | — | -40.5% | $84 ($58–$112) | — | Zoetis is the world's #1 animal-health company — 71% gross margins, 62% ROE, a genuine moat — now trading at a 5-year-low 12× earnings after a brutal −53% drawdown; but the crash reflects a *real* stall (US companion-animal demand softening, generics on Convenia/Cerenia, dermatology competition)… |
| AMGN Amgen Inc. | Hold | 6 | 5 | 3 | $374 | +14.3% | $380 ($270–$470) | — | Amgen is a high-margin, cash-generative big-pharma cash-cow (FY25 revenue $36.7B +9.9%, 71% gross margin, $8.1B FCF, 2.6% dividend) trading at a reasonable ~16–17× forward adjusted earnings — but it grows revenue at only ~3% a year, carries $45B of net debt against a buyback-hollowed balance sheet… |
| AMT American Tower Corporation | Hold | 6 | 5 | 2 | — | -5.4% | $195 ($150–$235) | — | The world's largest tower REIT — contracted, inflation-escalated cash flows and a 4%+ dividend — has been cut ~29% from its high and now trades at a decade-cheap multiple, but the growth engine is barely mid-single-digit, leverage is ~4.9× net, and there is no Synthos expert conviction behind it; a… |
| APD Air Products and Chemicals, Inc. | Hold | 6 | 5 | 3 | — | +27.2% | $315 ($225–$375) | — | Air Products is a genuinely durable, wide-moat industrial-gas franchise (on-site take-or-pay contracts, ~85 years old), but it is a low-single-digit-to-high-single-digit grower priced like a compounder, carrying elevated debt and burning free cash flow to fund a controversial clean-hydrogen… |
| CARR Carrier Global Corporation | Hold | 6 | 5 | 4 | — | +32.6% | $72 ($50–$92) | — | Carrier has finished a two-year transformation into a pure-play intelligent-climate company (Fire & Security and Access divested, Viessmann bought), and the market is already paying a growth multiple (45× trailing, 22× EV/EBITDA) for a business whose FY25 revenue actually *fell* ~3% — the bull case… |
| CHRW C.H. Robinson Worldwide, Inc. | Hold | 6 | 5 | 3 | — | +18.1% | $162 ($88–$204) | — | C.H. Robinson is a genuinely well-managed, asset-light freight broker executing a real cost-out and "Lean AI" turnaround — adjusted EPS rose 15% in Q1'26 despite flat volumes — but the stock has already re-rated to 38× trailing / 26× forward on that story, revenue actually *shrank 8%* in FY25, and… |
| CMG Chipotle Mexican Grill, Inc. | Hold | 6 | 5 | 3 | — | -4.4% | $38 ($26–$52) | — | Chipotle is a genuinely elite restaurant operator whose *engine has downshifted* — FY25 revenue grew only +5.4% to $11.9B, Q1'26 comps were +0.5% with operating margin falling to 12.9% (from 16.7%) and EPS *declining* year-over-year — yet the stock still trades at ~32× trailing; after a −48%… |
| DE Deere & Company | Hold | 6 | 5 | 3 | — | +33.4% | $640 ($470–$780) | — | Deere is a genuinely elite industrial franchise — a widening precision-ag moat, ~18% ROE, a dealer-funded capital-light core — but the stock trades at 35× trailing EPS in the middle of an agricultural down-cycle (revenue already −26% from the FY23 peak, Large Ag guided down another 15–20%), so you… |
| DPZ Domino's Pizza, Inc. | Hold | 6 | 5 | 2 | — | -25.2% | $340 ($235–$445) | — | Domino's is a genuinely excellent, high-return franchise business trading ~36% below its peak after a hard 12 months — but the growth engine has cooled to low-single-digit same-store sales, leverage is heavy (net-debt/EBITDA ~4.9×), and forward growth is only ~5% revenue / ~10% EPS. At ~18×… |
| FCX Freeport-McMoRan Inc. | Hold | 6 | 5 | 4 | — | +20.0% | $63 ($40–$88) | — | Freeport owns some of the best copper ore bodies on earth and sits squarely in the electrification/AI-power demand story, but it is a price-taker whose earnings swing with the copper price, the crown-jewel Grasberg mine is still ramping back from a September-2025 mud-rush incident, and at ~$61 the… |
| FE FirstEnergy Corp. | Hold | 6 | 5 | 2 | — | +8.4% | $50 ($40–$58) | — | FirstEnergy is a six-state regulated electric utility executing a large multi-year transmission-and-distribution ("Energize365") rate-base build; it offers a ~3.7% dividend and steady high-single-digit EPS growth, but it carries heavy leverage, negative free cash flow during the build, and a… |
| GS The Goldman Sachs Group, Inc. | Hold | 6 | 5 | 3 | — | +16.2% | $1015 ($660–$1300) | — | Goldman is executing exceptionally well right now — record $3.65T assets under supervision, a record Global Banking & Markets quarter, 21% ROTE — and the stock is genuinely cheap on earnings (~18× trailing, ~17× forward), but those earnings sit near the top of the investment-banking/trading cycle… |
| HUM Humana Inc. | Hold | 6 | 5 | 4 | — | +54.9% | $360 ($230–$500) | — | Humana is a #2 Medicare Advantage insurer whose GAAP earnings collapsed (FY25 adjusted EPS $17.14 → FY26 guided "at least $9.00") on a Bonus-Year-2026 Star Ratings funding headwind; the stock has already tripled off its 2025 lows (+124% in three months) on the bet that Stars and margins normalize… |
| INCY Incyte Corporation | Hold | 6 | 5 | 3 | — | +18.3% | $105 ($72–$135) | — | Incyte looks statistically cheap — 16× earnings, net cash, 92% gross margin, a 21% top-line year — but that low multiple is the market correctly pricing a concentration problem: Jakafi is ~69% of revenue and its exclusivity cliff is already visible in consensus (EPS peaks near $9.47 in FY28E then… |
| LUV Southwest Airlines Co. | Hold | 6 | 5 | 3 | — | +21.6% | $52 ($30–$72) | — | Southwest's 18-month "transformation" (assigned seating, extra-legroom, bag fees, Rapid Rewards monetization) is now fully implemented and *is* showing up in the numbers — Q1'26 RASM +11%, operating margin +8 points YoY — but the market has already re-rated the stock +50% in twelve months to fair… |
| LVS Las Vegas Sands Corp. | Hold | 6 | 5 | 3 | — | -27.8% | $58 ($34–$74) | — | LVS is a high-quality integrated-resort operator trading at a genuinely undemanding valuation (9× EV/EBITDA, 17× earnings) near its 52-week low, aggressively shrinking its share count — but it is a leveraged, deeply cyclical bet on Macao and Singapore with no secular growth engine and no expert… |
| NEM Newmont Corporation | Hold | 6 | 5 | 3 | — | -2.8% | $108 ($70–$150) | — | Newmont is the world's largest gold miner, now genuinely cheap on cash flow (12.5× earnings, 5.9× EV/EBITDA, ~12% free-cash-flow yield) with a rare net-*cash* balance sheet and a doubled buyback — but the entire earnings surge is a gold-price story on flat-to-declining ounces, the Street's own… |
| NXPI NXP Semiconductors N.V. | Hold | 6 | 5 | 4 | $273 | +25.9% | $285 ($175–$375) | — | NXPI is a high-quality automotive- and industrial-analog chipmaker coming off a three-year revenue decline ($13.3B FY23 → $12.3B FY25); the stock at ~26× trailing / ~18× forward is priced *for* a cyclical recovery that the estimates already assume — a solid business with no margin of safety and no… |
| ON ON Semiconductor Corporation (on | Hold | 6 | 5 | 5 | — | +68.5% | $95 ($53–$130) | — | onsemi is a high-beta power-and-sensing semiconductor company that has "moved beyond the cyclical trough" (management's own words, Q1'26) with a genuinely accelerating AI-datacenter and silicon-carbide EV story — but the stock has already rallied ~70% in twelve months, trades at 64× trough earnings… |
| ROK Rockwell Automation, Inc. | Hold | 6 | 5 | 3 | — | +21.2% | $465 ($355–$585) | — | Rockwell is a genuinely high-quality, wide-moat US automation franchise (52% gross margin, ~30% ROE, growing software/ARR mix) that is executing a clean cyclical recovery — but at ~36× forward earnings for only ~5% revenue growth, the market already pays full price, so we rate it Watch: a name to… |
| RVTY Revvity, Inc. | Hold | 6 | 5 | 3 | — | +17.6% | $116 ($82–$150) | — | Revvity is a high-quality, recurring-revenue diagnostics and life-sciences-tools franchise that is executing fine operationally — beating its own quarterly numbers — but is growing only 3–4% organically, carries 3.2× net-debt/EBITDA, and already trades roughly in line with a fair value, so there is… |
| SBAC SBA Communications Corporation | Hold | 6 | 5 | 3 | — | -4.6% | $207 ($158–$247) | — | SBAC is a high-quality, wide-moat US-and-emerging-markets tower REIT throwing off ~80% tower-cash-flow margins and a fast-growing dividend — but domestic leasing is essentially flat, EchoStar churn is a real drag, the balance sheet carries 6.6× net-debt/EBITDA, and at ~15× AFFO the stock is… |
| SRE Sempra | Hold | 6 | 5 | 3 | — | +5.4% | $100 ($78–$122) | — | Sempra is a regulated Texas + California utility with a visible $65B five-year rate-base growth plan and management guiding 7–9% long-term EPS growth, trading near fair value at ~18× forward adjusted EPS and a 2.8% yield — a reasonable defensive income holding, but the heavy leverage (5.4×… |
| SW Smurfit Westrock plc | Hold | 6 | 5 | 4 | — | +18.8% | $50 ($30–$60) | — | Smurfit Westrock is the year-old merger of Smurfit Kappa and WestRock — a $31B-revenue global packaging giant whose reported earnings are still depressed by merger accounting and a soft cycle (FY25 net income just $699M, 0.8% Q1'26 net margin), so the entire bull case is management delivering… |
| TECH Bio-Techne Corporation | Hold | 6 | 5 | 3 | — | +20.4% | $63 ($46–$82) | — | Bio-Techne is a genuinely high-quality life-science-tools franchise — 65% gross margins, sticky consumables, a fortress balance sheet — but after a −2% revenue quarter and a re-based ~5% forward growth rate, the stock has run to ~35× forward earnings and an RSI of 84 near its 52-week high, *above*… |
| VTR Ventas, Inc. | Hold | 6 | 5 | 3 | — | +19.6% | $89 ($70–$105) | — | Ventas is a well-run healthcare REIT riding a genuine, once-in-a-generation demographic tailwind (the Boomer 80+ wave now inflecting) with senior-housing same-store NOI growing 15%+ — but after a +47% twelve-month run the stock sits *at* its 52-week high on an overbought RSI, priced at ~24× FFO for… |
| WMB The Williams Companies, Inc. | Hold | 6 | 5 | 3 | — | +21.7% | $76 ($54–$90) | — | Williams owns one of the best natural-gas transportation franchises in North America — the Transco backbone plus a data-center/LNG demand tailwind — but the stock already prices that in at ~32× earnings and 16.8× EV/EBITDA on a 4.1× levered balance sheet with only ~0.8% free-cash-flow yield, so we… |
| JBHT J.B. Hunt Transport Services, In | Hold | 7 | 5 | 3 | — | +47.1% | $240 ($135–$320) | — | J.B. Hunt is a best-in-class North-American intermodal and logistics operator with a genuine cost-and-scale moat — but the stock has rallied ~89% in twelve months to 44× trailing earnings on a business whose revenue has *fallen three years running*, so we rate it Watch: own the operator, wait for a… |
| MCHP Microchip Technology Incorporate | Hold | 7 | 5 | 4 | $85 | +32.8% | $99 ($61–$124) | — | Microchip is a high-quality embedded-controller franchise coming off the deepest downcycle in its history (revenue fell from $7.6B to $4.4B, then began recovering to $4.7B), and the stock already prices in a full recovery — so the fundamentals say "great business, wrong price," and with zero expert… |
| NCLH Norwegian Cruise Line Holdings L | Hold | 7 | 5 | 3 | — | -11.4% | $22 ($14–$29) | — | Norwegian is the smallest and most heavily levered of the three big cruise operators — a recovered, cash-generating-at-the-operating-line business trading at a genuinely low ~10× forward earnings, but carrying ~$14.4B of net debt (6.3× EBITDA) into a cyclical, discretionary-spend industry; the… |
| AES The AES Corporation | Hold | 8 | 5 | 4 | — | +1.7% | $16 ($10–$22) | — | AES is a cheap, ~4.8%-yielding global power producer pivoting hard into US renewables and data-center contracts — the demand story is real, but it is one of the most leveraged names in the S&P 500 (7.8× net-debt/EBITDA, negative FCF), growth is only mid-single-digit, and there is zero expert… |
| COIN Coinbase Global, Inc. | Hold | 9 | 5 | 6 | — | -26.8% | $175 ($80–$360) | — | Coinbase is the best-capitalized, most-regulated on-ramp to crypto and owns real structural franchises (USDC/stablecoins, custody, derivatives, onchain infra) — but the stock is down ~61% from its high, earnings swing to GAAP losses on crypto-asset marks, and the forward EPS path is so dispersed… |
| SNDK Sandisk Corporation | Hold | 9 | 5 | 3 | $1,745 | +635.1% | $984 ($450–$1443) | — | Sandisk is a good company caught in a violent NAND memory up-cycle that has re-rated the stock ~38× in twelve months; the earnings are real *today* (Q3 FY26 EPS $24.43, 78% gross margin) but they are peak-cycle, the balance sheet was posting a $1.6B loss just a year ago, beta is 4.88, and at $1,745… |
| BRK-B Berkshire Hathaway Inc. | Hold | 3 | 4 | 2 | — | +1.0% | $540 ($445–$595) | — | Berkshire is the definition of a fortress balance sheet — ~$373B in cash and Treasuries, $176.9B of insurance float, a diversified engine of insurance, rail (BNSF), energy, and manufacturing — trading at a reasonable ~15× earnings and 1.5× book; but with revenue essentially flat, low-double-digit… |
| FOX Fox Corporation | Hold | 3 | 4 | 2 | — | -22.1% | $62 ($44–$80) | — | FOX is a genuinely cheap, cash-generative, low-leverage media operator (FY25 revenue $16.3B, ~$3B FCF, net-debt/EBITDA <1×) whose FOX News/FOX Sports live-programming franchise is more defensible than most legacy TV — but the top line barely grows (~2% forward CAGR), the moat is under secular… |
| AVB AvalonBay Communities, Inc. | Hold | 4 | 4 | 2 | — | +7.0% | $200 ($160–$235) | — | AvalonBay is a best-in-class, investment-grade apartment REIT (~$27.5B, coastal-concentrated, 3.6% dividend) trading roughly at fair value — a steady income compounder with ~2–4% FFO growth, not a wealth-multiplier — so with no expert conviction behind it and Same-Store NOI up only 0.2%, the honest… |
| CINF Cincinnati Financial Corporation | Hold | 4 | 4 | 2 | — | +17.6% | $178 ($150–$205) | — | Cincinnati Financial is a genuinely well-run, A+-rated, net-cash property-casualty insurer that has compounded book value for decades — but at a 52-week high, an overbought RSI of 89, and a price *above* the Street's own $182.5 target, the risk/reward here is a Watch, not a buy: own the quality on… |
| COP ConocoPhillips | Hold | 4 | 4 | 2 | — | +11.9% | $118 ($80–$155) | — | ConocoPhillips is a best-in-class, low-cost, low-leverage oil & gas producer trading cheaply (16.5× earnings, 5.9× EV/EBITDA, ~13% free-cash-flow yield) and returning a lot of that cash to holders — but it is fundamentally a bet on the price of oil and gas, not a growth compounder, so it earns a… |
| EG Everest Group, Ltd. | Hold | 4 | 4 | 2 | — | +9.4% | $390 ($270–$500) | — | Everest is a cheap (7.6× earnings, 0.98× book), low-leverage, A+-rated global reinsurer that just posted a clean quarter (Q1'26 combined ratio 91.2%, 16.7% operating ROE) after a brutal 2024 reserve blowup — but it is a *cyclical underwriter shrinking premiums to defend margin*, not a growth… |
| EOG EOG Resources, Inc. | Hold | 4 | 4 | 3 | — | +24.5% | $140 ($95–$185) | — | EOG is arguably the best-run shale operator in the US — fortress balance sheet (0.37× net-debt/EBITDA), 0.26 beta, ~5.9% FCF yield, ~3.1% dividend — trading at a genuinely cheap ~12.8× trailing earnings; but it is a commodity price-taker with no secular growth, so the honest verdict is Watch: a… |
| FOXA Fox Corporation | Hold | 4 | 4 | 2 | — | -22.7% | $63 ($40–$82) | — | Fox is a cheap (13× earnings), debt-light, cash-generative collection of politically and sports-driven live-TV assets (FOX News, the FOX broadcast network, the NFL, Tubi) that the market prices for slow decline — a reasonable value/income holding, but with low growth, a shrinking pay-TV base, and… |
| KMI Kinder Morgan, Inc. | Hold | 4 | 4 | 2 | — | +16.6% | $33 ($28–$40) | — | Kinder Morgan is a high-quality, fee-based North American pipeline toll-road throwing off a ~3.7% dividend and mid-single-digit growth — a solid *income* holding, but at 21.5× trailing earnings and only ~3% to our base-case fair value it is fairly-to-fully priced, so we rate it Watch rather than… |
| KR The Kroger Co. | Hold | 4 | 4 | 2 | — | -6.8% | $66 ($51–$80) | — | Kroger is a cheap, defensive, cash-generative grocer trading at ~11× forward adjusted earnings with a growing dividend and heavy buybacks — but revenue barely grows (~2%/yr), net margins are razor-thin (~1.3%), returns on capital are low (ROIC ~5%), and the stock is in a clear downtrend; it is a… |
| MDT Medtronic plc | Hold | 4 | 4 | 2 | — | -13.4% | $88 ($66–$108) | — | Medtronic is a cheap, ultra-diversified med-device blue-chip throwing off a 3.4% dividend it has raised for 49 straight years — FY26 delivered its best organic growth in a decade (+5.8%) — but ~6% organic top-line, flat margins, ~6% ROIC and a stock 21% below its high and trailing the market by ~27… |
| PEG Public Service Enterprise Group | Hold | 4 | 4 | 2 | — | +1.6% | $85 ($66–$100) | — | PEG is a well-run, predominantly regulated New Jersey electric-and-gas utility with a rare no-new-equity funding plan and a carbon-free nuclear fleet — a genuine sleep-at-night income compounder — but at ~$82 it trades near the Street's own target with only a ~4% base-case upside plus a ~3.2%… |
| PHM PulteGroup, Inc. | Hold | 4 | 4 | 2 | — | +14.0% | $134 ($95–$185) | — | A best-in-class, low-debt homebuilder trading at a single-digit-teens P/E and buying back ~5% of its stock a year — but it is a deeply cyclical business at the *wrong* end of the earnings cycle (FY25 EPS fell to $11.21 from $14.82, margins are compressing, and FY26 estimates call for another ~11%… |
| PPG PPG Industries, Inc. | Hold | 4 | 4 | 2 | — | +22.3% | $128 ($98–$158) | — | PPG is a high-quality, 140-year-old global coatings franchise trading at a reasonable ~18× earnings — but revenue has gone sideways for three years (FY25 $15.9B, flat), growth is GDP-plus at best, EPS gains lean on pricing and buybacks, and there is zero expert conviction in our KB. A fine… |
| REG Regency Centers Corporation | Hold | 4 | 4 | 2 | — | +17.3% | $82 ($66–$95) | — | Regency is one of the best-run grocery-anchored shopping-center REITs in the country — 96.6% leased, +4.4% same-property NOI, an A-/A3 balance sheet — but it is a low-growth, rate-sensitive income vehicle trading right at fair value, with no expert conviction behind it in our knowledge base, so it… |
| SOLV Solventum Corporation | Hold | 4 | 4 | 2 | — | -1.2% | $88 ($58–$102) | — | Solventum is 3M's former healthcare arm, spun out in 2024, trading at a genuine discount (9.5× earnings, 6.6× EV/EBITDA) because the market prices it as a low-growth, over-levered carve-out — the whole bull case is that management deleverages (net debt already cut from $8.1B to $4.2B), stabilizes… |
| TFC Truist Financial Corporation | Hold | 4 | 4 | 2 | — | +3.6% | $54 ($40–$66) | — | Truist is a large, cheap, well-capitalized Southeastern regional bank trading around book value with a ~4% dividend — a defensible income/value holding, but with a below-cost-of-capital ~8.5% ROE, only mid-teens forward EPS growth off a reset earnings base, cyclical credit exposure, and zero… |
| VICI VICI Properties Inc. | Hold | 4 | 4 | 2 | — | -3.3% | $31 ($24–$37) | — | VICI is a well-run, wide-spread experiential (casino) triple-net REIT trading at ~9× AFFO with a covered ~6.6% dividend and contractual rent escalators — a dependable income compounder you buy for yield + mid-single-digit growth, capped by heavy tenant concentration, 4.3× leverage, and a… |
| XOM Exxon Mobil Corporation | Hold | 4 | 4 | 2 | — | +13.9% | $152 ($95–$195) | — | Exxon is a best-in-class, fortress-balance-sheet cash machine that pumps out ~$52B of operating cash and hands ~$36B/yr back to shareholders — but its earnings ride a volatile, secularly-challenged commodity, growth is low-single-digit at best, and at $137 (near the Street's high-end DCF) it is… |
| ALL The Allstate Corporation | Hold | 5 | 4 | 2 | — | +20.3% | $245 ($190–$300) | — | Allstate screens statistically cheap (5.5× trailing EPS, 0.19 beta) because it is a well-run cyclical insurer printing near-record underwriting profit off a *benign-catastrophe, reserve-release* quarter — but the Street's own estimates have EPS falling ~$30 → ~$25 through 2028 as that normalizes… |
| BAC Bank of America Corporation | Hold | 5 | 4 | 2 | — | +6.8% | $62 ($45–$76) | — | Bank of America is a cheap (14× earnings, 1.4× book), extremely well-capitalized (CET1 11.2%) megabank that is executing well — Q1'26 EPS +25%, ROTCE 16%, every segment growing — but it is a deeply cyclical, rate- and GDP-levered business with only ~10.5% ROE and mid-single-digit revenue growth… |
| BALL Ball Corporation | Hold | 5 | 4 | 2 | — | +19.7% | $63 ($47–$81) | — | Ball is a well-run, near-duopoly aluminum-beverage-can maker throwing off ~$800M+ of free cash flow it funnels into buybacks — a legitimate low-growth cash-cow — but at $63 the stock already discounts management's "10%+ EPS growth" plan, the shares are technically overbought (RSI ~88), and there is… |
| BDX Becton, Dickinson and Company | Hold | 5 | 4 | 2 | — | +3.6% | $181 ($126–$232) | — | BD is a boring, cash-generative medical-technology "razor-and-blades" business — syringes, catheters, infusion pumps, pre-fillable drug-delivery systems — that the market has left for dead at ~12.5× forward adjusted earnings after years of tepid growth and a just-completed spin of its Life Sciences… |
| BIIB Biogen Inc. | Hold | 5 | 4 | 3 | — | +22.8% | $220 ($150–$300) | — | Biogen is a cheap (~15× forward), fortress-balance-sheet, ultra-low-beta pharma whose legacy neurology franchise is in structural decline — the entire investment case is whether Leqembi (Alzheimer's, with Eisai) plus a re-tooled pipeline can *stabilize* revenue around ~$10B and let cost discipline… |
| CF CF Industries Holdings, Inc. | Hold | 5 | 4 | 2 | — | +42.9% | $115 ($78–$150) | — | CF is a well-run, low-cost North American nitrogen producer trading at a genuinely cheap ~10× earnings / 5× EV-EBITDA with a fortress balance sheet and heavy buybacks — but the analyst estimates themselves show EPS *rolling over* from a 2026 spike toward the $7 range by 2030, so this is a cyclical… |
| CSX CSX Corporation | Hold | 5 | 4 | 2 | $49 | +34.9% | $47 ($36–$58) | — | CSX is a wide-moat Eastern-US railroad whose earnings have gone the *wrong* way for three years (revenue $14.85B→$14.09B, EPS $1.95→$1.54), yet the stock has rallied 46% in twelve months to the point where even the Street's price target ($47.15) sits below the tape — a great business, but priced… |
| CVX Chevron Corporation | Hold | 5 | 4 | 2 | — | +11.0% | $185 ($120–$235) | — | Chevron is a well-run, low-beta integrated oil major throwing off a ~4% dividend and $6B/quarter of shareholder returns, freshly enlarged by the Hess deal (+15% production) — but FY25 revenue fell 4.6% and EPS fell 32% because this is a commodity earner, so we own it *tactically* near the bottom of… |
| DG Dollar General Corporation | Hold | 5 | 4 | 2 | — | -11.0% | $122 ($82–$168) | — | Dollar General is a cheap, low-beta, cash-generative discounter mid-way through an operational repair — FY25 revenue $42.7B (+5.2%), EPS recovering to $6.85 from the $5.11 FY24 trough — but earnings are still ~36% below the FY22 peak of $10.68, forward growth is single-digit and decelerating, and… |
| DHI D.R. Horton, Inc. | Hold | 5 | 4 | 3 | — | +10.1% | $155 ($95–$182) | — | D.R. Horton is the best-run, largest-scale, lowest-cost homebuilder in America, trading at a genuinely modest 14.8× earnings with a fortress-lite balance sheet and heavy buybacks — but it is a deep cyclical in a demand downturn where earnings are still *falling* (FY25 EPS $11.57, FY26E $10.57), so… |
| DUK Duke Energy Corporation | Hold | 5 | 4 | 2 | — | +10.6% | $137 ($110–$158) | — | Duke Energy is a large, well-run regulated electric-and-gas utility — a low-beta, ~3.3%-yielding rate-base compounder growing adjusted EPS ~5-7% a year — trading right on top of the Street's target with no expert conviction behind it; own it for defensive income, not for capital appreciation. Watch. |
| EXC Exelon Corporation | Hold | 5 | 4 | 2 | $48 | +9.8% | $49 ($40–$58) | — | Exelon is a pure-play, fully-regulated transmission-and-distribution (T&D) utility across six utilities in the mid-Atlantic and Illinois — a low-beta, dividend-paying bond-proxy that earns a regulated return on a growing rate base, grows EPS ~6%/yr, and trades right on top of both Street consensus… |
| GPC Genuine Parts Company | Hold | 5 | 4 | 2 | — | +7.8% | $143 ($100–$176) | — | GPC is a ~$24B-revenue, 98-year-old auto- and industrial-parts distributor and Dividend King (69 straight annual raises) that is durable and cheap-ish (~17× forward earnings, 3.2% yield) but barely growing — a fine income holding, not a wealth-compounder — and after a +26% three-month run into an… |
| HAL Halliburton Company | Hold | 5 | 4 | 3 | — | +16.6% | $38 ($24–$52) | — | Halliburton is a well-run, cheaply-valued oilfield-services leader throwing off real free cash flow ($1.7B FY25), but revenue is *shrinking* (−3.3% in FY25, another roughly flat year guided for FY26) as North America activity fades, and with zero expert conviction behind it, the honest call is… |
| HSIC Henry Schein, Inc. | Hold | 5 | 4 | 3 | — | +14.4% | $88 ($62–$108) | — | Henry Schein is the world's largest dental/medical distributor — a genuinely defensive, sticky, low-beta business — but it is a low-growth, thin-margin, moderately levered compounder whose ~+2% upside to fair value offers no real margin of safety; there is no expert conviction behind it, so it… |
| HSY The Hershey Company | Hold | 5 | 4 | 2 | — | +0.1% | $199 ($145–$231) | — | Hershey owns an irreplaceable US-confectionery brand portfolio (Reese's, Hershey's, Kit Kat) throwing off ~$1.75B of free cash flow and a ~3.1% dividend — but FY25 GAAP EPS collapsed from $10.94 to $4.34 on a historic cocoa-price/derivative shock, the category is volume-flat, and the stock (down… |
| INVH Invitation Homes Inc. | Hold | 5 | 4 | 2 | — | +9.9% | $31 ($24–$38) | — | Invitation Homes is the largest US single-family rental landlord — a well-run, low-beta, ~3.9%-yield income REIT whose rents are durable but whose growth has *decelerated to low single digits*; at ~$31 it trades right on top of the Street's $31.69 target with little margin of safety and no growth… |
| IT Gartner, Inc. | Hold | 5 | 4 | 3 | — | -46.0% | $175 ($95–$250) | — | Gartner is a genuinely elite subscription-research franchise — 68% gross margin, ~21% ROIC, ~14% FCF yield — that the market has cut by two-thirds because growth stalled and AI threatens the core product; at ~10× forward earnings the price already reflects a lot of pain, so this is a cheap-quality… |
| KEY KeyCorp | Hold | 5 | 4 | 3 | — | +11.5% | $24 ($16–$30) | — | KeyCorp is a cleanly-recovering Cleveland regional bank — net interest margin re-expanding to 2.87%, fee businesses growing double-digits, CET1 11.4%, buybacks resumed — trading at a modest ~13–15× earnings and 1.25× book, but it is a mature, rate- and credit-cyclical bank with sub-10% ROE, no… |
| KIM Kimco Realty Corporation | Hold | 5 | 4 | 2 | — | +24.9% | $27.50 ($22.80–$31.35) | — | Kimco is a best-in-class, grocery-anchored open-air shopping-center REIT with 96.3% occupancy, double-digit rent spreads and a fortress balance sheet — a genuinely durable ~4%-yield income machine — but at ~13.8× 2026E FFO with only mid-single-digit FFO growth, the stock is roughly fairly valued… |
| LH Labcorp Holdings Inc. | Hold | 5 | 4 | 2 | — | +14.4% | $300 ($225–$360) | — | Labcorp is a well-run, defensive diagnostics-and-CRO duopolist throwing off ~$1.2B of free cash flow, but it grows revenue only in the low-single-digits and trades roughly in line with fair value — a fine business at a fair price, which is a Watch, not a buy: you are paid to wait, not to win. |
| MAS Masco Corporation | Hold | 5 | 4 | 2 | — | +30.4% | $82 ($62–$100) | — | Masco is a well-run, high-margin, cash-generative maker of Behr paint and Delta/hansgrohe plumbing whose earnings grow mainly because it shrinks its share count — but the top line is flat-to-down (FY25 revenue −3.4%), the stock now sits *at its 52-week high on a 78 RSI*, and the fair value lands… |
| MDLZ Mondelez International, Inc. | Hold | 5 | 4 | 2 | $61 | +13.2% | $64 ($48–$76) | — | Mondelez is a genuinely durable global snacking franchise (Oreo, Cadbury, Milka, belVita) throwing off ~$3.2B of free cash flow — but a historic cocoa-cost shock collapsed 2025 GAAP earnings (EPS $1.89 vs $3.44), the stock still trades ~20× forward for only ~3% revenue / ~8% EPS growth, and there… |
| MKC McCormick & Company, Incorpo | Hold | 5 | 4 | 2 | — | -21.5% | $55 ($40–$68) | — | McCormick is a genuinely high-quality, wide-moat spice franchise (38% gross margin, 26% ROE, a 39-year dividend-raise streak) — but it grows only mid-single-digits, carries 3.4× net-debt/EBITDA, and the stock is in a real down-trend (−31% over 12 months), so at ~$53 it is close to fairly valued… |
| MRK Merck & Co., Inc. | Hold | 5 | 4 | 3 | — | +23.0% | $130 ($95–$165) | — | Merck is a cheap, cash-generative, low-beta mega-cap trading at ~13.5× FY27E earnings — but the discount is *earned*: its one megablockbuster, Keytruda, is roughly $30B of the ~$58B pharma business and faces a 2028 US patent cliff, so the top line is stalling (FY25 revenue +1.2%) right as the… |
| PPL PPL Corporation | Hold | 5 | 4 | 2 | — | +5.3% | $37 ($30–$44) | — | PPL is a well-run, low-beta, three-state regulated electric-and-gas utility guiding to 6–8% annual EPS growth through 2029 — a legitimate income compounder, but with the stock near our fair value, a thin margin of safety, and no accelerating growth or expert conviction, it is a Watch, not a buy… |
| PRU Prudential Financial, Inc. | Hold | 5 | 4 | 2 | — | +0.1% | $115 ($82–$143) | — | Prudential is a cheap (11.5× earnings, 1.2× book), well-capitalised, 4.9%-yielding life insurer and asset manager (PGIM, $1.43T AUM) whose earnings are steady but structurally low-growth — the kind of name you own for the dividend and a possible re-rating toward book, not for capital appreciation… |
| PSA Public Storage | Hold | 5 | 4 | 3 | — | +27.0% | $320 ($255–$375) | — | Public Storage is the highest-quality operator in a boring, mature category — 77% Same-Store NOI margins, a fortress ~$2.9B free-cash-flow engine and a ~3.6% dividend — but 2026 Same-Store revenue is guided flat-to-down and organic Core FFO growth is low-single-digit, so at ~$330 (roughly fair… |
| RF Regions Financial Corporation | Hold | 5 | 4 | 2 | — | +11.7% | $32 ($23–$39) | — | Regions is a genuinely well-run, cheap (12.5× earnings, 3.5% yield), well-capitalized (CET1 10.7%) Southeast regional bank throwing off top-quartile returns (18% ROTCE) — but it is a low-growth, rate-sensitive, credit-cyclical business with no exponential engine, so the honest verdict is Watch: own… |
| SYY Sysco Corporation | Hold | 5 | 4 | 2 | — | +15.1% | $88 ($66–$108) | — | Sysco is the dominant North American food-distribution utility — #1 share, real scale moat, a 45+ year dividend-raiser — but it is a low-growth, thin-margin, leveraged operator trading at a fair-to-full multiple, so the honest call is Watch: own it for defensive income if you must, but there is no… |
| TGT Target Corporation | Hold | 5 | 4 | 2 | — | +33.2% | $132 ($92–$175) | — | Target is a cheap, cash-generative, dividend-paying big-box retailer that just delivered a genuinely encouraging quarter (Q1 FY26 sales +6.7%, comps +5.6%) and raised guidance — but it is also a business whose revenue has gone *nowhere* for four years, whose ROIC has slipped to 12.4%, and which… |
| TSCO Tractor Supply Company | Hold | 5 | 4 | 2 | — | -36.5% | $34 ($25–$42) | — | A financially sturdy, low-beta rural-lifestyle retailer that has been cut nearly in half from its peak — the de-rate is real and the ~3% dividend is well-covered, but with comps running roughly flat, EPS growing only ~7%, and the stock in a clear downtrend, this is a *prove-it* name to Watch, not… |
| ZBH Zimmer Biomet Holdings, Inc. | Hold | 5 | 4 | 2 | — | -2.7% | $108 ($76–$133) | — | Zimmer Biomet is a cheap, cash-generative, low-beta orthopedic-implant leader (FY25 revenue $8.23B, ~10× forward adjusted earnings, ~8.7% FCF yield) whose stock has de-rated on years of low-single-digit organic growth and rising leverage — a tactical value buy where the payoff is multiple re-rating… |
| AKAM Akamai Technologies, Inc. | Hold | 6 | 4 | 4 | — | +29.7% | $122 ($75–$155) | — | Akamai is a profitable, cash-generative infrastructure company mid-way through a hard pivot — from a shrinking content-delivery (CDN) business toward Security and a fast-growing enterprise cloud (CIS/Linode) leg — and the stock is cheap *because* the market is unsure the transition math works; the… |
| AMCR Amcor plc | Hold | 6 | 4 | 3 | — | +7.9% | $48 ($34–$62) | — | Amcor is a newly-doubled global packaging giant (the April-2025 Berry Global merger) that trades cheap (~11× forward earnings) and pays a ~5.75% dividend, but the "growth" you see in the headlines is *acquired*, not organic — volumes are actually down ~1.5% YoY — and the company is carrying ~4.9×… |
| APTV Aptiv PLC | Hold | 6 | 4 | 3 | — | -22.6% | $62 ($38–$88) | — | Aptiv just spun off its largest, steadiest business (Electrical Distribution Systems → "Versigent," April 1 2026), leaving a smaller (~$13B revenue), higher-margin, but more concentrated "New Aptiv" that trades at ~10× earnings and 8.6× EV/EBITDA — statistically cheap, but it is a leveraged… |
| BG Bunge Global S.A. | Hold | 6 | 4 | 3 | — | +19.5% | $120 ($78–$150) | — | Bunge is a 200-year-old, well-managed global grain trader and oilseed crusher that just doubled its footprint by absorbing Viterra — the stock is genuinely cheap on forward earnings (~11× FY26E) and pays a 2.6% dividend, but it is a thin-margin, highly cyclical, capital-intensive commodity business… |
| BLDR Builders FirstSource, Inc. | Hold | 6 | 4 | 3 | — | -17.7% | $93 ($55–$135) | — | BLDR is the #1 US supplier of structural building products to pro homebuilders — a genuinely good, share-gaining, cash-generative franchise that has bought back half its shares since 2021 — but it is a *deep cyclical* caught mid-downturn (FY25 revenue −7.4%, Q1'26 a net loss), so the stock is cheap… |
| CNC Centene Corp. | Hold | 6 | 4 | 3 | — | +64.9% | $68 ($40–$80) | — | Centene is a ~$195B-revenue Medicaid/government managed-care giant priced for distress (13% free-cash-flow yield, 0.14× EV/sales) that is visibly recovering — Q1'26 adjusted EPS of $3.37 beat by ~$0.50 and management *raised* FY26 adjusted-EPS guidance to ">$3.40" — but the earnings are… |
| CVS CVS Health Corporation | Hold | 6 | 4 | 3 | — | +32.0% | $118 ($72–$150) | — | CVS is a $402B-revenue integrated health giant coming off a brutal 2025 (a Q3 loss dragged full-year GAAP EPS to $1.39) that is now visibly recovering — Q1'26 adjusted EPS $2.57 beat and management *raised* full-year 2026 guidance — and the stock, up 50% in a year, trades at ~14× current-year… |
| D Dominion Energy, Inc. | Hold | 6 | 4 | 3 | — | +19.0% | $71 ($56–$84) | — | Dominion is a Virginia-centric regulated electric utility riding a genuine data-center demand tailwind, but it is priced right on top of the Street ($69.75 vs $70.43 consensus), carries 6.5× net-debt/EBITDA, runs deeply negative free cash flow through a multi-year capex build, and grows earnings at… |
| DAL Delta Air Lines, Inc. | Hold | 6 | 4 | 2 | — | +33.6% | $95 ($60–$125) | — | Delta is the highest-quality US network airline — premium brand, loyal hub franchise, an investment-grade balance sheet rebuilt post-COVID, and a genuinely cheap EV/EBITDA (7.7×) — but after a +89% 12-month run the stock now sits near its 52-week high at an overbought RSI of 83, forward EPS… |
| DOC Healthpeak Properties, Inc. | Hold | 6 | 4 | 2 | — | +36.1% | $21 ($16–$26) | — | Healthpeak is a well-run, hard-asset healthcare REIT (outpatient medical, lab, senior housing) throwing off a covered ~5.6% dividend — a legitimate *income* holding — but after a +22% year it trades slightly above the Street's own price targets, growth is low-single-digit, and there is no expert… |
| DVN Devon Energy Corporation | Hold | 6 | 4 | 2 | — | +10.5% | $44 ($28–$60) | — | Devon is a low-cost, low-leverage US shale producer trading at a genuinely cheap ~7.5× forward earnings and a ~10.7% free-cash-flow yield, returning cash via a fixed-plus-variable dividend and buybacks — but forward estimates show flat-to-declining earnings and production, so this is a well-run… |
| ES Eversource Energy | Hold | 6 | 4 | 2 | — | +10.6% | $76 ($58–$90) | — | Eversource is a New England regulated electric-and-gas utility finishing a painful cleanup — it has exited offshore wind and just closed the Aquarion water sale to become a "pure-play pipes and wires" monopoly — but the reward for that de-risking is only a 5–7% earnings grower with a 4.1% dividend… |
| EXE Expand Energy Corporation | Hold | 6 | 4 | 3 | — | -17.8% | $100 ($62–$138) | — | Expand Energy is the largest US natural-gas producer (the former Chesapeake, merged with Southwestern), and it is genuinely well-run — a fortress balance sheet, sub-2× EV/EBITDA-adjacent economics, and a 13% free-cash-flow yield. But the low headline multiple is a *peak-cycle* multiple on gas… |
| EXR Extra Space Storage Inc. | Hold | 6 | 4 | 3 | — | +14.6% | $150 ($118–$178) | — | Extra Space is the #2 US self-storage operator and the largest third-party manager — a genuinely good, wide-moat REIT — but it is a mature, ~2%-Core-FFO-growth business trading at a fair (not cheap) ~18× P/FFO, so the honest call is Watch: own it for the ~4.3% dividend and defensiveness if that is… |
| FDX FedEx Corporation | Hold | 6 | 4 | 3 | — | +34.6% | $330 ($210–$435) | — | FedEx is a cheap, cyclical, self-help story: FY26 revenue $94.7B and adjusted EPS $20.24 with the DRIVE cost program beating its $1B savings goal, now simplified by spinning off FedEx Freight (June 1, 2026) — but it is a mature, GDP-linked, ~5%-margin, sub-WACC-return network, so the reward is a… |
| FIS Fidelity National Information Se | Hold | 6 | 4 | 2 | — | -37.1% | $50 ($30–$70) | — | FIS is a cheap, cash-generative, post-Worldpay bank-technology utility trading at ~6.6× forward earnings with a 4% dividend — the numbers scream "value" — but the stock has fallen 49% in a year, growth is only mid-single-digit organically, and the one expert voice in our KB says the newer… |
| GM General Motors Company | Hold | 6 | 4 | 3 | — | -6.5% | $82 ($52–$112) | — | GM is genuinely cheap — ~0.4× sales, ~5.9× forward adjusted earnings, an 18% free-cash-flow yield, and a management buying back ~9% of the float a year — but "cheap" is the whole thesis: revenue is flat-to-declining, GAAP earnings just took a multi-billion-dollar EV/restructuring hit, tariffs cost… |
| IBM International Business Machines | Hold | 6 | 4 | 3 | — | -2.3% | $295 ($200–$350) | — | IBM has genuinely reshaped itself into a software-led hybrid-cloud-and-AI business with strong free cash flow and a well-covered dividend — but at 25× trailing earnings for ~5% revenue growth, a leveraged balance sheet (net-debt/EBITDA 3.3×), and a consensus EPS line that flattens after FY27, the… |
| LULU Lululemon Athletica Inc. | Hold | 6 | 4 | 3 | — | -43.0% | $138 ($86–$216) | — | Lululemon is a high-quality, net-cash, cash-generative apparel brand trading at a distressed-looking 9× earnings — but it is cheap *because* the core North America business is shrinking (Americas comps −5%), management just cut full-year guidance to flat-to-down revenue and a lower EPS, and the one… |
| MMM 3M Company | Hold | 6 | 4 | 2 | — | +0.2% | $162 ($110–$200) | — | Post-Solventum-spinoff 3M is a smaller (~$25B revenue), cleaner, self-help industrial trading at a reasonable ~18× forward earnings with margins recovering and cash returning to shareholders — but it grows organically at ~1–3%, carries a multi-billion-dollar litigation liability that will drain… |
| MPC Marathon Petroleum Corporation | Hold | 6 | 4 | 2 | — | +63.8% | $250 ($175–$340) | — | MPC is a best-in-class, shareholder-friendly downstream refiner throwing off large buybacks and a growing MPLX midstream distribution — but it is a *cyclical, not a compounder*, the stock trades within 0.3% of its 52-week high after a +57% run, and there is no expert conviction behind it in our KB… |
| NUE Nucor Corporation | Hold | 6 | 4 | 3 | — | +35.3% | $225 ($150–$300) | — | Nucor is the best-run steelmaker in North America — low-cost EAF mills, a fortress balance sheet (net-debt/EBITDA ~1.0×), and a genuine post-trough earnings rebound (Q1'26 EPS $3.23, a big beat) — but it is a *deeply cyclical commodity producer* with no secular growth, trading near the high end of… |
| OKE ONEOK, Inc. | Hold | 6 | 4 | 2 | — | +19.5% | $90 ($66–$112) | — | ONEOK is a well-run, fee-heavy natural-gas-and-NGL toll road that pays a ~4.8% dividend and grew EBITDA 13% last quarter — but after a multi-year acquisition spree it carries 4.3× net-debt/EBITDA, forward EPS growth is only high-single-digits and decelerating, and the stock already trades right at… |
| OMC Omnicom Group Inc. | Hold | 6 | 4 | 3 | — | -2.6% | $89 ($60–$108) | — | Omnicom just doubled its size by absorbing rival Interpublic (IPG, closed Nov 26 2025), and the combined entity is genuinely cheap (~8× EV/EBITDA, ~13% FCF yield, near-4% dividend) with real synergy upside — but organic growth is only ~3.9%, the balance sheet took on meaningful merger debt, and the… |
| OXY Occidental Petroleum Corporation | Hold | 6 | 4 | 3 | — | +18.9% | $52 ($34–$74) | — | Occidental is a cheap, low-beta, aggressively-deleveraging Permian-heavy oil producer that just sold its chemicals arm (OxyChem) to attack its debt — but with the chemicals cash engine gone the top line shrinks, forward EPS is flat-to-declining on flat oil, and the whole equity is ultimately a… |
| PSX Phillips 66 | Hold | 6 | 4 | 2 | — | +36.7% | $180 ($125–$235) | — | Phillips 66 is a well-run, integrated downstream energy company trading at roughly fair value — a cyclical cash-return story (2.8% dividend, buybacks) whose earnings gyrate violently with refining margins, not a secular grower; we rate it Watch because there is no margin of safety at ~$176 and no… |
| SBUX Starbucks Corporation | Hold | 6 | 4 | 3 | $104 | +23.8% | $100 ($72–$132) | — | Starbucks is a great brand mid-restructuring: revenue is flat-to-slightly-up, margins and EPS have collapsed (FY25 EPS $1.63 vs $3.31 in FY24) under CEO Brian Niccol's costly "Back to Starbucks" turnaround, yet the stock trades at ~79× trailing and pays a dividend its free cash flow no longer… |
| SLB SLB N.V. (Schlumberger) | Hold | 6 | 4 | 2 | — | +17.6% | $52 ($34–$66) | — | SLB is the highest-quality, most global oilfield-services company in the world, trading cheap (13.5× FY27E, 2.6% yield, 6.9% FCF yield) after a Middle-East-disruption-driven earnings dip — but it is a *deeply cyclical, low-growth* business with falling FY25 revenue and margins, zero expert… |
| SPG Simon Property Group, Inc. | Hold | 6 | 4 | 2 | — | +22.1% | $231 ($178–$270) | — | Simon is the highest-quality mall/outlet landlord in America — 96% occupancy, rents and tenant sales still rising, a raised FFO outlook and a fortress ~3.9% dividend — but it is a mature, levered, low-growth REIT trading roughly at fair value, so the honest call is Watch / own for income, not a… |
| SWK Stanley Black & Decker, Inc. | Hold | 6 | 4 | 2 | — | +23.7% | $92 ($66–$118) | — | Stanley Black & Decker is a cheap-on-recovery-earnings, dividend-paying tools cyclical mid-way through a self-help margin and deleveraging program — the numbers work *if* adjusted EPS climbs from ~$2.65 GAAP toward management's $4.90–5.70 range, but revenue is flat, leverage is high, and there is… |
| TSN Tyson Foods, Inc. | Hold | 6 | 4 | 2 | — | +0.5% | $60 ($42–$78) | — | Tyson is America's largest protein packer trading like the low-margin commodity processor it is — a 3.4%-yielding defensive staple whose forward "growth" is really a recovery off a beaten-down FY25 (net income $474M, 6.5% gross margin), where the Street's $73 target bakes in a beef-cycle turn we… |
| UPS United Parcel Service, Inc. | Hold | 6 | 4 | 2 | — | +11.6% | $115 ($77–$129) | — | UPS is a cheap, 5.9%-yielding industrial that has been *shrinking* — revenue fell to $88.7B in FY25 from $100B in 2022, EPS halved from $13.26 to $6.56, and the dividend now exceeds free cash flow — so the stock is priced near fair value for a self-help turnaround that has to prove margins can… |
| VLO Valero Energy Corporation | Hold | 6 | 4 | 3 | — | +64.5% | $255 ($175–$340) | — | Valero is the highest-quality independent refiner in the US — fortress balance sheet (0.6× net-debt/EBITDA), disciplined capital returns, and a Q1'26 that swung from a year-ago loss to $4.22/share — but you are being asked to pay a near-cycle-high price for a business whose earnings are *defined*… |
| WY Weyerhaeuser Company | Hold | 6 | 4 | 2 | — | +0.4% | $25 ($18–$32) | — | Weyerhaeuser owns an irreplaceable ~11-million-acre US timberland base and is the best-run name in the group, but the stock is a housing-cycle bet dressed as a bond substitute: earnings sit near a cyclical trough (FY25 EPS $0.45 vs $2.53 in 2022), the shares trade at 43× those depressed earnings… |
| CHTR Charter Communications, Inc. | Hold | 7 | 4 | 3 | — | -34.3% | $185 ($95–$300) | — | A hated, heavily levered cable operator trading at ~3.6× earnings and a ~21% free-cash-flow yield, where the entire return case is the company buying back a collapsing share count faster than the business erodes — genuinely cheap, but cheap for real reasons (flat revenue, shrinking broadband subs… |
| DVA DaVita Inc. | Hold | 7 | 4 | 2 | — | +106.8% | $205 ($150–$265) | — | DaVita is a genuinely dominant, cash-generative dialysis duopolist whose *earnings* keep rising — but almost entirely through a shrinking share count (buybacks), not organic growth; with the stock up 60% in a year to a fresh high, an RSI of 91, and a price now above every analyst target, the… |
| FISV Fiserv, Inc. | Hold | 7 | 4 | 2 | — | -22.1% | $58 ($34–$85) | — | Fiserv is a formerly-beloved payments compounder that has cratered ~78% from its high after organic revenue turned *negative* and margins compressed; it now trades at ~6× forward earnings with a ~15% FCF yield, so the debate is no longer "great growth stock" but "is this a cheap, mispriced… |
| IP International Paper Company | Hold | 7 | 4 | 3 | — | -1.5% | $40 ($26–$55) | — | International Paper is a 125-year-old containerboard giant in the middle of a self-inflicted, high-stakes reset — a new CEO's "80/20" cost program, the DS Smith acquisition, the sale of its cellulose-fibers arm, and a planned split of North America from EMEA — so the FY25 GAAP loss (−$3.5B, driven… |
| MGM MGM Resorts International | Hold | 7 | 4 | 5 | — | +29.1% | $48 ($30–$66) | — | MGM is a cash-generative but capital-intensive casino operator that looks statistically cheap (0.68× sales, 7× free cash flow, ~14% FCF yield, shrinking share count) yet carries real cyclicality, heavy lease-adjusted leverage, and a lumpy GAAP earnings line — the bull case is a small-cap re-rating… |
| SMCI Super Micro Computer, Inc. | Hold | 7 | 4 | 5 | — | -7.0% | $30 ($15–$49) | — | SMCI screens statistically cheap (8-10× forward EPS, 0.68× EV/sales) because it rode the AI-server wave to $22B revenue — but the market is discounting it for good reasons: gross margin has collapsed to ~8-10%, operating cash flow is deeply negative, net debt has swung to ~$7.5B, and the board is… |
| WYNN Wynn Resorts, Limited | Hold | 7 | 4 | 4 | — | -20.3% | $108 ($62–$150) | — | Wynn is a genuinely great luxury-casino operator trading cheaply near its 52-week low, but the equity is a leveraged bet — 6× net-debt/EBITDA and negative book value mean small swings in Macau or Las Vegas EBITDA move the stock hard, so it is a Watch until the 2027 UAE mega-resort de-risks the… |
| EIX Edison International | Hold | 8 | 4 | 2 | — | +26.1% | $74 ($50–$92) | — | Edison International is a cheap (8× trailing, 4.5% yield) Southern California regulated electric utility with a real, regulator-backed 5–7% earnings-growth engine — but the price is low for a reason: an open-ended, hard-to-quantify wildfire liability (the January 2025 Eaton Fire) and 5.7× leverage… |
| INTC Intel Corp. | Hold | 8 | 4 | 5 | $120 | +226.2% | $95 ($45–$165) | — | Intel is a genuine reshoring-and-turnaround story that the market has already re-rated violently (from a ~$19 low to $120, +427% in 12 months), pushing the stock above the Street's $98 average target while the company is still losing money (FY25 net loss −$267M, Q1'26 −$3.7B) and burning cash (FY25… |
| TSLA Tesla, Inc. | Hold | 9 | 4 | 7 | $393 | -12.5% | $360 ($150–$620) | — | Tesla is two companies trading as one price: a shrinking, margin-compressed car maker (FY25 revenue −2.9% to $94.8B, net income down 47% to $3.8B, ROE ~5%) and a call option on autonomy and humanoid robots that the smartest voices in our panel love — and the entire $1.48T market cap rests on the… |
| EA Electronic Arts Inc. | Hold | 4 | 3 | 2 | $205 | +0.4% | $210 ($150–$210) | — | EA is no longer a stock you value on its fundamentals — on 2025-09-29 it signed a definitive all-cash agreement to be taken private at $210/share (~$55B EV) by a Public Investment Fund / Silver Lake / Affinity Partners consortium, so at $205.21 the only question that matters is *will the deal… |
| ED Consolidated Edison, Inc. | Hold | 4 | 3 | 1 | — | +14.8% | $108 ($88–$124) | — | Con Edison is a 200-year-old, exceptionally low-beta (0.27) regulated New York utility that reliably grows earnings ~6–7% and has raised its dividend for 52 straight years — a genuine bond-proxy — but at ~19× earnings and slightly *above* both our fair value and the Street's own price target, you… |
| EQR Equity Residential | Hold | 4 | 3 | 2 | — | +10.8% | $70 ($56–$82) | — | Equity Residential is a high-quality, coastal-concentrated apartment REIT with fortress occupancy (96.5%) and record-low tenant turnover, but it grows revenue at ~3% and NOI at ~1–2%, trades right on top of both its 52-week high and the Street's fair value, and carries the rate-sensitivity of a… |
| HRL Hormel Foods Corporation | Hold | 4 | 3 | 1 | — | +5.5% | $24 ($18–$30) | — | Hormel is a 130-year-old, low-beta Dividend Aristocrat (SPAM, Skippy, Planters, Applegate, Jennie-O) whose earnings have gone sideways-to-down for four years; the stock is *reasonable* on forward adjusted EPS and pays ~4.7%, but with ~2% revenue growth, mid-single-digit ROIC and no expert… |
| KVUE Kenvue Inc. | Hold | 4 | 3 | 1 | — | +15.0% | $20.50 ($15.00–$21.00) | — | Kenvue is no longer a stock you value on its own fundamentals — it is a near-closed merger-arbitrage instrument: Kimberly-Clark has an approved, cash-and-stock agreement to buy it, so the ~$19.83 price mostly reflects the deal spread and KMB's share price, and the entire risk/reward reduces to… |
| MAA Mid-America Apartment Communitie | Hold | 4 | 3 | 1 | — | +2.4% | $142 ($115–$167) | — | MAA is a well-run, low-beta, investment-grade Sunbelt apartment REIT throwing off a safe ~4.3% dividend — but revenue is essentially flat (+0.8% in FY25), same-store NOI is *shrinking* (−1.3%), and new-lease pricing is still *negative* (−7%) as a wave of Sunbelt supply gets absorbed; at ~16× Core… |
| VZ Verizon Communications Inc. | Hold | 4 | 3 | 1 | — | +4.5% | $50 ($40–$60) | — | Verizon is a cheap, heavily-indebted, slow-growth cash machine: FY25 revenue $138.2B grew ~2.5%, it throws off ~$20B of free cash flow and pays a 6.5% dividend, and management's own 2026 guidance points to a modest 5–6% adjusted-EPS turnaround — a legitimate income/bond-proxy holding, but with no… |
| BF-B Brown-Forman Corporation | Hold | 5 | 3 | 1 | — | +0.3% | $28 ($21–$39) | — | Brown-Forman owns one of the best brands in beverage alcohol (Jack Daniel's) and a 42-year dividend-increase streak, but FY26 sales *fell* 1% and EPS *fell* 17%, management guides FY27 organic operating income *down* 3–5%, and the stock — while not expensive at ~17× — offers no growth catalyst; it… |
| BMY Bristol-Myers Squibb Company | Hold | 5 | 3 | 2 | — | +7.8% | $60 ($42–$78) | — | BMY is a cheap, high-yield, cash-generative pharma trading at 16× trailing / ~9× forward earnings and a ~10% free-cash-flow yield — but the low multiple is the market correctly pricing a shrinking revenue base: consensus has sales falling from ~$48B (2025) toward ~$37B (2030) as Eliquis (2028 US… |
| CMCSA Comcast Corporation | Hold | 5 | 3 | 2 | $24 | -15.0% | $30 ($21–$40) | — | Comcast is a cash-gushing, cheap (6.8× forward EPS, 5.5% yield, ~24% FCF yield) but structurally challenged cable-and-media conglomerate whose core broadband business is losing subscribers to fixed-wireless and fiber — the low multiple is *earned*, not a mispricing, so this is a Watch: own it for… |
| CPT Camden Property Trust | Hold | 5 | 3 | 2 | — | +6.5% | $115 ($92–$138) | — | Camden is a well-run, investment-grade Sunbelt apartment REIT trading at a fair ~17× Core FFO with a ~3.6% dividend — but rents are softening (new leases −5.2%, blended −1.4%), same-property NOI is guided *down* ~0.5% for 2026, and there is neither expert conviction nor a growth catalyst here; it… |
| ESS Essex Property Trust, Inc. | Hold | 5 | 3 | 2 | — | +14.0% | $285 ($235–$335) | — | Essex is a best-in-class, 32-year-dividend-growing West Coast apartment REIT with a genuine supply-constrained moat and fortress-quality occupancy (96.5%) — but it grows ~2–3% a year, trades near its 52-week high *above* the Street's price target, and carries 4.6× net-debt/EBITDA, so at $298 it is… |
| O Realty Income Corporation | Hold | 5 | 3 | 2 | — | +13.3% | $70 ($54–$85) | — | Realty Income is the gold-standard "sleep-well-at-night" net-lease REIT — 15,571 properties, 98.9% occupancy, an 8.7-year lease term and 114 straight quarterly dividend raises — but at $59.5B it has grown into a slow, spread-driven compounder guiding just +3.0–3.7% AFFO/share for 2026; you buy it… |
| PFE Pfizer Inc. | Hold | 5 | 3 | 2 | — | -2.3% | $26 ($18–$31) | — | Pfizer is a cheap, 7%-yielding mega-pharma that has fully round-tripped its COVID windfall (revenue $100B in 2022 → $62.6B in 2025) and now faces a wall of patent expirations that consensus expects to *shrink* revenue toward ~$53B by 2030 — the entire bull case is whether obesity, oncology… |
| TAP Molson Coors Beverage Company | Hold | 5 | 3 | 1 | — | -14.8% | $44 ($30–$56) | — | TAP is a cheap, cash-generative, high-dividend (4.8%) legacy brewer whose earnings-per-share still grind higher on aggressive buybacks — but underlying volumes are shrinking (brand volume −3.1% in Q1'26), revenue is flat-to-down, and there is no organic growth engine; it screens as a value/income… |
| TROW T. Rowe Price Group, Inc. | Hold | 5 | 3 | 2 | — | +15.8% | $108 ($82–$132) | — | T. Rowe Price is a high-quality, debt-free, 4.3%-yielding, 12.7× active asset manager that is *cheap for a reason* — assets under management still leak out the door ($13.7B of net outflows in Q1'26) and the effective fee rate keeps grinding lower, so earnings are flat-to-shrinking; the stock has… |
| UDR UDR, Inc. | Hold | 5 | 3 | 2 | — | +12.0% | $40 ($33–$47) | — | UDR is a well-run, coast-focused apartment REIT throwing off a secure ~4.2% dividend (now paid monthly — a first for a residential REIT), but same-store revenue is guided to just +1.25% and same-store NOI to roughly flat for 2026, so at ~16× FFOA the stock is fairly-to-fully priced with no growth… |
| APA APA Corporation | Hold | 6 | 3 | 3 | — | +32.3% | $36 ($20–$52) | — | APA is a cheap, low-beta, cash-generative oil & gas producer (FY25 FCF $1.8B, 7.5× earnings, net-debt/EBITDA 0.75×) that is doing the right defensive things — cutting costs, paying down debt — but it has no structural growth (revenue and production are flat-to-declining), so it is a Watch: a… |
| BAX Baxter International Inc. | Hold | 6 | 3 | 2 | — | +18.5% | $25 ($18–$33) | — | Post-Kidney-Care spin, Baxter is a slimmed-down, essential-hospital-products medtech trading at a genuinely cheap ~12× forward adjusted EPS with a low 0.61 beta — but it is a mid-turnaround, not a compounder: revenue is flat-to-down organically, GAAP earnings are still negative, and ~$8B of net… |
| BBY Best Buy Co., Inc. | Hold | 6 | 3 | 2 | — | +16.5% | $80 ($55–$100) | — | Best Buy is a well-run, cash-generative, cheap ($77.99, ~12× forward, 4.9% yield) but structurally *shrinking* big-box electronics retailer — revenue has fallen from $51.8B (FY22) to $41.7B (FY26) — so the case is a value/income hold, not growth; with no net-bullish expert coverage and a real… |
| BEN Franklin Resources, Inc. | Hold | 6 | 3 | 2 | — | +42.8% | $32 ($21–$42) | — | Franklin is a cheap-on-adjusted-earnings, 3.8%-yielding legacy active manager whose stock has re-rated 40% on AUM stabilization and an alternatives push — but forward EPS grows at low-single digits, GAAP margins have collapsed from ~27% to ~14%, and the whole model is structurally squeezed by… |
| CLX The Clorox Company | Hold | 6 | 3 | 1 | — | -3.5% | $103 ($80–$128) | — | Clorox is a high-quality, low-beta consumer-staples franchise (Clorox bleach, Glad, Kingsford, Brita, Burt's Bees, Hidden Valley, now Purell) throwing off a ~5% dividend — but it is essentially ex-growth (revenue ~$7B for a decade), is guiding to a ~6% sales decline and ~9% organic decline in FY26… |
| CRL Charles River Laboratories Inter | Hold | 6 | 3 | 2 | — | +15.6% | $220 ($165–$300) | — | Charles River is a genuinely high-quality, wide-moat contract research organization (the dominant supplier of research models and preclinical safety testing) caught in a cyclical demand trough — revenue is flat-to-declining, management itself guides 2026 organic revenue *down*, and after a sharp… |
| FANG Diamondback Energy, Inc. | Hold | 6 | 3 | 2 | $172 | +14.4% | $185 ($115–$235) | — | Diamondback is one of the best-run low-cost operators in the Permian Basin, but it is a commodity price-taker whose forward earnings are expected to *decline* ($20 FY26E EPS → ~$16 FY30E), it carries ~2.5× net-debt/EBITDA after the Endeavor deal, and the Street's $214 target bakes in an oil-price… |
| HPQ HP Inc. | Hold | 6 | 3 | 1 | — | -1.6% | $24 ($16–$31) | — | HP is a cheap, cash-generative, high-dividend mature hardware and printing business trading at ~8× earnings — the debate is not quality (it isn't a great business) but whether ~$2.8–3.0B of annual free cash flow returned via buybacks and a 5.4% dividend is enough to offset a slowly shrinking core… |
| HST Host Hotels & Resorts, Inc. | Hold | 6 | 3 | 2 | — | +31.7% | $23 ($17–$29) | — | Host is the largest, best-capitalized lodging REIT in the US — a well-run, investment-grade owner of luxury/upper-upscale hotels throwing off a fat (partly special-dividend-inflated) yield — but it is a mature, deeply cyclical, low-growth business with flat-to-declining forward earnings estimates… |
| KHC The Kraft Heinz Company | Hold | 6 | 3 | 1 | $25 | +4.6% | $25 ($17–$33) | — | Kraft Heinz is a cheap, cash-generative, high-yielding packaged-food giant whose brands are slowly losing pricing power — FY25 booked a $9B+ non-cash brand impairment and revenue has fallen three years running — so the whole question is whether ~13% FCF yield and a 6% dividend compensate you for a… |
| LEN Lennar Corporation | Hold | 6 | 3 | 2 | — | -14.2% | $92 ($55–$118) | — | Lennar is a well-run, newly asset-light #2 US homebuilder trading around book value in the deepest margin trough in years (gross margin on home sales ~15.6%, down from ~21% at the peak) — the balance sheet and cheapness cap the downside, but with earnings *falling* and mortgage rates still gating… |
| MO Altria Group, Inc. | Hold | 6 | 3 | 1 | — | +26.1% | $70 ($52–$84) | — | Altria is a cash machine in structural decline: FY25 revenue slipped to $20.1B on falling cigarette volumes, but Marlboro's pricing power still throws off ~$9B of free cash flow that funds a ~6% dividend — you are buying a high-yield, low-growth bond-proxy near fair value, not a stock that will… |
| MOS The Mosaic Company | Hold | 6 | 3 | 2 | — | -12.3% | $22 ($13–$34) | — | Mosaic is a cheap, well-financed, but deeply cyclical phosphate-and-potash miner trading below book value at a cyclical earnings trough — the balance sheet and the 4.2% dividend limit the downside, but there is no secular growth engine here, earnings are hostage to fertilizer prices and sulfur… |
| NKE NIKE, Inc. | Hold | 6 | 3 | 2 | — | -30.8% | $46 ($30–$68) | — | NIKE is a genuinely iconic, cash-generative, cheaply-priced global brand in the middle of a real operational stumble — FY26 revenue was flat ($46.4B), EPS fell to $2.10 (from $3.83 two years ago, and FY26's number was *flattered* by a one-time $0.52 tariff-recovery benefit), and the stock is down… |
| SJM The J. M. Smucker Company | Hold | 6 | 3 | 1 | — | +18.9% | $118 ($88–$140) | — | Smucker is a cheap, 3.8%-yielding consumer-staples name whose adjusted earnings power is real (~$9–10 of adj EPS, $1.0–1.2B free cash flow) but whose *growth is gone* — management itself guides FY27 sales down 3–4%, GAAP results have been buried under back-to-back goodwill impairments from the 2023… |
| SWKS Skyworks Solutions, Inc. | Hold | 6 | 3 | 3 | — | -1.3% | $66 ($42–$92) | — | Skyworks is a cheap, cash-generative, 4.5%-yielding RF-chip supplier whose revenue has fallen three years running as its smartphone franchise matured and concentrated on one customer — the stock screens as value, but the growth is gone, the chart is broken, and the entire forward story now hinges… |
| T AT&T Inc. | Hold | 6 | 3 | 2 | — | -17.2% | $24 ($15–$31) | — | AT&T is a cheap, high-yield, low-beta telecom that has finished shedding its media misadventure and is now a focused connectivity company converging fiber + 5G — but it is a no-growth utility with a heavy debt load, so the appeal is income and a modest re-rating, not compounding. With zero expert… |
| ALB Albemarle Corporation | Hold | 7 | 3 | 5 | — | -4.2% | $145 ($70–$210) | — | Albemarle is the world's largest lithium producer emerging from a brutal price crash — Q1'26 adjusted EBITDA jumped 148% as lithium and bromine pricing recovered — but with zero expert coverage in our KB, an earnings model that lives or dies on the lithium spot price (management's own outlook… |
| ARE Alexandria Real Estate Equities, | Hold | 7 | 3 | 2 | — | +7.4% | $55 ($34–$74) | — | Alexandria is the pioneer and largest owner of life-science lab campuses, trading at a fire-sale ~6× FFO and 0.63× book with a covered 6.6% dividend — but FFO/share is *falling*, the sector is in a genuine lab-space glut, the tape is broken (−29% over 12 months), and the only real bull tell is the… |
| BXP BXP, Inc. | Hold | 7 | 3 | 2 | — | +2.7% | $70 ($48–$88) | — | BXP owns the best Class-A office towers in five US gateway cities and trades at a cheap ~9.9× forward FFO with a covered 4% yield — but revenue has flatlined (~1%/yr), FFO is flat-to-down, and the balance sheet carries 8.2× net-debt/EBITDA into a structurally challenged office market; it is a… |
| F Ford Motor Company | Hold | 7 | 3 | 2 | — | +1.8% | $14 ($8–$20) | — | Ford is *statistically* cheap — ~7–8× forward earnings, 0.28× sales, a ~4.5% dividend, and $12.5B of FY25 free cash flow — but it is a mature, deeply cyclical, thin-margin manufacturer that just posted an FY25 net loss of $8.2B (a big Q4 charge), still loses ~$4B/yr in its EV segment, and carries a… |
| PSKY Paramount Skydance Corporation | Hold | 8 | 3 | 3 | — | -22.5% | $10 ($5–$15) | — | Paramount Skydance is a levered media turnaround — flat ~$29–30B revenue, a secular linear-TV decline being partly offset by a streaming (Paramount+/Pluto) ramp and a real $3B+ cost-out program — but the stock is dominated by one binary: the pending, debt-heavy Warner Bros. Discovery acquisition.… |
| AFL Aflac Incorporated | Avoid | 4 | 4 | 2 | — | +9.6% | $114 ($88–$128) | — | Aflac is a superbly-run, cash-generative supplemental-insurance compounder that has shrunk its share count ~26% in five years and carries almost no leverage — but reported revenue is *falling* (yen translation + a maturing Japan book), forward EPS growth is only ~4–5%, and at a fresh 52-week high… |
| DD DuPont de Nemours, Inc. | Avoid | 5 | 4 | 2 | — | +16.0% | $141 ($105–$174) | — | This is a brand-new, much smaller DuPont: after spinning off its Electronics business (Qnity) in November 2025 and selling Aramids in April 2026, the "RemainCo" is a ~$7B-revenue specialty-materials company in healthcare, water, construction and industrial — growing organic sales ~2–4% with rising… |
| KMB Kimberly-Clark Corporation | Avoid | 5 | 4 | 2 | — | +13.7% | $113 ($88–$140) | — | Kimberly-Clark is a low-beta, 50+-year dividend-raiser throwing off ~$1.6B of free cash flow and a 4.4% yield, but it sits in structurally low-growth tissue/personal-care categories, carries a levered balance sheet (net-debt/EBITDA ~2.1×), just slimmed to a smaller "continuing operations" base… |
| PCAR PACCAR Inc | Avoid | 5 | 4 | 2 | $120 | +9.1% | $118 ($88–$150) | — | PACCAR is a genuinely well-run, financially fortress-like heavy-truck manufacturer (Kenworth, Peterbilt, DAF) caught in the down-leg of a normal industry cycle — FY25 revenue fell 16% and EPS fell 43% off the FY23 peak — so the stock looks cheap on a *trailing* multiple but sits near mid-cycle fair… |
| CCI Crown Castle Inc. | Avoid | 7 | 4 | 3 | — | -13.8% | $82 ($58–$100) | — | Crown Castle just finished reinventing itself — on May 1, 2026 it sold its fiber and small-cells businesses for $8.5B cash and is now a pure-play US tower REIT — a simpler, cash-generative business, but one carrying ~$29B of net debt (~9–10× EBITDA), a dividend that was reset lower, flat organic… |
| EL The Estée Lauder Companies Inc. | Avoid | 7 | 4 | 3 | — | -20.1% | $77 ($41–$109) | — | Estée Lauder is a real, credible self-help turnaround — management's "Beauty Reimagined" plan is restoring organic sales growth and expanding margins for the first time in four years — but after a −77% peak-to-trough collapse the stock has already re-rated to price *in* that recovery (34× FY26E… |
| ADM Archer-Daniels-Midland Company | Avoid | 5 | 3 | 2 | — | +33.6% | $78 ($55–$96) | — | ADM is a low-multiple, dividend-paying global grain merchant whose earnings just bottomed (FY25 EPS $2.23 vs $7.72 in 2022): it screens cheap on free cash flow and management is guiding FY26 adjusted EPS *up* on U.S. biofuels-policy clarity, but revenue is shrinking, returns on capital are sub-5%… |
| GIS General Mills, Inc. | Avoid | 6 | 3 | 1 | — | -19.2% | $37 ($28–$48) | — | GIS is a cheap, 6.5%-yielding, low-beta packaged-food defensive whose core North American Retail business is in volume decline (FY26 organic sales −2%, GAAP loss driven by a $1.8B goodwill/brand impairment and a $1.0B Brazil-divestiture writedown) — the numbers say "value, not growth," and with… |
| IFF International Flavors & Frag | Avoid | 6 | 3 | 2 | — | +24.4% | $84 ($58–$104) | — | IFF is a post-merger deleveraging story: a mature, defensive flavors/fragrances/enzymes business that over-levered on the 2021 DuPont N&B deal, took ~$5B+ of impairments since, and is now selling assets (Food Ingredients) to fix the balance sheet — the stock has already re-rated to roughly fair… |
| STZ Constellation Brands, Inc. | Avoid | 6 | 3 | 2 | — | -0.4% | $160 ($113–$200) | — | Constellation is a cheap, cash-generative beer company (Modelo, Corona, Pacifico) trading at 13× earnings with a ~3% dividend — but revenue *fell 10% in FY26*, beer depletions have turned negative, management itself guides to roughly flat organic sales, and 100% of the beer it sells is brewed in… |
| LYB LyondellBasell Industries N.V. | Avoid | 8 | 3 | 2 | — | +23.2% | $55 ($34–$78) | — | LyondellBasell is a well-run commodity-chemicals major caught in the worst petrochemical down-cycle in a decade — it lost money on a TTM basis, shut its Houston refinery, and is paying a 7.7% dividend it did not earn in cash last year; the stock is genuinely cheap on normalized mid-cycle earnings… |
| MRNA Moderna, Inc. | Avoid | 8 | 3 | 5 | — | +170.5% | $42 ($18–$85) | — | Moderna is a cash-rich but deeply loss-making mRNA platform whose COVID franchise has collapsed (FY25 revenue $1.94B, −39% YoY; net loss −$2.8B), and the stock has tripled in a year on pipeline hope into a 52-week high with an RSI of 86 — yet the Street's own price target is ~44% below spot. The… |
| WBD Warner Bros. Discovery, Inc. | Avoid | 8 | 3 | 3 | $26 | -8.1% | $28 ($16–$38) | — | WBD is a heavily indebted, restructuring media conglomerate whose revenue is *declining* (FY25 $37.3B, −5%) and whose GAAP earnings are consensus-negative through 2030 — but it trades at a genuinely cheap ~7.5× EV/EBITDA and generates ~$3B of free cash flow, so the entire bull case is the 2026… |
| VTRS Viatris Inc. | Avoid | 6 | 2 | 1 | — | +34.1% | $19 ($13–$26) | — | Viatris is a cheap, cash-generative, dividend-paying generics-and-brands business trading at ~7× forward *adjusted* earnings with a ~10% free-cash-flow yield — the value is real, but so is the ~$13.4B net debt and a top line that management itself guides to be roughly *flat*; you are paid to wait… |
| DOW Dow Inc. | Avoid | 7 | 2 | 2 | — | +18.5% | $29 ($14–$46) | — | Dow is a blue-chip commodity-chemical maker caught in a deep industry down-cycle — FY25 swung to a $2.62B net loss on falling volumes and prices, free cash flow is negative (−$1.45B), leverage is stretched on trough earnings, and the dividend has already been cut roughly in half; the stock is… |
| SATS EchoStar Corporation | Avoid | 8 | 2 | 5 | — | -6.6% | $105 ($35–$210) | — | EchoStar is not a growth compounder — it is a highly leveraged bet on the value of its wireless spectrum and the DISH/Boost wireless build, wrapped around a shrinking legacy satellite/broadband business (Hughes) and a ~$29B net-debt load roughly equal to its entire market cap; the equity is… |